id.exposure	id.outcome	exposure	outcome	method	nsnp	egger_intercept	egger_intercept_se	egger_intercept_pval	Q	Q_df	Q_pval	exposure_name	exposure_cat
ieu-a-974	ieu-a-1126	Body mass index	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	36	0.016404706446996608	0.0061346760672075585	0.011432685089128168	150.2678824254173	35	3.119477071807039e-16	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1126	Body mass index	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	36	0.016404706446996608	0.0061346760672075585	0.011432685089128168	124.15578790022977	34	3.409117133658707e-12	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-95	ieu-a-1126	Body mass index	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.033413078225803534	0.026215109232065093	0.23438286686330365	95.39110613954361	10	4.538984233154986e-16	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1126	Body mass index	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.033413078225803534	0.026215109232065093	0.23438286686330365	80.80539866041957	9	1.1179457873452908e-13	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-b-19953	ieu-a-1126	Body mass index (BMI)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	415	0.005292460768236643	0.001608473736130327	0.0010864560337807193	1168.1224364102245	414	4.7419010441988147e-73	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1126	Body mass index (BMI)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	415	0.005292460768236643	0.001608473736130327	0.0010864560337807193	1138.283205621304	413	4.2229184901725474e-69	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-248	ieu-a-1126	Body mass index (BMI)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	289	0.0065749882766165295	0.001988029297975015	0.0010619885043836811	775.8900860613039	288	2.110937513428912e-46	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1126	Body mass index (BMI)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	289	0.0065749882766165295	0.001988029297975015	0.0010619885043836811	747.4049386479379	287	9.716665805990016e-43	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-34	ieu-a-1126	Comparative body size at age 10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	144	0.009722161375809172	0.0021916460605441055	1.82397678431607e-5	415.14867433783127	143	2.4417978520896154e-28	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1126	Comparative body size at age 10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	144	0.009722161375809172	0.0021916460605441055	1.82397678431607e-5	364.62009699548526	142	1.6223466499089555e-21	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-4650	ieu-a-1126	Comparative body size at age 10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	204	0.004812529488839059	0.0020247249959719125	0.018393718987323483	691.7319904928067	203	1.3467831308270294e-54	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1126	Comparative body size at age 10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	204	0.004812529488839059	0.0020247249959719125	0.018393718987323483	672.911906309978	202	5.678913128028697e-52	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-a-35	ieu-a-1126	Comparative height size at age 10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	342	-0.002214541116982584	0.002000134985268629	0.2689919653142802	1329.4668144688774	341	1.3520800955357083e-116	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1126	Comparative height size at age 10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	342	-0.002214541116982584	0.002000134985268629	0.2689919653142802	1324.6905934115932	340	4.0519705497619493e-116	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ieu-a-85	ieu-a-1126	Extreme body mass index	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.01312334665433615	0.028992718261941955	0.6697691724237826	25.17659562589041	6	3.166777757799637e-4	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1126	Extreme body mass index	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.01312334665433615	0.028992718261941955	0.6697691724237826	24.185542007615396	5	1.9999308405815666e-4	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-1034	ieu-a-1126	Height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.2931863772569295	0.2747835631176409	0.3977221933387066	37.481444624202226	3	3.6392438798597254e-8	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1126	Height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.2931863772569295	0.2747835631176409	0.3977221933387066	23.88547950955482	2	6.506299121108908e-6	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-51	ieu-a-1126	Hip circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.02697685451628981	0.011000418433222194	0.027917416775278873	67.38128703181768	15	1.3019862594467221e-8	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1126	Hip circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.02697685451628981	0.011000418433222194	0.027917416775278873	47.13388156634689	14	1.827068249661389e-5	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ukb-a-388	ieu-a-1126	Hip circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	261	0.0058806753842391615	0.002578815930854001	0.023398215481848044	1013.4053674628938	260	1.9295117243347047e-89	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1126	Hip circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	261	0.0058806753842391615	0.002578815930854001	0.023398215481848044	993.4589957853075	259	1.6334002463504042e-86	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ieu-a-101	ieu-a-1126	Hip circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.10775111113888165	0.09120718604396881	0.32257137262655666	39.565983072169125	4	5.3218668074261326e-8	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1126	Hip circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.10775111113888165	0.09120718604396881	0.32257137262655666	27.003327958704816	3	5.877905264528929e-6	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ukb-a-269	ieu-a-1126	Impedance of whole body	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	333	-0.0035469623474313353	0.00227501031786886	0.11992893941755807	1364.1762954907706	332	5.524094535258912e-125	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1126	Impedance of whole body	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	333	-0.0035469623474313353	0.00227501031786886	0.11992893941755807	1354.231148187806	331	1.1798660603415331e-123	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ieu-a-90	ieu-a-1126	Obesity class 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.016095638302375218	0.012518505454026243	0.21939170953125706	102.68121258267615	15	4.039946260743461e-15	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1126	Obesity class 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.016095638302375218	0.012518505454026243	0.21939170953125706	91.83693138157007	14	1.704993980716442e-13	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-91	ieu-a-1126	Obesity class 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.02333934794470408	0.01349304663005001	0.12193157672670409	42.30098393968041	9	2.895266485547289e-6	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1126	Obesity class 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.02333934794470408	0.01349304663005001	0.12193157672670409	30.786823251329075	8	1.533201290836637e-4	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-93	ieu-a-1126	Overweight	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.024419119460700422	0.015090496759784274	0.13159069620957334	79.4628994340386	13	1.3920992557219245e-11	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1126	Overweight	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.024419119460700422	0.015090496759784274	0.13159069620957334	65.22930918996042	12	2.4726708723251777e-9	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ukb-b-16881	ieu-a-1126	Sitting height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	550	-9.8263387866223e-4	0.001368504833101954	0.47304192115016763	1821.4534844142195	549	4.762737539311181e-136	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1126	Sitting height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	550	-9.8263387866223e-4	0.001368504833101954	0.47304192115016763	1819.7414207198967	548	4.7528029286002635e-136	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-195	ieu-a-1126	Sitting height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	406	-2.4096204430159836e-4	0.0018239791909467479	0.8949647225538175	1495.2517437344684	405	1.3842300146150953e-124	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1126	Sitting height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	406	-2.4096204430159836e-4	0.0018239791909467479	0.8949647225538175	1495.187152778678	404	7.355946378830543e-125	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-b-10787	ieu-a-1126	Standing height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	710	-0.0011968638637656303	0.0010290738233120979	0.2452012359906737	2175.680762491166	709	1.4033056863618333e-148	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1126	Standing height	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	710	-0.0011968638637656303	0.0010290738233120979	0.2452012359906737	2171.531896546204	708	3.247974900836979e-148	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ieu-a-68	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	24	0.016779394142308245	0.010754445709536913	0.132976617950408	102.1043589514326	23	6.086049602042404e-12	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	24	0.016779394142308245	0.010754445709536913	0.132976617950408	91.93202448345598	22	1.6041017278354703e-10	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ukb-b-9405	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	344	0.00629905750467817	0.0018615059140649787	7.977230517880171e-4	1011.326053538487	343	4.0055488231231905e-67	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	344	0.00629905750467817	0.0018615059140649787	7.977230517880171e-4	978.5629548321743	342	1.1392846982647745e-62	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ieu-a-62	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	17	0.02272943021679632	0.010550075193970198	0.04787081886534515	62.70234280916967	16	1.8230556039798008e-7	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	17	0.02272943021679632	0.010550075193970198	0.04787081886534515	47.88489859499879	15	2.654054515108431e-5	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-105	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.011831861321589705	0.02882421358414097	0.7090079330737165	12.751788753017905	4	0.012554486211297497	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1126	Waist circumference	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.011831861321589705	0.02882421358414097	0.7090079330737165	12.07366482690659	3	0.0071350291216049876	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-75	ieu-a-1126	Waist-to-hip ratio	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	0.005361003973297504	0.022215136672957856	0.8120330849589961	141.14264740537317	19	1.1035806124491238e-20	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1126	Waist-to-hip ratio	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	0.005361003973297504	0.022215136672957856	0.8120330849589961	140.68747365855313	18	4.720156370061051e-21	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-109	ieu-a-1126	Waist-to-hip ratio	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.19407204320131416	0.11101224340690091	0.22253787070743905	15.170083799819789	3	0.0016769207920961414	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1126	Waist-to-hip ratio	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.19407204320131416	0.11101224340690091	0.22253787070743905	6.000566658355603	2	0.0497729642368684	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-a-266	ieu-a-1126	Whole body fat-free mass	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	375	0.002299391612986501	0.0018385660838747203	0.2118483443329868	1311.009755303861	374	2.8898015625324416e-104	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1126	Whole body fat-free mass	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	375	0.002299391612986501	0.0018385660838747203	0.2118483443329868	1305.5352212932416	373	1.095338022712886e-103	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-2346	ieu-a-1126	Duration of moderate activity	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.013146100013755765	0.0242798408395029	0.6169509414037395	16.4287741155929	5	0.005720783584267417	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1126	Duration of moderate activity	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.013146100013755765	0.0242798408395029	0.6169509414037395	15.30693533444705	4	0.004105172396579081	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-a-508	ieu-a-1126	Number of days/week of moderate physical activity 10+ minutes	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	-0.028680542321566704	0.03913572112195138	0.4965472062181603	23.71020227856798	6	5.90386096512589e-4	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1126	Number of days/week of moderate physical activity 10+ minutes	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	-0.028680542321566704	0.03913572112195138	0.4965472062181603	21.410436753420868	5	6.774436269465741e-4	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-b-969	ieu-a-1126	Time spend outdoors in summer	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	44	-0.017279957687177737	0.008838488662140303	0.05724982273536598	97.33254653736614	43	4.320713568847406e-6	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1126	Time spend outdoors in summer	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	44	-0.017279957687177737	0.008838488662140303	0.05724982273536598	89.21340425060531	42	2.987390756265244e-5	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-8865	ieu-a-1126	Time spent doing light physical activity	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.005162882674498645	0.03326909458040947	0.9019876178633466	0.39142301053276857	2	0.8222494150898638	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1126	Time spent doing light physical activity	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.005162882674498645	0.03326909458040947	0.9019876178633466	0.3673404562193538	1	0.5444575282887191	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-a-487	ieu-a-1126	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01502147385099878	0.10736672715565933	0.9115061603322547	2.6213801862809842	2	0.2696339196478382	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1126	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01502147385099878	0.10736672715565933	0.9115061603322547	2.5710536772028942	1	0.10883521755590894	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-7663	ieu-a-1126	Types of physical activity in last 4 weeks: Strenuous sports	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.02234080440765923	0.022803154424707744	0.3826943162037613	12.505915791534184	5	0.028476082694096762	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1126	Types of physical activity in last 4 weeks: Strenuous sports	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.02234080440765923	0.022803154424707744	0.3826943162037613	10.085701257110612	4	0.03900853660193039	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-a-482	ieu-a-1126	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.22536514662136173	0.1351648158181653	0.1707744900095236	17.747008320494537	5	0.0032807709207948476	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1126	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.22536514662136173	0.1351648158181653	0.1707744900095236	10.470197617000228	4	0.03320999540020153	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-16886	ieu-a-1126	Types of transport used (excluding work): Car/motor vehicle	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.0522061255696797	0.05425418832684962	0.4069078873173573	17.694348822252177	4	0.0014159000690448465	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1126	Types of transport used (excluding work): Car/motor vehicle	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.0522061255696797	0.05425418832684962	0.4069078873173573	13.521152305528961	3	0.0036350056131441736	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1126	Types of transport used (excluding work): Cycle	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.016685377573840535	0.01892118812593245	0.4117963431259592	11.754694133114958	7	0.10891998314699367	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1126	Types of transport used (excluding work): Cycle	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.016685377573840535	0.01892118812593245	0.4117963431259592	10.406015469810084	6	0.1085625291282557	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1126	Types of transport used (excluding work): Public transport	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.0049778556861929555	0.01937754911282829	0.8046523981848231	20.979519625385787	8	0.007202033269292214	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1126	Types of transport used (excluding work): Public transport	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.0049778556861929555	0.01937754911282829	0.8046523981848231	20.78358583042763	7	0.004104011538601315	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1126	Types of transport used (excluding work): Walk	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.08951642081215297	0.057282095666263445	0.1788775604779571	23.55947491309949	6	6.29201747486893e-4	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1126	Types of transport used (excluding work): Walk	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.08951642081215297	0.057282095666263445	0.1788775604779571	15.82846275543014	5	0.0073512734123638325	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-4711	ieu-a-1126	Usual walking pace	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	-4.849110605469014e-4	0.008996770081036548	0.9572267331291955	246.84265208080876	52	3.891505017632883e-27	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1126	Usual walking pace	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	-4.849110605469014e-4	0.008996770081036548	0.9572267331291955	246.82859237520546	51	1.76136103704498e-27	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-1004	ieu-a-1126	Added milk to espresso	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0923559077991458	0.05016048554995036	0.3167482146241619	3.420669014087975	2	0.18080530185333263	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1126	Added milk to espresso	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0923559077991458	0.05016048554995036	0.3167482146241619	0.03062060834462179	1	0.861089493341002	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-d-1468_5	ieu-a-1126	Cereal type: Other (e.g. Cornflakes, Frosties)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.047736972133546156	0.0404555028325289	0.2719008151552172	107.3068385735229	9	5.191344822200508e-19	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1126	Cereal type: Other (e.g. Cornflakes, Frosties)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.047736972133546156	0.0404555028325289	0.2719008151552172	91.399161829987	8	2.4172268438427707e-16	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-b-2221	ieu-a-1126	Cherry intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.07879409977421217	0.06914585221154781	0.4585400769448947	3.475041950079238	2	0.17595605985312845	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1126	Cherry intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.07879409977421217	0.06914585221154781	0.4585400769448947	1.5118478985071884	1	0.21885732985736414	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1126	Dairy smoothie intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.012086112481355821	0.06843685808668944	0.8887188547695599	0.6391513843633593	2	0.7264572131635256	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1126	Dairy smoothie intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.012086112481355821	0.06843685808668944	0.8887188547695599	0.607962981349432	1	0.4355558161307816	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-16576	ieu-a-1126	Dried fruit intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	40	0.0010673088469119304	0.008476346668627316	0.9004621630286249	108.01345184415113	39	2.132457739653587e-8	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1126	Dried fruit intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	40	0.0010673088469119304	0.008476346668627316	0.9004621630286249	107.96840380599537	38	1.2589588314979306e-8	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-3881	ieu-a-1126	Fresh fruit intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	0.0053216803209208295	0.005347399045483454	0.3243421615971629	136.55993762033177	52	1.6057996012577445e-9	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1126	Fresh fruit intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	0.0053216803209208295	0.005347399045483454	0.3243421615971629	133.9585055241242	51	2.2366678852962856e-9	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-d-1418_1	ieu-a-1126	Milk type used: Full cream	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.016336240810439395	0.16783365307598372	0.9382286264863795	39.54436229217386	2	2.5885158766125675e-9	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1126	Milk type used: Full cream	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.016336240810439395	0.16783365307598372	0.9382286264863795	39.17322424617682	1	3.8782251509138226e-10	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1126	Milk type used: Skimmed	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.07928771836816408	0.0368233583836708	0.2767936522465879	25.99118104397983	2	2.270318286484054e-6	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1126	Milk type used: Skimmed	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.07928771836816408	0.0368233583836708	0.2767936522465879	4.611447220947778	1	0.03175921970475376	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-b-14238	ieu-a-1126	Mineral and other dietary supplements: None of the above	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.02684696871546527	0.027772788815887493	0.3781087279821741	11.427574775169301	6	0.07602710608650143	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1126	Mineral and other dietary supplements: None of the above	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.02684696871546527	0.027772788815887493	0.3781087279821741	9.628182543857088	5	0.08648267716057859	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1126	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	-0.03304369370683011	0.013672531699983174	0.026496559640105364	55.83293177807858	19	1.731335205972613e-5	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1126	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	-0.03304369370683011	0.013672531699983174	0.026496559640105364	42.154156940425054	18	0.0010523557651126992	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1126	Never eat eggs, dairy, wheat, sugar: Wheat products	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.03938644358373824	0.042858488115263195	0.425874346904016	11.022737546557261	4	0.026309660650623307	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1126	Never eat eggs, dairy, wheat, sugar: Wheat products	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.03938644358373824	0.042858488115263195	0.425874346904016	8.601346071545354	3	0.03508875416274274	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-6500	ieu-a-1126	Pancake intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.01165053034800771	0.08534847340072124	0.9039226148379924	2.006581255565554	3	0.5710418645400204	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1126	Pancake intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.01165053034800771	0.08534847340072124	0.9039226148379924	1.9879475222293028	2	0.37010306387641856	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-8006	ieu-a-1126	Poultry intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.09783023783998104	0.2146838890238877	0.6677170237503062	42.434886692680365	6	1.5087543540947534e-7	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1126	Poultry intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.09783023783998104	0.2146838890238877	0.6677170237503062	40.742779169212525	5	1.0575042545209886e-7	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-4643	ieu-a-1126	Age at hysterectomy	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.004471848352871621	0.06088850411980197	0.9481376827773954	8.720158462413604	3	0.03325247201979938	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1126	Age at hysterectomy	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.004471848352871621	0.06088850411980197	0.9481376827773954	8.69670385265333	2	0.012928101496532812	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-a-320	ieu-a-1126	Age at last live birth	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.04416489834198837	0.0269640999510633	0.24309716801722348	3.194620013720388	3	0.36258091114210905	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1126	Age at last live birth	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.04416489834198837	0.0269640999510633	0.24309716801722348	0.5118551261002332	2	0.7741980473062982	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-b-17422	ieu-a-1126	Age at menopause (last menstrual period)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	102	-0.0014597626356168257	0.003231082116366823	0.6524004299063844	395.37347016091826	101	1.942373380958237e-36	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1126	Age at menopause (last menstrual period)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	102	-0.0014597626356168257	0.003231082116366823	0.6524004299063844	394.5681093811056	100	1.315448019054258e-36	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-4564	ieu-a-1126	Age last used hormone-replacement therapy (HRT)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.03340855676007755	0.029052235593804262	0.36911021299341873	24.725127315919018	3	1.762469229384047e-5	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1126	Age last used hormone-replacement therapy (HRT)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.03340855676007755	0.029052235593804262	0.36911021299341873	14.883984586582873	2	5.861163179488797e-4	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-9487	ieu-a-1126	Age started hormone-replacement therapy (HRT)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	22	-0.031392001656954195	0.009564276999749245	0.0037253234018864985	114.0063034221007	21	8.871261230207432e-15	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1126	Age started hormone-replacement therapy (HRT)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	22	-0.031392001656954195	0.009564276999749245	0.0037253234018864985	74.09519581447225	20	3.853317800309436e-8	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-18541	ieu-a-1126	Ever used hormone-replacement therapy (HRT)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	-0.009732460897935884	0.02085333053432204	0.6649933237017882	40.27642890322059	5	1.3134387935587065e-7	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1126	Ever used hormone-replacement therapy (HRT)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	-0.009732460897935884	0.02085333053432204	0.6649933237017882	38.19645653667627	4	1.0207105964714454e-7	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18105	ieu-a-1126	Had menopause	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.02701121449981147	0.016944600415387787	0.15494500549502263	74.87700539899988	8	5.220464859703335e-13	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1126	Had menopause	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.02701121449981147	0.016944600415387787	0.15494500549502263	54.934736582739184	7	1.5359631389891535e-9	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-a-316	ieu-a-1126	Had menopause	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.0256040049169651	0.01951400604085699	0.24649762683951534	55.94745766522314	6	2.9830446092740534e-10	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1126	Had menopause	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.0256040049169651	0.01951400604085699	0.24649762683951534	41.617892461000224	5	7.03789384052723e-8	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-b-1209	ieu-a-1126	Number of live births	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.041026805838476225	0.05254458232177332	0.4573998803711611	53.465441504801355	9	2.385119292963577e-8	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1126	Number of live births	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.041026805838476225	0.05254458232177332	0.4573998803711611	49.679557887378	8	4.709049630578445e-8	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-a-317	ieu-a-1126	Number of live births	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.004018229332849638	0.02868384241921103	0.9113945420696297	1.0276745125932776	2	0.5981957387312866	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1126	Number of live births	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.004018229332849638	0.02868384241921103	0.9113945420696297	1.00789524617612	1	0.3154076014023032	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-26	ieu-a-1126	Average weekly red wine intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.016225142378138536	0.01624194317571282	0.3392796220885096	104.42862513947517	12	7.519068980457893e-17	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1126	Average weekly red wine intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.016225142378138536	0.01624194317571282	0.3392796220885096	95.74273735128968	11	1.2390738475805448e-15	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-b-1707	ieu-a-1126	Average weekly spirits intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.10216125212818068	0.11113512658645565	0.5267682870817959	52.564484192743556	2	3.852718563704859e-12	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1126	Average weekly spirits intake	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.10216125212818068	0.11113512658645565	0.5267682870817959	28.489844498152454	1	9.419124696888771e-8	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-d-20406	ieu-a-1126	Ever addicted to alcohol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	2.3880248583368674e-4	1	0.987670592738482	Ever addicted to alcohol (M/F) Neale lab/2018 [  6K]	Alcohol
ukb-b-223	ieu-a-1126	Current tobacco smoking	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	34	-0.001785846822640383	0.0052896348106397225	0.7378599542852573	43.150043865981495	33	0.11112949044057312	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1126	Current tobacco smoking	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	34	-0.001785846822640383	0.0052896348106397225	0.7378599542852573	42.99689135901817	32	0.09274786197559814	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-17685	ieu-a-1126	Maternal smoking around birth	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.011705856924656234	0.014120531951903154	0.4210166795649566	30.369257593234355	15	0.010657478545511113	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1126	Maternal smoking around birth	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.011705856924656234	0.014120531951903154	0.4210166795649566	28.948243176420196	14	0.010620119788000464	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-4801	ieu-a-1126	Number of unsuccessful stop-smoking attempts	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.09925395822751659	0.06966978533208354	0.389626044494679	28.48508330773614	2	6.524432635994983e-7	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1126	Number of unsuccessful stop-smoking attempts	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.09925395822751659	0.06966978533208354	0.389626044494679	9.402312888562228	1	0.0021671189128837707	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-a-225	ieu-a-1126	Smoking status: Current	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	-0.015267018287022075	0.011373487720944672	0.20246033533834676	28.253127132807194	14	0.013166278785386062	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1126	Smoking status: Current	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	-0.015267018287022075	0.011373487720944672	0.20246033533834676	24.813816937852344	13	0.024418360387956164	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-d-22506_114	ieu-a-1126	Tobacco smoking: Never smoked	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.12818043173497987	0.07325401766164318	0.33052884480020567	3.3103782966250295	2	0.19105591438373573	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1126	Tobacco smoking: Never smoked	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.12818043173497987	0.07325401766164318	0.33052884480020567	0.24855190324822646	1	0.6180965775490278	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
met-a-558	ieu-a-1126	1-arachidonoylglycerophosphocholine*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.001439012754677946	0.007897150589349398	0.8852545739441402	0.4551847863695956	2	0.7964488316538593	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1126	1-arachidonoylglycerophosphocholine*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.001439012754677946	0.007897150589349398	0.8852545739441402	0.4219809360453816	1	0.5159502471452627	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-682	ieu-a-1126	1-arachidonoylglycerophosphoethanolamine*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.604936148746351	1	0.43670083538854243	1-arachidonoylglycerophosphoethanolamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1126	1-arachidonoylglycerophosphoinositol*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.019400123713016304	0.08519454716015473	0.8574623353644979	6.542818354459406	2	0.03795290700204839	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1126	1-arachidonoylglycerophosphoinositol*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.019400123713016304	0.08519454716015473	0.8574623353644979	6.220270136389158	1	0.012629584165267903	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-427	ieu-a-1126	2-hydroxyisobutyrate	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.047647742398096486	1	0.8272081296109414	2-hydroxyisobutyrate (M/F) Shin/2014 [  6K]	Metabolites
met-a-500	ieu-a-1126	3-dehydrocarnitine*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.00304152862013819	0.02318938387927648	0.9169746345641108	0.8463758935932011	2	0.6549555247504649	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1126	3-dehydrocarnitine*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.00304152862013819	0.02318938387927648	0.9169746345641108	0.8291728458390099	1	0.36251181833137813	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-841	ieu-a-1126	Albumin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.053976298750608345	0.04345498091748639	0.4315186687884122	2.1468974985607625	2	0.3418276045477698	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1126	Albumin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.053976298750608345	0.04345498091748639	0.4315186687884122	0.6040355268790012	1	0.4370424190600281	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-851	ieu-a-1126	Average number of double bonds in a fatty acid chain	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-2.4260190352633622e-4	0.010407706085217946	0.9828668884255474	6.220766943163514	4	0.1832567424188215	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1126	Average number of double bonds in a fatty acid chain	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-2.4260190352633622e-4	0.010407706085217946	0.9828668884255474	6.219640465990316	3	0.10139972605028606	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-a-362	ieu-a-1126	Betaine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.027152141005271403	0.012245932254398698	0.26973255518603967	5.620823718011512	2	0.06018020152958575	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1126	Betaine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.027152141005271403	0.012245932254398698	0.26973255518603967	0.7046813011260877	1	0.40121516582983674	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-c-875	ieu-a-1126	Cholesterol esters in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.0036160342676674504	0.008161328567391974	0.6663028642717806	18.353265708155753	12	0.10537759690759352	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1126	Cholesterol esters in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.0036160342676674504	0.008161328567391974	0.6663028642717806	18.031468871014493	11	0.08085329099984825	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-887	ieu-a-1126	Cholesterol esters in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.0017164075940272916	0.005997785760562073	0.7805860480652702	9.259006785997178	11	0.5979982883089734	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1126	Cholesterol esters in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.0017164075940272916	0.005997785760562073	0.7805860480652702	9.17711148997372	10	0.5153817095246411	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-910	ieu-a-1126	Cholesterol esters in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.0011752887095970819	0.008018291181895296	0.8859003777409595	21.0054336877333	13	0.07282122427955376	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1126	Cholesterol esters in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.0011752887095970819	0.008018291181895296	0.8859003777409595	20.96789327590096	12	0.050852585430871566	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-958	ieu-a-1126	Concentration of chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.0011380608589709696	0.01288442123801386	0.9330443086471899	6.341630012218612	6	0.3860280036683571	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1126	Concentration of chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.0011380608589709696	0.01288442123801386	0.9330443086471899	6.331750058670075	5	0.2752631381889707	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-878	ieu-a-1126	Concentration of large HDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.011972154842451416	0.007268428885647607	0.133933244761588	12.412235484566201	10	0.25841379808145565	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1126	Concentration of large HDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.011972154842451416	0.007268428885647607	0.133933244761588	9.53720645770736	9	0.389231675820405	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-890	ieu-a-1126	Concentration of large VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	-0.0019499478233637915	0.0068451391160539304	0.7829820817674862	9.189945038801458	9	0.41992870441980973	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1126	Concentration of large VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	-0.0019499478233637915	0.0068451391160539304	0.7829820817674862	9.09766213729759	8	0.3341244460124889	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-913	ieu-a-1126	Concentration of medium VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	-0.0032782714988659387	0.00570928035409295	0.5764374476535855	14.685771775552018	13	0.3273779022724219	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1126	Concentration of medium VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	-0.0032782714988659387	0.00570928035409295	0.5764374476535855	14.293062513691954	12	0.28238668526860783	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1126	Concentration of small HDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-8.208301184642523e-4	0.009403737577468603	0.935942791593577	2.310919847652964	4	0.6787816348456246	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1126	Concentration of small HDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-8.208301184642523e-4	0.009403737577468603	0.935942791593577	2.3033007144767144	3	0.5118888726423585	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1126	Concentration of small VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.0029395132579340577	0.008026542299671036	0.7200888631782413	23.61687806110308	14	0.05094358605327148	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1126	Concentration of small VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.0029395132579340577	0.008026542299671036	0.7200888631782413	23.375712464734562	13	0.037382445434048124	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-950	ieu-a-1126	Concentration of very large VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	-0.00552360605213843	0.010339315328770086	0.6123852943368006	7.702366374063004	7	0.3595690374644299	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1126	Concentration of very large VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	-0.00552360605213843	0.010339315328770086	0.6123852943368006	7.352620397897782	6	0.2894640406912668	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-876	ieu-a-1126	Free cholesterol in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.009216317621960608	0.00747401530146867	0.2393661257510758	28.85846511320377	14	0.010920758600915277	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1126	Free cholesterol in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.009216317621960608	0.00747401530146867	0.2393661257510758	25.836451510772232	13	0.017880924669022552	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1126	Free cholesterol in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	-8.692562591436914e-4	0.007204127373367799	0.9066104773289937	9.014018217829328	10	0.5307737141479775	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1126	Free cholesterol in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	-8.692562591436914e-4	0.007204127373367799	0.9066104773289937	8.999459172860277	9	0.43732411366473584	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1126	Free cholesterol in medium HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.0022095402034291774	0.010825833198482075	0.851337599458931	3.408170976422932	4	0.49197778543322057	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1126	Free cholesterol in medium HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.0022095402034291774	0.010825833198482075	0.851337599458931	3.36149511059236	3	0.33917497009204955	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1126	Free cholesterol in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.0021133974574535906	0.007346832635410454	0.7794794964989283	18.653204848049665	11	0.06760980610091798	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1126	Free cholesterol in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.0021133974574535906	0.007346832635410454	0.7794794964989283	18.500118459601968	10	0.047090986367484856	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1126	Free cholesterol in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.001117373092880112	0.00896530654594235	0.9028775768640197	21.682454052240843	13	0.06048148185863226	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1126	Free cholesterol in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.001117373092880112	0.00896530654594235	0.9028775768640197	21.654423509244307	12	0.041580425148916036	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1126	Free cholesterol in very large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-4.302838659918881e-4	0.0066619400630397885	0.949660572805634	13.015506947890177	12	0.36791457891421914	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1126	Free cholesterol in very large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-4.302838659918881e-4	0.0066619400630397885	0.949660572805634	13.010572797144086	11	0.29263493795269124	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-573	ieu-a-1126	Isobutyrylcarnitine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.006843752369244021	0.008679546322582847	0.5749389481055929	1.1181045357144719	2	0.5717506736488314	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1126	Isobutyrylcarnitine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.006843752369244021	0.008679546322582847	0.5749389481055929	0.4963849869977381	1	0.4810928487580703	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1126	Isovalerylcarnitine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.13772780979444357	0.1090872761110499	0.4264552806569455	9.504534723447124	2	0.008632100902651004	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1126	Isovalerylcarnitine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.13772780979444357	0.1090872761110499	0.4264552806569455	3.6640106700300326	1	0.05559964276502486	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-c-896	ieu-a-1126	Mean diameter for LDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.0010328574855565397	0.01248393338904974	0.9367534164496758	18.24280046869166	7	0.010921263547837144	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1126	Mean diameter for LDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.0010328574855565397	0.01248393338904974	0.9367534164496758	18.222011976309737	6	0.005700678912905657	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1126	Mean diameter for VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.0071149193009688305	0.008889931485484434	0.4390747551756522	12.474799993446666	13	0.4891466169323945	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1126	Mean diameter for VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.0071149193009688305	0.008889931485484434	0.4390747551756522	11.834264604043216	12	0.45908030081784823	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-959	ieu-a-1126	Phospholipids in chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	-0.007519210634770254	0.009041427887830399	0.43745101607299053	5.802590718951997	7	0.5629798329404486	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1126	Phospholipids in chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	-0.007519210634770254	0.009041427887830399	0.43745101607299053	5.110966080770069	6	0.5296618146010748	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1126	Phospholipids in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.008260601041811835	0.007492460350268525	0.30669148128498736	6.842495684314011	8	0.5537178034820937	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1126	Phospholipids in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.008260601041811835	0.007492460350268525	0.30669148128498736	5.626941314805972	7	0.5839197709225789	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1126	Phospholipids in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	6.080872683005587e-5	0.0063320652345452986	0.9924836020588215	20.41983699597318	14	0.11745081728827751	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1126	Phospholipids in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	6.080872683005587e-5	0.0063320652345452986	0.9924836020588215	20.41969213650115	13	0.08522812773035217	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1126	Phospholipids in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.004265626126536343	0.008817873394212885	0.6372723577597096	22.334995900360834	13	0.05038369635347569	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1126	Phospholipids in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.004265626126536343	0.008817873394212885	0.6372723577597096	21.907772691531406	12	0.03856655534354049	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1126	Phospholipids in very large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.004610451672991901	0.010033334984913447	0.6597956957293045	8.904304986132084	8	0.350432942014579	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1126	Phospholipids in very large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.004610451672991901	0.010033334984913447	0.6597956957293045	8.643574588217499	7	0.27926857370706065	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-355	ieu-a-1126	Proline	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.004859864047550635	0.007821654313272915	0.6460654179386401	0.9709512266782477	2	0.6154044325914346	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1126	Proline	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.004859864047550635	0.007821654313272915	0.6460654179386401	0.5848946061079563	1	0.4444001614631096	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1126	Pyroglutamine*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.003762989116130404	0.012164734175159769	0.8090142656034043	0.7049148185439227	2	0.7029585086878203	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1126	Pyroglutamine*	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.003762989116130404	0.012164734175159769	0.8090142656034043	0.609226113320804	1	0.4350793410112312	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-844	ieu-a-1126	Ratio of bisallylic groups to double bonds	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.003068508904362909	0.011371545470013506	0.8125749164342442	4.41001807398953	3	0.22045827483524827	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1126	Ratio of bisallylic groups to double bonds	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.003068508904362909	0.011371545470013506	0.8125749164342442	4.255102244885626	2	0.1191286684590346	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1126	Ratio of bisallylic groups to total fatty acids	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.0049664320688735195	0.008130693907013266	0.5743203232562024	8.234073580488108	5	0.14379846658197193	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1126	Ratio of bisallylic groups to total fatty acids	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.0049664320688735195	0.008130693907013266	0.5743203232562024	7.531554080810081	4	0.11032591346396997	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-a-464	ieu-a-1126	Serine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02372550733399316	0.07225173391916934	0.7980136033417522	2.855244379317407	2	0.23987863053453623	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1126	Serine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02372550733399316	0.07225173391916934	0.7980136033417522	2.5773337665968947	1	0.10840411895677028	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-c-864	ieu-a-1126	Total cholesterol in HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.008100283114253825	0.007436660587581545	0.3016018951463199	14.474540344325156	11	0.20783785539909558	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1126	Total cholesterol in HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.008100283114253825	0.007436660587581545	0.3016018951463199	12.939366730375754	10	0.2270816816413637	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1126	Total cholesterol in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.004653364070595117	0.00709651412777502	0.5243739511971315	20.47132776578386	13	0.08406496729969555	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1126	Total cholesterol in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.004653364070595117	0.00709651412777502	0.5243739511971315	19.76318690750835	12	0.07170038266789845	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1126	Total cholesterol in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	2.3913973334868685e-4	0.007880378434712412	0.9765343410567124	8.523010512481838	9	0.4824152992270836	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1126	Total cholesterol in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	2.3913973334868685e-4	0.007880378434712412	0.9765343410567124	8.522029527449112	8	0.3842046221680085	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1126	Total cholesterol in medium HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.009252150713413876	0.011324976793214508	0.45980999152684715	8.253803687181481	5	0.1427915989063831	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1126	Total cholesterol in medium HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.009252150713413876	0.011324976793214508	0.45980999152684715	7.0735201269374635	4	0.1320536567332498	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1126	Total cholesterol in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.0014632674487147577	0.008255760150259157	0.8620500460777623	26.752788688964877	14	0.02072828222968094	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1126	Total cholesterol in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.0014632674487147577	0.008255760150259157	0.8620500460777623	26.688295955944195	13	0.013721973085681407	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1126	Total cholesterol in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.003514755689776049	0.008292034744705088	0.678100083524541	25.363345523827316	15	0.0452715042057788	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1126	Total cholesterol in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.003514755689776049	0.008292034744705088	0.678100083524541	25.041973129463365	14	0.034155277917381384	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1126	Total cholesterol in very large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-9.007750507132223e-4	0.006866786990889818	0.8980024993578002	13.331682152946282	12	0.3454005891987515	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1126	Total cholesterol in very large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-9.007750507132223e-4	0.006866786990889818	0.8980024993578002	13.31085936119315	11	0.27349426588586845	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-957	ieu-a-1126	Total lipids in chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.0062670849821881815	0.008732336581578478	0.496196775579681	6.897366003226428	8	0.5477456140576045	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1126	Total lipids in chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.0062670849821881815	0.008732336581578478	0.496196775579681	6.382291284829685	7	0.49588593176116086	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-877	ieu-a-1126	Total lipids in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.01141314848448183	0.007415228274884191	0.15815139364633718	12.186704212960052	10	0.2727554425349424	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1126	Total lipids in large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.01141314848448183	0.007415228274884191	0.15815139364633718	9.647330904933547	9	0.3797825820081127	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-889	ieu-a-1126	Total lipids in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.0075737808782853225	0.009176455031682873	0.4363938027443617	8.248428925970359	8	0.4095869141165079	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1126	Total lipids in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.0075737808782853225	0.009176455031682873	0.4363938027443617	7.51692330146119	7	0.3771085870181589	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-912	ieu-a-1126	Total lipids in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.005843483924100207	0.005697580154517617	0.32924571600934593	11.64453682434784	11	0.3909463557882376	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1126	Total lipids in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.005843483924100207	0.005697580154517617	0.32924571600934593	10.536257581588151	10	0.39476893079899755	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1126	Total lipids in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.004971862198813786	0.00879782955721525	0.5824010183995656	24.040545646237526	13	0.030759144529189004	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1126	Total lipids in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.004971862198813786	0.00879782955721525	0.5824010183995656	23.41732320625004	12	0.024384831559185156	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1126	Total lipids in very large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.0024294720155723835	0.006400612683468191	0.7114912890211234	10.999227464288456	12	0.5289848942627584	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1126	Total lipids in very large HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.0024294720155723835	0.006400612683468191	0.7114912890211234	10.85515509234918	11	0.455476615886468	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1126	Total lipids in very large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	-0.0044817350825604	0.010067838231553486	0.6718186958279541	6.958143696111809	7	0.4332509165612046	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1126	Total lipids in very large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	-0.0044817350825604	0.010067838231553486	0.6718186958279541	6.7356844859184735	6	0.3459841026108684	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-960	ieu-a-1126	Triglycerides in chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.006447785235799194	0.009010147668968347	0.4973994716906752	7.552734277105054	8	0.47833180074895243	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1126	Triglycerides in chylomicrons and largest VLDL particles	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.006447785235799194	0.009010147668968347	0.4973994716906752	7.037861438798019	7	0.4249484226410902	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1126	Triglycerides in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.006727331925419438	0.008369435782139696	0.44794533565562644	5.444428799107916	8	0.7091887345551282	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1126	Triglycerides in large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.006727331925419438	0.008369435782139696	0.44794533565562644	4.798338307546149	7	0.6845573141491064	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1126	Triglycerides in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.0036175033858675803	0.00576797703838761	0.5433459432420704	9.97400358912002	12	0.6182414028919243	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1126	Triglycerides in medium VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.0036175033858675803	0.00576797703838761	0.5433459432420704	9.580661113453754	11	0.5684537439150267	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1126	Triglycerides in small HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	-0.007166037971781275	0.008092983278626623	0.39894651024796324	11.689766112023198	10	0.3063557184557255	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1126	Triglycerides in small HDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	-0.007166037971781275	0.008092983278626623	0.39894651024796324	10.753006172846582	9	0.29301981599091526	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1126	Triglycerides in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	-0.006858270705144354	0.0058946130563968325	0.26724767814389705	13.235682334154868	13	0.42977622225457435	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1126	Triglycerides in small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	-0.006858270705144354	0.0058946130563968325	0.26724767814389705	11.881994134280827	12	0.4552028564789598	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1126	Triglycerides in very large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.002537383515789786	0.00923738661016799	0.7914875612565383	8.965654714427583	8	0.3452015748958214	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1126	Triglycerides in very large VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.002537383515789786	0.00923738661016799	0.7914875612565383	8.870045054561318	7	0.2621214799287294	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-956	ieu-a-1126	Triglycerides in very small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	19	0.010706061640834347	0.008006049215068773	0.1987609416339473	34.28101968348204	18	0.011625724800605617	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1126	Triglycerides in very small VLDL	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	19	0.010706061640834347	0.008006049215068773	0.1987609416339473	31.018216552565033	17	0.019870619090369093	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-a-316	ieu-a-1126	Uridine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-7.551601492048474e-4	0.019662474894650585	0.9755618903600832	0.35240578503358166	2	0.8384478512836526	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1126	Uridine	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-7.551601492048474e-4	0.019662474894650585	0.9755618903600832	0.3509307519373065	1	0.5535867263030605	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-485	ieu-a-1126	X-02269	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.19958997715663002	1	0.6550520083706324	X-02269 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1126	X-03094	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-5.451071514381995e-4	0.015778020220940856	0.9746099419121879	4.554567253141827	4	0.3361261611361734	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1126	X-03094	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-5.451071514381995e-4	0.015778020220940856	0.9746099419121879	4.552755863623007	3	0.20763258060172227	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1126	X-10510	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01224103750109498	0.010529460766948317	0.45223739129465773	1.375279733627996	2	0.5027612534383014	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1126	X-10510	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01224103750109498	0.010529460766948317	0.45223739129465773	0.02375438555315944	1	0.8775115093514134	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1126	X-11315	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.020948554785859268	0.05221552277621205	0.7571071038322965	7.833240758332439	2	0.019908263560165406	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1126	X-11315	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.020948554785859268	0.05221552277621205	0.7571071038322965	6.747229439916808	1	0.009389337377533039	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1126	X-11440	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.002423650220543541	0.00728731942754062	0.7955963239295577	0.13329863228582084	2	0.9355232167085992	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1126	X-11440	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.002423650220543541	0.00728731942754062	0.7955963239295577	0.022686115794337013	1	0.880276187090202	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-517	ieu-a-1126	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.0002370541979133	1	0.3172531544848242	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate (M/F) Shin/2014 [  2K]	Metabolites
met-a-519	ieu-a-1126	X-11469	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.3454610725744573	1	0.5566938216471882	X-11469 (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1126	X-12510--2-aminooctanoic acid	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.007915047038123168	0.013474761476787188	0.661890132223145	3.972532387454878	2	0.1372067737261196	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1126	X-12510--2-aminooctanoic acid	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.007915047038123168	0.013474761476787188	0.661890132223145	2.953475898093842	1	0.08569306647505276	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
prot-a-54	ieu-a-1126	Advanced glycosylation end product-specific receptor, soluble	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.00678839712016945	0.0184538768924314	0.7374011112145566	9.2555338995579	4	0.05502023675354726	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1126	Advanced glycosylation end product-specific receptor, soluble	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.00678839712016945	0.0184538768924314	0.7374011112145566	8.856068687229865	3	0.03126702239305846	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1126	Alcohol dehydrogenase [NADP(+)]	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.007029589965091411	0.010935037701076478	0.6362784408990501	1.804574282767165	2	0.4056408400223943	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1126	Alcohol dehydrogenase [NADP(+)]	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.007029589965091411	0.010935037701076478	0.6362784408990501	1.2768910794474848	1	0.2584778877003917	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1411	ieu-a-1126	Alpha-L-iduronidase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.04196903544592052	1	0.8376788078178168	Alpha-L-iduronidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1126	Angiopoietin-related protein 4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.022938706222101073	0.02670156592207715	0.5481652962787742	1.25261647089086	2	0.5345616383905617	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1126	Angiopoietin-related protein 4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.022938706222101073	0.02670156592207715	0.5481652962787742	0.5146028524377115	1	0.47315307641473947	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1126	Beta-1,4-galactosyltransferase 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.03340584291755218	0.027045156590532884	0.30467555783112166	24.5756936695211	4	6.122242652407252e-5	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1126	Beta-1,4-galactosyltransferase 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.03340584291755218	0.027045156590532884	0.30467555783112166	16.290798901734878	3	9.88461193136719e-4	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1126	Beta-1,4-glucuronyltransferase 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.006403377918217515	0.025005206721561948	0.8404029547877949	2.900753363196146	2	0.23448194642220363	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1126	Beta-1,4-glucuronyltransferase 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.006403377918217515	0.025005206721561948	0.8404029547877949	2.7222349665447867	1	0.09895936399574773	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1126	Beta-crystallin B2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.1358732383216573	0.050365453350682605	0.2259857935642432	16.528181042722405	2	2.5760310213393057e-4	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1126	Beta-crystallin B2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.1358732383216573	0.050365453350682605	0.2259857935642432	1.9966785937503293	1	0.157644321960267	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1126	C-C motif chemokine 14	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.008589901905192762	0.0114476678743243	0.5901867571111027	0.6761580802704165	2	0.7131389190740259	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1126	C-C motif chemokine 14	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.008589901905192762	0.0114476678743243	0.5901867571111027	0.1131140389493114	1	0.7366263227014052	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1126	C-C motif chemokine 17	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.009237882270466787	0.00850004642691184	0.3382310708419195	3.403993613797221	5	0.6379617580364281	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1126	C-C motif chemokine 17	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.009237882270466787	0.00850004642691184	0.3382310708419195	2.2228512385033947	4	0.6948479384333431	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1126	C-C motif chemokine 23	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.04157074362751854	0.03168567988036606	0.41461166521958415	2.511804469896779	2	0.2848187588262035	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1126	C-C motif chemokine 23	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.04157074362751854	0.03168567988036606	0.41461166521958415	0.7905323823057608	1	0.37393919332939557	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1126	C-C motif chemokine 3-like 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.012963649081678106	0.01475062833000626	0.540991640060769	0.7786941005376845	2	0.6774991029631137	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1126	C-C motif chemokine 3-like 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.012963649081678106	0.01475062833000626	0.540991640060769	0.006309702972372567	1	0.9366877132737033	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1126	C-reactive protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.11946837843782197	0.060000088781908975	0.29629976040211076	3.9665934445005147	2	0.13761481085465174	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1126	C-reactive protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.11946837843782197	0.060000088781908975	0.29629976040211076	0.001968108919757591	1	0.9646147564989515	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1126	Cadherin-7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.016662260231466892	0.02244742215412205	0.5352557605389159	10.965805120878223	3	0.011912224548981599	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1126	Cadherin-7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.016662260231466892	0.02244742215412205	0.5352557605389159	8.597331488116598	2	0.013586675025695032	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-488	ieu-a-1126	Cadherin-related family member 3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.10305361037307584	1	0.7481955060959653	Cadherin-related family member 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1126	Calcium/calmodulin-dependent protein kinase type 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02363442091755319	0.03882997975343842	0.6519179945529003	1.0738666347643702	2	0.5845380993536934	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1126	Calcium/calmodulin-dependent protein kinase type 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02363442091755319	0.03882997975343842	0.6519179945529003	0.7033944525757677	1	0.40164545427398257	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1126	Calpastatin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.005358112114186554	0.006305377872059192	0.4849515216428415	0.8837341440617457	3	0.829351254199519	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1126	Calpastatin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.005358112114186554	0.006305377872059192	0.4849515216428415	0.16162747391847468	2	0.9223654780439993	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-550	ieu-a-1126	Carbohydrate sulfotransferase 11	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.634533575968558	1	0.4256972285753502	Carbohydrate sulfotransferase 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-643	ieu-a-1126	Carboxypeptidase A4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.505785528881344	1	0.47696898192622783	Carboxypeptidase A4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1126	Cardiotrophin-1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.14839470731345786	0.09227823692763552	0.354168145650465	2.608976012970299	2	0.2713114091732415	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1126	Cardiotrophin-1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.14839470731345786	0.09227823692763552	0.354168145650465	0.02291809896525612	1	0.8796702478687041	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-722	ieu-a-1126	Cathepsin F	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	16.143944375840274	1	5.870596250115147e-5	Cathepsin F (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1126	Cell growth regulator with EF hand domain protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.010221234509234234	0.011096152621100256	0.4542153370635986	2.456260644031192	3	0.48324764841539114	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1126	Cell growth regulator with EF hand domain protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.010221234509234234	0.011096152621100256	0.4542153370635986	1.6077410764139104	2	0.4475931805693749	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1126	Cerebral cavernous malformations 2 protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.027893828955466018	0.027892903217444052	0.42263695656399514	15.094765858189902	3	0.001737429883205858	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1126	Cerebral cavernous malformations 2 protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.027893828955466018	0.027892903217444052	0.42263695656399514	10.062954582055427	2	0.006529157975962438	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1126	Coiled-coil domain-containing protein 134	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.07299555512841355	0.03101930373557406	0.25581067558937676	5.5820918668818535	2	0.06135700499836426	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1126	Coiled-coil domain-containing protein 134	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.07299555512841355	0.03101930373557406	0.25581067558937676	0.04440058589853652	1	0.8331100863308719	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1126	Complement C1q tumor necrosis factor-related protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.007830786955884619	0.007456120117940103	0.3528657766050801	6.013481898025069	5	0.3049092810762552	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1126	Complement C1q tumor necrosis factor-related protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.007830786955884619	0.007456120117940103	0.3528657766050801	4.713661317380017	4	0.31795882484549626	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1126	Complement C1q tumor necrosis factor-related protein 5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0425188288181129	0.023938250166886423	0.21768589458033055	7.500415573438508	3	0.05754777507526279	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1126	Complement C1q tumor necrosis factor-related protein 5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0425188288181129	0.023938250166886423	0.21768589458033055	2.910046039571795	2	0.2333949911365861	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1126	Complement component C8	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01902765164042867	0.010981545306862133	0.33323108183152345	3.551606729533307	2	0.16934734714484947	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1126	Complement component C8	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01902765164042867	0.010981545306862133	0.33323108183152345	0.549380132700791	1	0.4585710822193258	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1126	Complement factor B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.012766430971962913	0.006774497784706237	0.20017335294824026	4.339252759374854	3	0.22708459692818495	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1126	Complement factor B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.012766430971962913	0.006774497784706237	0.20017335294824026	0.7879737652231316	2	0.674362902062559	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1126	Complement factor H-related protein 5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.013802161591497965	0.009782012635059425	0.3925151446560982	2.6710413265540107	2	0.26302119432164267	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1126	Complement factor H-related protein 5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.013802161591497965	0.009782012635059425	0.3925151446560982	0.680194824186858	1	0.4095196451944714	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1126	Contactin-4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03204350633412152	0.02650331406708592	0.4399365399915249	1.4618305871415678	2	0.48146810369089316	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1126	Contactin-4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03204350633412152	0.02650331406708592	0.4399365399915249	5.8385874500885136e-5	1	0.9939033715259294	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1126	Contactin-5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.005626099234559182	0.030612879869910667	0.8842918673204068	0.2561258898182325	2	0.8797979985966379	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1126	Contactin-5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.005626099234559182	0.030612879869910667	0.8842918673204068	0.22235003091837854	1	0.637255117178597	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1126	Corneodesmosin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.01858380561055048	0.024373450463568615	0.5254363580645423	6.0957433524213	3	0.10704388816449358	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1126	Corneodesmosin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.01858380561055048	0.024373450463568615	0.5254363580645423	4.722917028283397	2	0.09428261034504794	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1126	CREB-binding protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.02067027760121132	0.011291995756355628	0.20865584556438313	4.2572430245690605	3	0.23499289724540423	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1126	CREB-binding protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.02067027760121132	0.011291995756355628	0.20865584556438313	0.9064221991222073	2	0.635583947971185	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-735	ieu-a-1126	CUB and zona pellucida-like domain-containing protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.0341052857032498	1	0.8534830426216721	CUB and zona pellucida-like domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-706	ieu-a-1126	Cystatin-8	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.5534675069093641	1	0.45690432387061825	Cystatin-8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1126	Delta-like protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0035660814131963435	0.012293428248006872	0.8202621876192913	0.1072475250929706	2	0.9477886330100338	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1126	Delta-like protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0035660814131963435	0.012293428248006872	0.8202621876192913	0.023100941861167977	1	0.8791948701852299	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1126	Desmocollin-3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-3.460365601390113e-4	0.26191559116844265	0.9991589138050572	2.038964649031526	2	0.36078165965922615	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1126	Desmocollin-3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-3.460365601390113e-4	0.26191559116844265	0.9991589138050572	2.038961090013341	1	0.15331432547942375	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1126	Diamine acetyltransferase 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.022635348982698856	0.01605313206496498	0.3927167331975213	2.2691930311370325	2	0.3215518363235138	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1126	Diamine acetyltransferase 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.022635348982698856	0.01605313206496498	0.3927167331975213	0.28101700695938386	1	0.5960354079095237	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1126	Dihydropteridine reductase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.005309615360800228	0.008696319716059149	0.6036319606682172	1.1314780658928119	3	0.7694810973749249	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1126	Dihydropteridine reductase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.005309615360800228	0.008696319716059149	0.6036319606682172	0.7586959010118531	2	0.6843074661080315	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1126	Discoidin, CUB and LCCL domain-containing protein 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03805071342125061	0.05874438820224882	0.63408348900644	1.3043656931813647	2	0.5209074737394519	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1126	Discoidin, CUB and LCCL domain-containing protein 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03805071342125061	0.05874438820224882	0.63408348900644	0.884806890478856	1	0.3468884821584907	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1126	DnaJ homolog subfamily B member 11	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.015716820393402147	0.019691942965210728	0.5711713627339859	4.058742896594815	2	0.13141809826319617	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1126	DnaJ homolog subfamily B member 11	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.015716820393402147	0.019691942965210728	0.5711713627339859	2.4793502215187977	1	0.11534989848536004	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1126	DnaJ homolog subfamily B member 9	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0018496302878743766	0.02886722882714305	0.9547394788640233	5.033695549434869	3	0.1693463531547164	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1126	DnaJ homolog subfamily B member 9	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0018496302878743766	0.02886722882714305	0.9547394788640233	5.02338394973655	2	0.08113085168343022	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1126	Dual specificity protein kinase CLK2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.012405194994479419	0.012309346717475486	0.49753106478433445	1.6601662373812964	2	0.4360130439820272	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1126	Dual specificity protein kinase CLK2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.012405194994479419	0.012309346717475486	0.49753106478433445	0.6445323541953295	1	0.4220743156234414	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1126	E3 ubiquitin-protein ligase RNF8	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.021301211494033172	0.018215270219291403	0.45038545716580264	1.7195936040338218	2	0.4232480767360458	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1126	E3 ubiquitin-protein ligase RNF8	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.021301211494033172	0.018215270219291403	0.45038545716580264	0.3520619986721608	1	0.5529481972090426	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1126	Endothelin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.00685408684684738	0.012292506332929819	0.6761858419939615	0.5095576048775889	2	0.7750879265596629	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1126	Endothelin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.00685408684684738	0.012292506332929819	0.6761858419939615	0.19865932115692775	1	0.6558051865112354	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1126	Eotaxin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	1.5714172690604518e-5	0.013464406545413206	0.9992570078402361	0.007453025984120545	2	0.9962804218405573	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1126	Eotaxin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	1.5714172690604518e-5	0.013464406545413206	0.9992570078402361	0.007451663885320193	1	0.9312096389867559	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1126	Epididymal secretory protein E1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.021072398173199565	0.010765327290959399	0.3006808832794772	8.970939875737647	2	0.011271589329260012	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1126	Epididymal secretory protein E1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.021072398173199565	0.010765327290959399	0.3006808832794772	1.8567451437253601	1	0.17300092781973242	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1126	Epididymal-specific lipocalin-10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.015227153461451256	0.01699874853056712	0.5349625074540219	4.67674047331047	2	0.09648475748319087	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1126	Epididymal-specific lipocalin-10	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.015227153461451256	0.01699874853056712	0.5349625074540219	2.594695917198384	1	0.10722201649855019	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1126	Epididymis-specific alpha-mannosidase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.06861039547965397	0.0269268638036679	0.2380893515531695	7.246823934890967	2	0.026691450590746773	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1126	Epididymis-specific alpha-mannosidase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.06861039547965397	0.0269268638036679	0.2380893515531695	0.7543786549772139	1	0.38509345376865944	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1126	Estrogen sulfotransferase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.019550703780698887	0.01725880639422586	0.4604127827587221	6.335193514475247	2	0.042104664140809545	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1126	Estrogen sulfotransferase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.019550703780698887	0.01725880639422586	0.4604127827587221	2.774667279596623	1	0.09576655512120877	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1126	Extracellular sulfatase Sulf-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.05114288104375098	0.03502638090069724	0.3822910262964489	2.487665587671415	2	0.28827719075108776	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1126	Extracellular sulfatase Sulf-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.05114288104375098	0.03502638090069724	0.3822910262964489	0.35570168664816515	1	0.55090315418926	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-71	ieu-a-1126	fatty acid binding protein 4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.006730978095838607	0.0449398710263089	0.9053522985352935	0.02278555726106901	2	0.9886718733172306	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1126	fatty acid binding protein 4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.006730978095838607	0.0449398710263089	0.9053522985352935	3.5228066346657005e-4	1	0.9850252711958196	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1126	Ferritin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0025937858459751453	0.016824812036638822	0.9026225560193215	4.558548875968202	2	0.10235844718053042	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1126	Ferritin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0025937858459751453	0.016824812036638822	0.9026225560193215	4.452722619939907	1	0.03484564994047879	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1126	Fibroblast growth factor 7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.010495731336238458	0.017600005921753096	0.6576704465492721	0.3749191552163914	2	0.8290626301975459	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1126	Fibroblast growth factor 7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.010495731336238458	0.017600005921753096	0.6576704465492721	0.01928801448582533	1	0.8895439510447715	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1117	ieu-a-1126	Filamin-A	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.03229273923694493	1	0.8573866752000946	Filamin-A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1126	Galanin peptides	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0026112955650057224	0.05554239865180554	0.9700916918422313	7.854470756458157	2	0.01969805501670012	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1126	Galanin peptides	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0026112955650057224	0.05554239865180554	0.9700916918422313	7.837147846836493	1	0.0051183300326884335	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1126	Gamma-interferon-inducible protein 16	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.008091907730560306	0.0216095713614237	0.7719012619370196	1.6527640856392891	2	0.4376297512712554	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1126	Gamma-interferon-inducible protein 16	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.008091907730560306	0.0216095713614237	0.7719012619370196	1.4495135008549909	1	0.22860603144737784	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1126	GDH/6PGL endoplasmic bifunctional protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.019552050540313188	0.01667862192180482	0.3618190819380286	11.101453549936036	3	0.011189738727575184	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1126	GDH/6PGL endoplasmic bifunctional protein	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.019552050540313188	0.01667862192180482	0.3618190819380286	6.580110341173719	2	0.03725179413617732	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1126	Glycolipid transfer protein domain-containing protein 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02034676497873045	0.01980800026749062	0.4914588546039838	1.069394696423493	2	0.585846570828586	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1126	Glycolipid transfer protein domain-containing protein 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02034676497873045	0.01980800026749062	0.4914588546039838	0.014256193944062162	1	0.9049590121865727	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1126	Glycosaminoglycan xylosylkinase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.06487372869652816	0.01879794584594193	0.1795509257556683	16.21076405023678	2	3.019098711239532e-4	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1126	Glycosaminoglycan xylosylkinase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.06487372869652816	0.01879794584594193	0.1795509257556683	1.2556611924172882	1	0.2624739683345408	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1126	Granulins	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.010606390858413056	0.007505932350554828	0.2931798487053746	2.4246031746948624	3	0.4890711823328497	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1126	Granulins	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.010606390858413056	0.007505932350554828	0.2931798487053746	0.42784273866529804	2	0.8074118698608754	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-55	ieu-a-1126	growth differentiation factor 15	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.00692070362977496	0.012466701504493857	0.677375640907955	0.8981981935191974	2	0.6382028517254632	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1126	growth differentiation factor 15	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.00692070362977496	0.012466701504493857	0.677375640907955	0.5900232104013552	1	0.4424101435401751	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1126	Hemoglobin subunit zeta	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-5.757626463946653e-4	0.008597811001466083	0.9574315556662883	0.010583331757310858	2	0.9947223103219018	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1126	Hemoglobin subunit zeta	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-5.757626463946653e-4	0.008597811001466083	0.9574315556662883	0.006098861134155993	1	0.9377523209435673	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1313	ieu-a-1126	Heparin-binding EGF-like growth factor	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	8.55585187369268	1	0.0034441329815803057	Heparin-binding EGF-like growth factor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1126	Hepatocyte nuclear factor 4-alpha	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.01932750160721923	0.013900845295073577	0.2586075987556558	4.113011288556752	4	0.39092743394834684	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1126	Hepatocyte nuclear factor 4-alpha	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.01932750160721923	0.013900845295073577	0.2586075987556558	2.1798458770912736	3	0.5359290069423673	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1126	Histo-blood group ABO system transferase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.021325641407039513	0.009235926861060078	0.26018849797191873	5.478467417265916	2	0.06461984555533623	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1126	Histo-blood group ABO system transferase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.021325641407039513	0.009235926861060078	0.26018849797191873	0.14704327513867121	1	0.7013770764561761	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1126	Histone-lysine N-methyltransferase SUV420H2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.010729222671970386	0.012123628459326232	0.5387963448936852	0.7875663328869954	2	0.6745002946829283	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1126	Histone-lysine N-methyltransferase SUV420H2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.010729222671970386	0.012123628459326232	0.5387963448936852	0.0043688549934200885	1	0.9473003488403182	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1126	HLA class II histocompatibility antigen, DQ alpha 2 chain	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.010843753627265371	0.008645398547953454	0.3364635395672815	5.402125710685425	3	0.14461119771538508	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1126	HLA class II histocompatibility antigen, DQ alpha 2 chain	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.010843753627265371	0.008645398547953454	0.3364635395672815	3.0236743760891205	2	0.22050449737503827	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1126	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0030157910619568492	0.03528466446138916	0.9396734407398102	17.632834359654296	3	5.235902004952792e-4	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1126	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0030157910619568492	0.03528466446138916	0.9396734407398102	17.5686632957361	2	1.53113413285472e-4	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1126	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.004011094487461809	0.01734340298807278	0.8553097363941374	4.6132487879318536	2	0.09959688460311991	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1126	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.004011094487461809	0.01734340298807278	0.8553097363941374	4.379023167909426	1	0.036383843215790926	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1126	Inducible T-cell costimulator	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01764555824766929	0.019070700375346097	0.5246980075829208	1.2100527498356215	2	0.5460600241615212	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1126	Inducible T-cell costimulator	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01764555824766929	0.019070700375346097	0.5246980075829208	0.353927079327556	1	0.5518984798391015	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1126	Intercellular adhesion molecule 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03950903622418574	0.026016150319834095	0.37071497187519475	26.174252623243277	2	2.0717304957995383e-6	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1126	Intercellular adhesion molecule 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03950903622418574	0.026016150319834095	0.37071497187519475	7.916592788374246	1	0.004898343551240677	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-38	ieu-a-1126	interleukin 1 receptor like 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.009485355790061111	0.01603537526491495	0.6599393734916149	1.2968708310947903	2	0.5228632007645786	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1126	interleukin 1 receptor like 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.009485355790061111	0.01603537526491495	0.6599393734916149	0.9469667599384229	1	0.33049258608696086	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1126	Interleukin-17 receptor A	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0035782253688105142	0.006802696222032776	0.6917286957855868	0.43711861005795016	2	0.8036758160137742	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1126	Interleukin-17 receptor A	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0035782253688105142	0.006802696222032776	0.6917286957855868	0.16044150341704458	1	0.6887503603117716	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1126	Interleukin-21	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.009026817771791961	0.016541737853396948	0.6819858398031685	1.177292913383173	2	0.5550780987364352	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1126	Interleukin-21	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.009026817771791961	0.016541737853396948	0.6819858398031685	0.8795049891362836	1	0.3483372947239226	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1126	Interleukin-3 receptor subunit alpha	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.014398381777162945	0.018498021477835393	0.5789303571324003	7.842670836660831	2	0.01981461626661044	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1126	Interleukin-3 receptor subunit alpha	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.014398381777162945	0.018498021477835393	0.5789303571324003	4.883763198911936	1	0.02711045120670495	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1540	ieu-a-1126	Interleukin-6 receptor subunit alpha	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.7201401973770538	1	0.3960979257254199	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1541	ieu-a-1126	Interleukin-6 receptor subunit alpha	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.738080369812207	1	0.39027649883142773	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1126	Interleukin-6 receptor subunit beta	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0011632091918540193	0.042383819426964134	0.9805973533935303	25.04328766866098	3	1.5122035245143342e-5	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1126	Interleukin-6 receptor subunit beta	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0011632091918540193	0.042383819426964134	0.9805973533935303	25.033859805085157	2	3.6640923655105478e-6	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1126	Kallikrein-12	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01722782621334784	0.011084716551064256	0.36397791849209976	2.6502131237909468	2	0.2657746361308845	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1126	Kallikrein-12	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01722782621334784	0.011084716551064256	0.36397791849209976	0.23468677085780423	1	0.6280702257339073	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1659	ieu-a-1126	Kallikrein-14	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.5629423641661543	1	0.45307714275131655	Kallikrein-14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1126	Kallikrein-7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.003836962362534418	0.006895568707820076	0.6767415244065622	0.5340619680107094	2	0.7656493482143503	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1126	Kallikrein-7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.003836962362534418	0.006895568707820076	0.6767415244065622	0.2244377676594156	1	0.6356791681806699	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1126	Kelch-like protein 13	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0014166895009993068	0.03499746687475859	0.9742438383522942	0.9402188253199755	2	0.6249338888628849	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1126	Kelch-like protein 13	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0014166895009993068	0.03499746687475859	0.9742438383522942	0.9385802133294575	1	0.3326432421176422	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1644	ieu-a-1126	Killer cell immunoglobulin-like receptor 2DL5A	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.14080884988761197	1	0.7074782265314826	Killer cell immunoglobulin-like receptor 2DL5A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1126	Kunitz-type protease inhibitor 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.009017229375773145	0.011895034724770808	0.5870605188623161	0.8021490175582442	2	0.6696001680882021	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1126	Kunitz-type protease inhibitor 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.009017229375773145	0.011895034724770808	0.5870605188623161	0.22748393980881018	1	0.6333957575975642	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2666	ieu-a-1126	L-Selectin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	8.221822748439687	1	0.004138960641433199	L-Selectin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1792	ieu-a-1126	Leucine-rich repeat neuronal protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	2.8040181904736428	1	0.0940283908259689	Leucine-rich repeat neuronal protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1126	Leukocyte immunoglobulin-like receptor subfamily B member 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.027280706937575127	0.06009135018323262	0.728695077358791	0.2958252618750665	2	0.8625064680317166	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1126	Leukocyte immunoglobulin-like receptor subfamily B member 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.027280706937575127	0.06009135018323262	0.728695077358791	0.08972083691287902	1	0.76453235405173	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1746	ieu-a-1126	Leukocyte immunoglobulin-like receptor subfamily B member 4	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.41788605875823176	1	0.5179937489483335	Leukocyte immunoglobulin-like receptor subfamily B member 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1126	Low affinity immunoglobulin gamma Fc region receptor II-a	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.00693959280203383	0.014889723903933274	0.6870008196086511	6.365221389436737	3	0.09513210502681063	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1126	Low affinity immunoglobulin gamma Fc region receptor II-a	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.00693959280203383	0.014889723903933274	0.6870008196086511	5.741630280966797	2	0.056652727821223735	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1126	Low-density lipoprotein receptor-related protein 1B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01020724415355093	0.01908792702052072	0.6873823811401236	2.9165541031620013	2	0.23263675075283471	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1126	Low-density lipoprotein receptor-related protein 1B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01020724415355093	0.01908792702052072	0.6873823811401236	2.2680042812743038	1	0.13206987705345838	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2356	ieu-a-1126	Lysosomal Pro-X carboxypeptidase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.4317310909019804	1	0.5111407485953762	Lysosomal Pro-X carboxypeptidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1126	MAGUK p55 subfamily member 6	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.021352090787242064	0.01893255312665862	0.4618098309859389	5.336748378962345	2	0.06936490788114061	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1126	MAGUK p55 subfamily member 6	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.021352090787242064	0.01893255312665862	0.4618098309859389	2.3489956282978173	1	0.12536375506523084	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1126	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.022482354111157957	0.04109341516653604	0.6812974822020081	7.90912222754121	2	0.019167078870895558	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1126	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.022482354111157957	0.04109341516653604	0.6812974822020081	6.0871133614300055	1	0.013617138302139334	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1126	MAP kinase-activated protein kinase 5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0013459418027500108	0.015515115455881948	0.9387733184776066	6.251787947429661	3	0.09998251333072462	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1126	MAP kinase-activated protein kinase 5	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0013459418027500108	0.015515115455881948	0.9387733184776066	6.22835182912543	2	0.044415093902192684	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1126	Maspardin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0019733198010304966	0.008639994204051994	0.8570519900504301	0.07958875745040214	2	0.9609870182141481	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1126	Maspardin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0019733198010304966	0.008639994204051994	0.8570519900504301	0.027425098682834475	1	0.8684676157888171	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1126	MHC class I polypeptide-related sequence B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.016735600210412496	0.00874128788733566	0.1956459965745381	4.769495945731023	3	0.18947509906951182	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1126	MHC class I polypeptide-related sequence B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.016735600210412496	0.00874128788733566	0.1956459965745381	1.1040084860214636	2	0.5757946207825262	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1126	Multimerin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.011241120145440682	0.013481109642871473	0.4920967967785178	6.991949611190574	3	0.0721548088886753	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1126	Multimerin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.011241120145440682	0.013481109642871473	0.4920967967785178	5.188266688185491	2	0.07471059640496515	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1126	Myeloblastin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.005062400004415896	0.011466257344367611	0.7353149270196169	0.2974710561756596	2	0.8617970058642936	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1126	Myeloblastin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.005062400004415896	0.011466257344367611	0.7353149270196169	0.1025451569632358	1	0.7487964635522443	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1126	Myeloblastin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.021312997197379585	0.02415873153609399	0.539789363371395	7.228038290203854	2	0.026943339767471264	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1126	Myeloblastin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.021312997197379585	0.02415873153609399	0.539789363371395	4.064603088481235	1	0.04379097520376533	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1126	Myeloperoxidase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.002245990079037691	0.008076139300225596	0.80704760748969	1.055945091192299	3	0.7877183170591674	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1126	Myeloperoxidase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.002245990079037691	0.008076139300225596	0.80704760748969	0.97860439720639	2	0.613054034924798	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1126	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02006928091452708	0.04281510335364024	0.72094992135324	17.989802115244263	2	1.240406705756839e-4	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1126	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02006928091452708	0.04281510335364024	0.72094992135324	14.749124238648825	1	1.2280455309121344e-4	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1126	NAD-dependent protein deacetylase sirtuin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02822091645943302	0.013448852187605055	0.28311581031628336	5.213063596339542	2	0.07379001916637136	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1126	NAD-dependent protein deacetylase sirtuin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02822091645943302	0.013448852187605055	0.28311581031628336	0.8098293959062209	1	0.3681706946488917	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2025	ieu-a-1126	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.3499576376847614	1	0.5541371113261698	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1126	Neural cell adhesion molecule 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.05978322882780293	0.033397930862099294	0.32433256630009477	3.7737637291347963	2	0.15154360637842243	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1126	Neural cell adhesion molecule 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.05978322882780293	0.033397930862099294	0.32433256630009477	0.5695637624906225	1	0.4504323176232301	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1126	Neurensin-1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.04386158772202454	0.0356590094825322	0.4345638664539126	1.532718776491377	2	0.46470179125722366	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1126	Neurensin-1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.04386158772202454	0.0356590094825322	0.4345638664539126	0.019749370965126967	1	0.888239311378748	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1126	Neuropeptide W	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.00460384296941086	0.011319875549964296	0.7540912123080822	0.4361090124551011	2	0.8040816130167351	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1126	Neuropeptide W	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.00460384296941086	0.011319875549964296	0.7540912123080822	0.27070055958687583	1	0.6028622177700595	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1126	Neutrophil-activating peptide 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.03183391614837973	0.03795167802702147	0.5556670306977318	0.7266853958908144	2	0.6953480982983061	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1126	Neutrophil-activating peptide 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.03183391614837973	0.03795167802702147	0.5556670306977318	0.023097806741477146	1	0.8792030050084256	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1126	PAX-interacting protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-1.7561408421023334e-4	0.016724859754902677	0.9933156216880953	1.585995526969233	2	0.4524863131487853	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1126	PAX-interacting protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-1.7561408421023334e-4	0.016724859754902677	0.9933156216880953	1.5858206841521394	1	0.20792425914803947	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2341	ieu-a-1126	Peptidyl-prolyl cis-trans isomerase E	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.5965103623319792	1	0.4399125870118519	Peptidyl-prolyl cis-trans isomerase E (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1126	PH and SEC7 domain-containing protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.014197529436845014	0.010744936063547617	0.3172979647376253	4.6626982980090785	3	0.19822902848352664	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1126	PH and SEC7 domain-containing protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.014197529436845014	0.010744936063547617	0.3172979647376253	2.489498228376891	2	0.288013157481976	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1126	Platelet-activating factor acetylhydrolase IB subunit beta	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0015961722093862881	0.06634436867209868	0.9846865858164404	1.4309816905132657	2	0.4889520530893327	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1126	Platelet-activating factor acetylhydrolase IB subunit beta	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0015961722093862881	0.06634436867209868	0.9846865858164404	1.4301538739234068	1	0.23173932782314968	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1126	Plexin-B2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.020116978466976097	0.012157218451307319	0.3460630109915012	4.721747592570632	2	0.09433775519138003	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1126	Plexin-B2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.020116978466976097	0.012157218451307319	0.3460630109915012	1.2631245359723078	1	0.2610604861845259	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1126	Potassium voltage-gated channel subfamily E member 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.001109260316641049	0.015939517396796533	0.9557677736923453	0.5415763704291837	2	0.7627780469633947	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1126	Potassium voltage-gated channel subfamily E member 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.001109260316641049	0.015939517396796533	0.9557677736923453	0.5367333464765968	1	0.463789695509345	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1126	PR domain zinc finger protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.21497551435181672	0.08138919384254188	0.2304060091392367	7.081631924089275	2	0.02898966296433328	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1126	PR domain zinc finger protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.21497551435181672	0.08138919384254188	0.2304060091392367	0.10502106226351089	1	0.7458853923596995	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1126	Pro-FMRFamide-related neuropeptide FF	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01160420925044868	0.0356571936085328	0.7997015355278959	0.7949991967104594	2	0.6719982125521025	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1126	Pro-FMRFamide-related neuropeptide FF	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01160420925044868	0.0356571936085328	0.7997015355278959	0.6890892414005881	1	0.40647433631203883	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1126	Probable carboxypeptidase X1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.003675877980013668	0.01414304280293413	0.8381196316515119	1.603496514725263	2	0.4485441077128571	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1126	Probable carboxypeptidase X1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.003675877980013668	0.01414304280293413	0.8381196316515119	1.5020316795243929	1	0.2203590192975604	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1126	Prostaglandin F2 receptor negative regulator	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0038127225330928474	0.009486335469642952	0.7567105680662753	0.5320763090324051	2	0.7664098849447819	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1126	Prostaglandin F2 receptor negative regulator	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0038127225330928474	0.009486335469642952	0.7567105680662753	0.370538776534008	1	0.5427107351645303	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1126	Protein eva-1 homolog C	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-5.657490521446719e-4	0.02535087139181894	0.9857950737518667	0.8275112426033074	2	0.6611625055573982	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1126	Protein eva-1 homolog C	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-5.657490521446719e-4	0.02535087139181894	0.9857950737518667	0.8270132052850498	1	0.3631376161213529	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1126	Protein FAM3B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.05424954602495851	0.011266659129988301	0.13036136626540593	23.39233710086705	2	8.325657465065027e-6	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1126	Protein FAM3B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.05424954602495851	0.011266659129988301	0.13036136626540593	0.2076143743913999	1	0.6486436931748236	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2030	ieu-a-1126	Protein kinase C-binding protein NELL1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.466484186142484	1	0.2259012301966101	Protein kinase C-binding protein NELL1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2329	ieu-a-1126	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.38011489220879363	1	0.5375417544039586	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1126	Protein S100-A13	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Wald ratio	1	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1126	Protein S100-A13	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1126	Protein shisa-3 homolog	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.025862035168870492	0.016658334366800445	0.3642946730809316	19.301420935734022	2	6.4379810995186e-5	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1126	Protein shisa-3 homolog	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.025862035168870492	0.016658334366800445	0.3642946730809316	5.6598243787083655	1	0.01735786101260007	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1126	Protein-tyrosine sulfotransferase 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.05463863575833316	0.037670220815305536	0.2840068512744436	15.572306707897917	3	0.0013874855479679966	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1126	Protein-tyrosine sulfotransferase 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.05463863575833316	0.037670220815305536	0.2840068512744436	7.589223019813308	2	0.02249164189974594	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1126	Reticulon-4 receptor	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.007682209009039054	0.012584926512626176	0.6510986892524846	0.37375445886567255	2	0.8295455739145481	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1126	Reticulon-4 receptor	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.007682209009039054	0.012584926512626176	0.6510986892524846	0.0011304191999933519	1	0.9731788121513351	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2493	ieu-a-1126	Retinoic acid receptor responder protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.04359698816668	1	0.30698638076826185	Retinoic acid receptor responder protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1126	Rho GTPase-activating protein 30	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.019556811607154844	0.013512987918824259	0.24363177409141415	3.2660378525076026	4	0.5143312027718306	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1126	Rho GTPase-activating protein 30	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.019556811607154844	0.013512987918824259	0.24363177409141415	1.1714753356358292	3	0.7598535157567607	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2561	ieu-a-1126	RING finger protein 122	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.13212566970163703	1	0.7162381732066853	RING finger protein 122 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1126	rRNA methyltransferase 3, mitochondrial	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0032181319171575343	0.007855865943541717	0.721773107872143	2.5135730361322155	3	0.4728431250965614	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1126	rRNA methyltransferase 3, mitochondrial	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0032181319171575343	0.007855865943541717	0.721773107872143	2.31899683588525	2	0.31364345936690646	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1126	Secretory phospholipase A2 receptor	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Wald ratio	1	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1126	Secretory phospholipase A2 receptor	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2820	ieu-a-1126	Serine protease inhibitor Kazal-type 6	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.4826785411319672	1	0.22335590950334044	Serine protease inhibitor Kazal-type 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1126	Serine/threonine-protein kinase 16	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.021948003509601285	0.012954258751945941	0.23229651515826155	3.7843752019023773	3	0.2857087953539802	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1126	Serine/threonine-protein kinase 16	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.021948003509601285	0.012954258751945941	0.23229651515826155	0.9138265835305659	2	0.6332352443925986	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2878	ieu-a-1126	Serine/threonine-protein kinase 17B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	2.7495301467925835	1	0.09728301227880315	Serine/threonine-protein kinase 17B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1126	Sialic acid-binding Ig-like lectin 7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.011109215900795673	0.009615599715721372	0.45419865347218813	1.6642679681824777	2	0.4351197562354854	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1126	Sialic acid-binding Ig-like lectin 7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.011109215900795673	0.009615599715721372	0.45419865347218813	0.32947453217391787	1	0.5659686664979363	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1126	Solute carrier family 22 member 16	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.005899944016912495	0.022190180511639165	0.8152309451697435	9.876379107477005	3	0.019646722260657473	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1126	Solute carrier family 22 member 16	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.005899944016912495	0.022190180511639165	0.8152309451697435	9.539203439518575	2	0.008483758400503277	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1126	Stromal interaction molecule 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.013261765257502726	0.03178252012129037	0.748343127219335	3.846816185549137	2	0.1461081624625845	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1126	Stromal interaction molecule 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.013261765257502726	0.03178252012129037	0.748343127219335	3.276365221182679	1	0.07028442644334229	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1126	Syntaxin-7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.004196388349157947	0.012834182030782156	0.7988202759721649	2.026711100657464	2	0.36299887266479575	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1126	Syntaxin-7	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.004196388349157947	0.012834182030782156	0.7988202759721649	1.8309642349622237	1	0.17601369731081298	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1126	Tenascin-X	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.017658356704178597	0.03762102395778742	0.7206203054182873	2.18107953749947	2	0.33603506351986256	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1126	Tenascin-X	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.017658356704178597	0.03762102395778742	0.7206203054182873	1.787312142149434	1	0.18125399490579283	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1126	Thioredoxin domain-containing protein 12	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	-0.026263649472456907	0.03343785353821557	0.4677601058666084	14.086257390764732	6	0.02868732322446495	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1126	Thioredoxin domain-containing protein 12	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	-0.026263649472456907	0.03343785353821557	0.4677601058666084	12.539115126994083	5	0.028102636036066882	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1126	Thiosulfate sulfurtransferase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0010580380099661881	0.00970468365955785	0.9308665679564142	0.7399298291341221	2	0.6907585657755385	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1126	Thiosulfate sulfurtransferase	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0010580380099661881	0.00970468365955785	0.9308665679564142	0.728043718366099	1	0.3935180313600479	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1126	Torsin-1A-interacting protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0105027507064189	0.02206083945312033	0.6809529577720732	9.168475954294081	3	0.02713277640011108	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1126	Torsin-1A-interacting protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0105027507064189	0.02206083945312033	0.6809529577720732	8.235207479487883	2	0.016283487202075494	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1126	Transmembrane glycoprotein NMB	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.010416241853012315	0.009304606525467612	0.464152611412591	1.5809737771323034	2	0.4536238772263274	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1126	Transmembrane glycoprotein NMB	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.010416241853012315	0.009304606525467612	0.464152611412591	0.32775733083288544	1	0.5669826465233133	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3000	ieu-a-1126	Transmembrane protein 132C	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	5.4545171016515495	1	0.019517797914454495	Transmembrane protein 132C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1126	Trefoil factor 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.023294257260465114	0.01791277125386555	0.32312648553312495	7.271819371021736	3	0.06372054639009066	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1126	Trefoil factor 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.023294257260465114	0.01791277125386555	0.32312648553312495	3.9401789362340653	2	0.1394443798308457	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1126	Trypsin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.014587211369930263	0.028319694394754222	0.697193612382399	2.0573790670908623	2	0.3574751128969841	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1126	Trypsin-2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.014587211369930263	0.028319694394754222	0.697193612382399	1.6259773113904499	1	0.20226034695149608	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1126	Trypsin-3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.04594526454155791	0.01751290896195345	0.11974680798297294	7.115871746448026	3	0.06829482877978257	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1126	Trypsin-3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.04594526454155791	0.01751290896195345	0.11974680798297294	0.23307519044813693	2	0.8899966367247307	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2930	ieu-a-1126	Tubulin-specific chaperone A	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.4302610772354476	1	0.2317218352725069	Tubulin-specific chaperone A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1126	Tumor necrosis factor receptor superfamily member 1B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0053154361782711415	0.00967192976677445	0.6800885722714698	0.6649561910581815	2	0.7171443773600934	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1126	Tumor necrosis factor receptor superfamily member 1B	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0053154361782711415	0.00967192976677445	0.6800885722714698	0.36292517227138654	1	0.5468861408926693	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1126	Tyrosine-protein kinase receptor Tie-1, soluble	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.004941110986479505	0.006604172601779389	0.5323667116133083	0.8478146061091782	3	0.8379994839600946	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1126	Tyrosine-protein kinase receptor Tie-1, soluble	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.004941110986479505	0.006604172601779389	0.5323667116133083	0.28804103783913637	2	0.8658699811604269	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1126	Ubiquitin carboxyl-terminal hydrolase 25	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-9.443292919292097e-4	0.015675522097375078	0.9616948627214661	0.7474024473190598	2	0.6881824937630032	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1126	Ubiquitin carboxyl-terminal hydrolase 25	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-9.443292919292097e-4	0.015675522097375078	0.9616948627214661	0.7437733142462881	1	0.388454825625352	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1126	Ubiquitin-like protein ISG15	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.004994284505880682	0.010145001870640925	0.6712471803672722	1.7438208952626102	3	0.6272357515186622	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1126	Ubiquitin-like protein ISG15	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.004994284505880682	0.010145001870640925	0.6712471803672722	1.5014713021913546	2	0.47201918355585604	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1126	Urea transporter 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.011871083110145751	0.02098398858459994	0.6285891864757365	7.708267220225506	3	0.05244186418184157	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1126	Urea transporter 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.011871083110145751	0.02098398858459994	0.6285891864757365	6.644942648825872	2	0.03606359668815082	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3193	ieu-a-1126	Vascular cell adhesion protein 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	23.197464428314372	1	1.4618995398145453e-6	Vascular cell adhesion protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1126	Vascular endothelial growth factor receptor 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0013517294100549172	0.025622612387532606	0.9627222754868825	17.070465175565683	3	6.83545776485357e-4	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1126	Vascular endothelial growth factor receptor 2	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0013517294100549172	0.025622612387532606	0.9627222754868825	17.04674356646931	2	1.9876809128587433e-4	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1126	Vascular endothelial growth factor receptor 3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0016914138593499771	0.025547930010744145	0.9532368461782085	16.97576863273935	3	7.148985903088732e-4	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1126	Vascular endothelial growth factor receptor 3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0016914138593499771	0.025547930010744145	0.9532368461782085	16.938646148271758	2	2.098068790071018e-4	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1126	Xyloside xylosyltransferase 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.006387230898932321	0.026271733417137635	0.8481695887524902	0.29047579134508394	2	0.8648165325263046	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1126	Xyloside xylosyltransferase 1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.006387230898932321	0.026271733417137635	0.8481695887524902	0.23136758575504834	1	0.6305116332235845	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1126	Zinc fingers and homeoboxes protein 3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03261262009440325	0.01485618226508448	0.2721212731718197	4.856235902984707	2	0.08820267818753541	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1126	Zinc fingers and homeoboxes protein 3	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03261262009440325	0.01485618226508448	0.2721212731718197	0.03723569739402411	1	0.8469859604697003	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
ieu-a-1	ieu-a-1126	Adiponectin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	-0.007897106136869175	0.0039429611520485535	0.07620350867592596	15.318080432424715	10	0.12088836245713783	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1126	Adiponectin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	-0.007897106136869175	0.0039429611520485535	0.07620350867592596	10.595571180395812	9	0.30445163946321535	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1126	Apoliprotein A	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	222	-0.0013814400260338563	0.001276815472397458	0.28046288113952783	589.4894172170987	221	2.623917458974029e-35	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1126	Apoliprotein A	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	222	-0.0013814400260338563	0.001276815472397458	0.28046288113952783	586.3694041186247	220	4.274614468982282e-35	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-780	ieu-a-1126	HDL cholesterol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	37	-3.5139661758367753e-6	0.003463550966324257	0.9991962623787874	75.2267018045012	36	1.3832344328801866e-4	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1126	HDL cholesterol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	37	-3.5139661758367753e-6	0.003463550966324257	0.9991962623787874	75.22669959214042	35	9.167420162208187e-5	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1126	HDL cholesterol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	245	-0.0011200976375898058	0.0011898993298161376	0.3474664460743915	645.1570874692002	244	5.566109045043443e-38	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1126	HDL cholesterol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	245	-0.0011200976375898058	0.0011898993298161376	0.3474664460743915	642.8130221190148	243	7.103326268627844e-38	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-299	ieu-a-1126	HDL cholesterol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	78	8.563053254234032e-4	0.002518803285302391	0.7348205736285786	193.84742737089923	77	4.770929744477251e-12	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1126	HDL cholesterol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	78	8.563053254234032e-4	0.002518803285302391	0.7348205736285786	193.5530833017654	76	3.2376046355734884e-12	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1126	IGF-1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	318	-8.148556835996525e-4	0.0015040356837277072	0.5883522183439196	967.8950328163787	317	4.809203279305109e-67	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1126	IGF-1	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	318	-8.148556835996525e-4	0.0015040356837277072	0.5883522183439196	966.9968120787664	316	3.714762570132653e-67	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-1049	ieu-a-1126	Iron	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.016264653795498615	0.00858660722726072	0.309232678434144	4.197296319129022	2	0.12262208174759875	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1126	Iron	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.016264653795498615	0.00858660722726072	0.309232678434144	0.609345746337355	1	0.43503425458762796	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1126	Platelet count	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	394	-1.7865911247447072e-4	0.0011438204726186784	0.8759596733452781	1039.024675062354	393	8.364024988887732e-60	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1126	Platelet count	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	394	-1.7865911247447072e-4	0.0011438204726186784	0.8759596733452781	1038.9600133234621	392	5.231062863051333e-60	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ieu-a-1047	ieu-a-1126	Putamen volume	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.003932279948348471	0.01939785994388911	0.8581076184161109	3.658588073320284	3	0.3007687158215565	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1126	Putamen volume	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.003932279948348471	0.01939785994388911	0.8581076184161109	3.5849280807699366	2	0.16654927949917678	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1126	Reticulocyte percentage	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	249	-6.295370229036546e-4	0.0014476922452338525	0.6640469597883751	659.8082483006908	248	4.0095808963659193e-39	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1126	Reticulocyte percentage	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	249	-6.295370229036546e-4	0.0014476922452338525	0.6640469597883751	659.303495797944	247	2.8664629047569132e-39	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ieu-a-302	ieu-a-1126	Triglycerides	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	0.005400698041649264	0.003151731369489534	0.09268162452503098	220.3731585664292	52	1.316604893030414e-22	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1126	Triglycerides	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	0.005400698041649264	0.003151731369489534	0.09268162452503098	208.37598627103102	51	6.509722130474447e-21	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-783	ieu-a-1126	Triglycerides	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	27	0.006378932128958569	0.004428761229576915	0.162177637697381	77.78260220968365	26	4.585153707831803e-7	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1126	Triglycerides	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	27	0.006378932128958569	0.004428761229576915	0.162177637697381	71.82252241182351	25	2.05603026830564e-6	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ukb-a-11	ieu-a-1126	Morning/evening person (chronotype)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	77	0.0012357007716662725	0.00430976147251302	0.7751162616228287	201.98128771700812	76	2.2616234080174933e-13	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1126	Morning/evening person (chronotype)	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	77	0.0012357007716662725	0.00430976147251302	0.7751162616228287	201.76013399079653	75	1.4638155613734621e-13	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-b-4424	ieu-a-1126	Sleep duration	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	66	-3.970411992284708e-5	0.006189154578602855	0.9949014710850481	223.02857181126072	65	3.4440772634546505e-19	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1126	Sleep duration	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	66	-3.970411992284708e-5	0.006189154578602855	0.9949014710850481	223.0284283981887	64	1.8266709948682018e-19	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-a-14	ieu-a-1126	Snoring	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	0.012905288683445261	0.019316310263367237	0.5125443344947298	110.28420849990157	19	7.06601631515723e-15	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1126	Snoring	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	0.012905288683445261	0.019316310263367237	0.5125443344947298	107.61557023544376	18	8.73268196671071e-15	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-b-15895	ieu-a-1126	Treatment/medication code: allopurinol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.00726013073629964	0.00910185061935997	0.4435994093619401	80.97500690758557	11	9.557338228390375e-13	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1126	Treatment/medication code: allopurinol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.00726013073629964	0.00910185061935997	0.4435994093619401	76.13114412308465	10	2.864583127295015e-12	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-a-142	ieu-a-1126	Treatment/medication code: allopurinol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.003906355464919559	0.00916105164449398	0.6788431622100369	66.64742820122552	11	5.272937721759183e-10	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1126	Treatment/medication code: allopurinol	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.003906355464919559	0.00916105164449398	0.6788431622100369	65.45725371087458	10	3.313591348030756e-10	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1126	Treatment/medication code: aspirin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	-0.019853042379953507	0.019716251644859576	0.3601797707209349	25.600583706625578	6	2.6419515245013525e-4	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1126	Treatment/medication code: aspirin	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	-0.019853042379953507	0.019716251644859576	0.3601797707209349	21.28442544121114	5	7.157025840482593e-4	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1126	Treatment/medication code: insulin product	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.01862596107481384	0.02047771709033079	0.3981122489038388	76.88218781918681	7	5.943861966300209e-14	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1126	Treatment/medication code: insulin product	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.01862596107481384	0.02047771709033079	0.3981122489038388	67.56575440289397	6	1.289266439084677e-12	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1126	Treatment/medication code: ramipril	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	-0.012743306740424678	0.018003298063336674	0.5181135688325845	17.36586415368215	5	0.003855733822966071	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1126	Treatment/medication code: ramipril	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	-0.012743306740424678	0.018003298063336674	0.5181135688325845	15.432805538657517	4	0.0038828100687066055	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ieu-a-974	ieu-a-1127	Body mass index	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	36	0.012305869069106497	0.006208196572231747	0.055586424539674995	100.22165325800556	35	3.318948452471068e-8	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1127	Body mass index	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	36	0.012305869069106497	0.006208196572231747	0.055586424539674995	89.83961498266007	34	6.218902421246666e-7	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-95	ieu-a-1127	Body mass index	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.028614646573623632	0.024637771731915843	0.2753490484786381	58.031520601601414	10	8.527399797972874e-9	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1127	Body mass index	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.028614646573623632	0.024637771731915843	0.2753490484786381	50.46764393335039	9	8.796713484960337e-8	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-b-19953	ieu-a-1127	Body mass index (BMI)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	415	0.003941674180562033	0.0017598939256326495	0.02564034857140567	969.8595356315209	414	1.3752634205030999e-46	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1127	Body mass index (BMI)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	415	0.003941674180562033	0.0017598939256326495	0.02564034857140567	958.220847680915	413	2.544764908412383e-45	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-248	ieu-a-1127	Body mass index (BMI)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	289	0.00554498943936327	0.002162052614424167	0.010835605805163398	636.4920333046143	288	2.2583990079906733e-28	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1127	Body mass index (BMI)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	289	0.00554498943936327	0.002162052614424167	0.010835605805163398	622.2313953861097	287	7.612648614988775e-27	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-34	ieu-a-1127	Comparative body size at age 10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	144	0.00831795450433062	0.0024068407360018492	7.23511615740696e-4	335.8786673306926	143	1.4728616467602795e-17	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1127	Comparative body size at age 10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	144	0.00831795450433062	0.0024068407360018492	7.23511615740696e-4	309.81959717377026	142	1.6133823739681094e-14	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-4650	ieu-a-1127	Comparative body size at age 10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	204	0.004105804091600885	0.002200408508651646	0.06350100175213061	568.8105291195301	203	2.096736878148084e-36	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1127	Comparative body size at age 10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	204	0.004105804091600885	0.002200408508651646	0.06350100175213061	559.1725869101815	202	2.816568214599104e-35	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-a-35	ieu-a-1127	Comparative height size at age 10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	342	-0.0033488345193555666	0.0021915514687996097	0.12742599052405643	1125.9475069287043	341	1.3219312695438994e-84	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1127	Comparative height size at age 10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	342	-0.0033488345193555666	0.0021915514687996097	0.12742599052405643	1118.267689670193	340	1.0639327994962911e-83	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ieu-a-85	ieu-a-1127	Extreme body mass index	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.00942195696045084	0.03346586901164502	0.7895768644607829	23.184025984834257	6	7.371289449922726e-4	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1127	Extreme body mass index	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.00942195696045084	0.03346586901164502	0.7895768644607829	22.8222280736022	5	3.6502870740155686e-4	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-1034	ieu-a-1127	Height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.3438645527498804	0.2721843233313164	0.33379026890164853	29.33244732911553	3	1.9066368856742507e-6	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1127	Height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.3438645527498804	0.2721843233313164	0.33379026890164853	16.313668665393056	2	2.8676877392435853e-4	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-51	ieu-a-1127	Hip circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.014183759433507696	0.012093020822165911	0.26041126079266924	43.99787102738972	15	1.1004849018147839e-4	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1127	Hip circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.014183759433507696	0.012093020822165911	0.26041126079266924	40.06136583768621	14	2.4956091898043793e-4	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ukb-a-388	ieu-a-1127	Hip circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	261	0.004933091981450935	0.0027757334262148606	0.07670539382491211	818.4433226783699	260	4.863549616059928e-59	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1127	Hip circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	261	0.004933091981450935	0.0027757334262148606	0.07670539382491211	808.5826269544216	259	8.000174255885152e-58	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ieu-a-101	ieu-a-1127	Hip circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.15154367327092608	0.11334238161383964	0.273551966013791	46.02852516799904	4	2.429416684770914e-9	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1127	Hip circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.15154367327092608	0.11334238161383964	0.273551966013791	28.841826638607856	3	2.417526613206543e-6	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ukb-a-269	ieu-a-1127	Impedance of whole body	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	333	-0.002541390987588839	0.002418916336073502	0.2941940685840977	1084.3212734665376	332	1.2489174222573671e-80	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1127	Impedance of whole body	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	333	-0.002541390987588839	0.002418916336073502	0.2941940685840977	1080.7172685634232	331	2.4173859027448365e-80	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ieu-a-90	ieu-a-1127	Obesity class 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.0128623947420408	0.011238102997864444	0.2715933671860069	56.88002465918298	15	8.600278803804559e-7	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1127	Obesity class 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.0128623947420408	0.011238102997864444	0.2715933671860069	52.0132257268181	14	2.7975640190926037e-6	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-91	ieu-a-1127	Obesity class 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.023319151000919205	0.017415087794233196	0.21736184217435794	44.32233534001322	9	1.2309129513209774e-6	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1127	Obesity class 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.023319151000919205	0.017415087794233196	0.21736184217435794	36.207454613378495	8	1.6089152759276245e-5	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-93	ieu-a-1127	Overweight	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.02406411552511078	0.014955237311658163	0.13357549533737342	55.00748242267899	13	4.028758172151658e-7	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1127	Overweight	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.02406411552511078	0.014955237311658163	0.13357549533737342	45.245327786103864	12	9.353834308101672e-6	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ukb-b-16881	ieu-a-1127	Sitting height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	550	-0.0018344863140929801	0.0014993250749966507	0.2216511120558786	1539.5352729122872	549	9.07196669381844e-95	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1127	Sitting height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	550	-0.0018344863140929801	0.0014993250749966507	0.2216511120558786	1535.3409523525559	548	2.0928776902256053e-94	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-195	ieu-a-1127	Sitting height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	406	-8.8439622692008e-4	0.0019929643368580587	0.6574542714758873	1255.674529297426	405	8.223433162144341e-88	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1127	Sitting height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	406	-8.8439622692008e-4	0.0019929643368580587	0.6574542714758873	1255.0627725187815	404	5.733648629055486e-88	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-b-10787	ieu-a-1127	Standing height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	710	-0.001670987014354296	0.0011636108905709903	0.1514338024604113	1956.542738347663	709	2.870255084628593e-117	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1127	Standing height	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	710	-0.001670987014354296	0.0011636108905709903	0.1514338024604113	1950.8604464300015	708	1.0602571906695864e-116	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ieu-a-68	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	24	0.02024795109173714	0.01087414787013862	0.07601106501037283	76.20067066974909	23	1.294305188025283e-7	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	24	0.02024795109173714	0.01087414787013862	0.07601106501037283	65.8265744430606	22	2.950002164114931e-6	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ukb-b-9405	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	344	0.004102541980528014	0.002013642135963953	0.04238200879295407	815.6712885930617	343	1.6742443589230791e-40	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	344	0.004102541980528014	0.002013642135963953	0.04238200879295407	805.8901095946325	342	1.8657300091464975e-39	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ieu-a-62	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	17	0.009624431924915154	0.011884950223839959	0.43071492335821504	44.644201997193534	16	1.5733827293044555e-4	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	17	0.009624431924915154	0.011884950223839959	0.43071492335821504	42.774183324670226	15	1.7067386427004573e-4	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-105	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.008017592126585494	0.02354414440932369	0.7559058002985445	5.932219170986006	4	0.20426769304500575	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1127	Waist circumference	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.008017592126585494	0.02354414440932369	0.7559058002985445	5.711445698073634	3	0.12652479713786954	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-75	ieu-a-1127	Waist-to-hip ratio	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	0.007482426822828451	0.021365598257402554	0.7302464069128661	91.87860591238626	19	1.5387029334092523e-11	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1127	Waist-to-hip ratio	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	0.007482426822828451	0.021365598257402554	0.7302464069128661	91.25681034704037	18	8.58246910271312e-12	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-109	ieu-a-1127	Waist-to-hip ratio	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.15893190052362807	0.07691756389394555	0.1747773995740311	6.163648979510084	3	0.10391419189305477	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1127	Waist-to-hip ratio	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.15893190052362807	0.07691756389394555	0.1747773995740311	1.894207043253207	2	0.3878628343312201	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-a-266	ieu-a-1127	Whole body fat-free mass	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	374	-1.8911626624823098e-4	0.001980069697437064	0.9239612523273234	1063.6851579266295	373	1.2372395536804296e-67	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1127	Whole body fat-free mass	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	374	-1.8911626624823098e-4	0.001980069697437064	0.9239612523273234	1063.6590749996917	372	7.363822460385119e-68	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-2346	ieu-a-1127	Duration of moderate activity	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.0022641022454478964	0.030752460608657998	0.9448446785234632	17.298168560544653	5	0.0039676871678861764	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1127	Duration of moderate activity	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.0022641022454478964	0.030752460608657998	0.9448446785234632	17.274759480475897	4	0.0017091989308152657	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-a-508	ieu-a-1127	Number of days/week of moderate physical activity 10+ minutes	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	-0.03273485328421956	0.04494283392076663	0.49905707501955443	21.54631104704576	6	0.0014627018025091991	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1127	Number of days/week of moderate physical activity 10+ minutes	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	-0.03273485328421956	0.04494283392076663	0.49905707501955443	19.47947024146203	5	0.0015642732230646587	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-b-969	ieu-a-1127	Time spend outdoors in summer	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	44	-0.015320764169948306	0.009321986368866787	0.10774418752268368	74.52737652238055	43	0.0020183849073175985	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1127	Time spend outdoors in summer	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	44	-0.015320764169948306	0.009321986368866787	0.10774418752268368	70.02396790893236	42	0.004273035758024451	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-8865	ieu-a-1127	Time spent doing light physical activity	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	6.733408646195109e-4	0.039060632521294845	0.9890268122314286	0.016505466049365217	2	0.9917812272904875	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1127	Time spent doing light physical activity	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	6.733408646195109e-4	0.039060632521294845	0.9890268122314286	0.016208305329819758	1	0.8986935873418692	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-a-487	ieu-a-1127	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.013011969639418223	0.08044805450641593	0.8979148250385945	0.9664625532762916	2	0.6167871584161976	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1127	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.013011969639418223	0.08044805450641593	0.8979148250385945	0.9403015141267822	1	0.3322003120037454	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-7663	ieu-a-1127	Types of physical activity in last 4 weeks: Strenuous sports	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.028179145673666278	0.022108369249669725	0.2714629487270708	9.353969747636329	5	0.095751511950765	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1127	Types of physical activity in last 4 weeks: Strenuous sports	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.028179145673666278	0.022108369249669725	0.2714629487270708	6.652203550367276	4	0.15544941254663724	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-a-482	ieu-a-1127	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.09893253074413298	0.12895757633508934	0.485756534919161	7.739526303553555	5	0.1711871559895124	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1127	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.09893253074413298	0.12895757633508934	0.485756534919161	6.746814290077655	4	0.1498883234271885	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-16886	ieu-a-1127	Types of transport used (excluding work): Car/motor vehicle	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.04525494450305308	0.04537873546552068	0.39213175683557633	8.891197517500892	4	0.06387731148153977	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1127	Types of transport used (excluding work): Car/motor vehicle	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.04525494450305308	0.04537873546552068	0.39213175683557633	6.677493652547918	3	0.08291936554780534	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1127	Types of transport used (excluding work): Cycle	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.02478381840425113	0.0213196873136516	0.28918129520481095	11.375640282676745	7	0.12305239108627393	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1127	Types of transport used (excluding work): Cycle	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.02478381840425113	0.0213196873136516	0.28918129520481095	9.284504413343106	6	0.15819860144022288	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1127	Types of transport used (excluding work): Public transport	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.013529721000703326	0.02118710627605942	0.5434142086354017	18.572411931875365	8	0.01732145304461397	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1127	Types of transport used (excluding work): Public transport	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.013529721000703326	0.02118710627605942	0.5434142086354017	17.550027665758883	7	0.014173833325472934	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1127	Types of transport used (excluding work): Walk	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.07127849602515364	0.0441077253141366	0.16701450280984104	10.039964813213036	6	0.12297907233383903	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1127	Types of transport used (excluding work): Walk	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.07127849602515364	0.0441077253141366	0.16701450280984104	6.595272310357586	5	0.2525215756701812	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-4711	ieu-a-1127	Usual walking pace	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	-0.002146591232058529	0.009510586855494996	0.8223325881699552	193.74432217227178	52	3.3181746587588476e-18	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1127	Usual walking pace	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	-0.002146591232058529	0.009510586855494996	0.8223325881699552	193.55098770512217	51	1.8092465156090632e-18	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-1004	ieu-a-1127	Added milk to espresso	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.1296969096367046	0.060378283155194216	0.27737294684331687	4.614400834594433	2	0.09953953099395907	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1127	Added milk to espresso	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.1296969096367046	0.060378283155194216	0.27737294684331687	1.8679285413815194e-4	1	0.9890954770676186	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-d-1468_5	ieu-a-1127	Cereal type: Other (e.g. Cornflakes, Frosties)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.05281785674338589	0.04624481528678969	0.286427173128359	97.70652425531945	9	4.574676835032859e-17	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1127	Cereal type: Other (e.g. Cornflakes, Frosties)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.05281785674338589	0.04624481528678969	0.286427173128359	84.00820812013406	8	7.6022595341469e-15	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-b-2221	ieu-a-1127	Cherry intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0970181241252017	0.11865786762298333	0.5636618708321459	5.181709677912446	2	0.07495593743518947	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1127	Cherry intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0970181241252017	0.11865786762298333	0.5636618708321459	3.1055773871917043	1	0.07802456045130013	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1127	Dairy smoothie intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.019033408573385948	0.08071321893203834	0.8525687843825456	0.056101702768066704	2	0.9723389207641876	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1127	Dairy smoothie intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.019033408573385948	0.08071321893203834	0.8525687843825456	4.928667051773282e-4	1	0.9822879378142518	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-16576	ieu-a-1127	Dried fruit intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	40	0.00463460445357297	0.0104533349776246	0.660018495606727	116.39196566416831	39	1.2441509299174779e-9	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1127	Dried fruit intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	40	0.00463460445357297	0.0104533349776246	0.660018495606727	115.79298299120853	38	8.598457523628025e-10	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-3881	ieu-a-1127	Fresh fruit intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	0.008943780497442572	0.006054889081502405	0.14579315320525243	126.01675564838904	52	4.392852230186867e-8	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1127	Fresh fruit intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	0.008943780497442572	0.006054889081502405	0.14579315320525243	120.84670819505156	51	1.3390429063753004e-7	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-d-1418_1	ieu-a-1127	Milk type used: Full cream	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.032158339583710706	0.14979245365972785	0.8653702007828717	22.95343176950277	2	1.036873131818654e-5	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1127	Milk type used: Full cream	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.032158339583710706	0.14979245365972785	0.8653702007828717	21.942118021722724	1	2.8099860557903954e-6	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1127	Milk type used: Skimmed	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.06467004582978295	0.025262117243697955	0.23707946493483092	11.51928500393563	2	0.0031522383160277386	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1127	Milk type used: Skimmed	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.06467004582978295	0.025262117243697955	0.23707946493483092	1.5250458259806179	1	0.21685750340531632	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-b-14238	ieu-a-1127	Mineral and other dietary supplements: None of the above	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.0362057719212842	0.023853427823059287	0.18950893942604505	6.642178260352574	6	0.3552087622541199	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1127	Mineral and other dietary supplements: None of the above	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.0362057719212842	0.023853427823059287	0.18950893942604505	4.338329172940057	5	0.501801250142015	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1127	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	-0.03694336045824041	0.013846989310114164	0.015681327750458652	42.592634364734884	19	0.0014731857778668154	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1127	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	-0.03694336045824041	0.013846989310114164	0.015681327750458652	30.522548326761637	18	0.03266556124815709	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1127	Never eat eggs, dairy, wheat, sugar: Wheat products	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.015013408067297992	0.05148178370456237	0.7895753095604111	9.366934035899341	4	0.05255444595559211	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1127	Never eat eggs, dairy, wheat, sugar: Wheat products	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.015013408067297992	0.05148178370456237	0.7895753095604111	9.10871557213611	3	0.027879835114550645	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-6500	ieu-a-1127	Pancake intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.14366454373970022	0.10242301908430122	0.2957996963712469	2.687370079964079	3	0.44237788566652936	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1127	Pancake intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.14366454373970022	0.10242301908430122	0.2957996963712469	0.7199185159511722	2	0.6977047513959895	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-8006	ieu-a-1127	Poultry intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.08146445885376881	0.20500685207693778	0.7074879237125786	26.92721327449913	6	1.4942532561786252e-4	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1127	Poultry intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.08146445885376881	0.20500685207693778	0.7074879237125786	26.102852046831732	5	8.522924702415067e-5	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-4643	ieu-a-1127	Age at hysterectomy	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.002249249048531454	0.052205287542483526	0.969548646236019	4.366247350249618	3	0.224535521871358	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1127	Age at hysterectomy	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.002249249048531454	0.052205287542483526	0.969548646236019	4.362198594810959	2	0.11291733265687325	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-a-320	ieu-a-1127	Age at last live birth	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.050759516834826685	0.03209515138622414	0.25456159894066105	4.316636761277709	3	0.22924068519726132	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1127	Age at last live birth	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.050759516834826685	0.03209515138622414	0.25456159894066105	1.8153925183808366	2	0.4034526044787532	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-b-17422	ieu-a-1127	Age at menopause (last menstrual period)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	102	-0.002391852487581192	0.003597724535593413	0.5076935612472082	345.1690970580851	101	1.9587816031970166e-28	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1127	Age at menopause (last menstrual period)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	102	-0.002391852487581192	0.003597724535593413	0.5076935612472082	343.6501957239639	100	1.8066275654332736e-28	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-4564	ieu-a-1127	Age last used hormone-replacement therapy (HRT)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.042078870648321755	0.023013541514760587	0.20899313245382517	17.514660046146542	3	5.537779268161775e-4	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1127	Age last used hormone-replacement therapy (HRT)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.042078870648321755	0.023013541514760587	0.20899313245382517	6.5558797456981726	2	0.03770585570501945	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-9487	ieu-a-1127	Age started hormone-replacement therapy (HRT)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	22	-0.034202075055487724	0.010397729380695579	0.003664605187771995	94.51343612002456	21	2.6576151367507313e-11	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1127	Age started hormone-replacement therapy (HRT)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	22	-0.034202075055487724	0.010397729380695579	0.003664605187771995	61.33250352566526	20	4.420858693595448e-6	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-18541	ieu-a-1127	Ever used hormone-replacement therapy (HRT)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	-0.01569553677557258	0.022203644323609346	0.5186395784080707	33.999435100652455	5	2.381621071731341e-6	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1127	Ever used hormone-replacement therapy (HRT)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	-0.01569553677557258	0.022203644323609346	0.5186395784080707	30.22377772307597	4	4.406933669200003e-6	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18105	ieu-a-1127	Had menopause	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.023209261864255912	0.01997309833114281	0.2833082119294814	63.718020365399184	8	8.6466781177961e-11	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1127	Had menopause	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.023209261864255912	0.01997309833114281	0.2833082119294814	53.414355400813655	7	3.0704110868218286e-9	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-a-316	ieu-a-1127	Had menopause	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.02613831803225943	0.02192569104892112	0.2866990079111958	47.13808844544045	6	1.7561416590291144e-8	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1127	Had menopause	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.02613831803225943	0.02192569104892112	0.2866990079111958	36.7051677889224	5	6.862368808051215e-7	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-b-1209	ieu-a-1127	Number of live births	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.02418156975508239	0.04797331751282356	0.6278032024018343	30.20449671121665	9	4.049159343928654e-4	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1127	Number of live births	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.02418156975508239	0.04797331751282356	0.6278032024018343	29.274733334031104	8	2.837475586611291e-4	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-a-317	ieu-a-1127	Number of live births	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.024673172515066698	0.03402126489036271	0.6005480877634819	0.6817471725065913	2	0.7111488015088785	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1127	Number of live births	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.024673172515066698	0.03402126489036271	0.6005480877634819	0.15579157930784085	1	0.693061040271305	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-26	ieu-a-1127	Average weekly red wine intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.015287002961115941	0.0173634450821491	0.3974632042600963	83.43183518465761	12	9.104688249657568e-13	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1127	Average weekly red wine intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.015287002961115941	0.0173634450821491	0.3974632042600963	77.9397268173613	11	3.6878369008307406e-12	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-b-1707	ieu-a-1127	Average weekly spirits intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.08266509533734975	0.1298820712503125	0.6391640829612388	38.40979349766088	2	4.5647743762010475e-9	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1127	Average weekly spirits intake	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.08266509533734975	0.1298820712503125	0.6391640829612388	27.336281720224015	1	1.70973090165942e-7	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-d-20406	ieu-a-1127	Ever addicted to alcohol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.374545023405199	1	0.540537204372514	Ever addicted to alcohol (M/F) Neale lab/2018 [  6K]	Alcohol
ukb-b-223	ieu-a-1127	Current tobacco smoking	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	34	-0.004322996589027468	0.0065321914813597295	0.5128380201411613	46.67749007109792	33	0.057683418238936135	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1127	Current tobacco smoking	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	34	-0.004322996589027468	0.0065321914813597295	0.5128380201411613	46.047250458453846	32	0.05150600070373229	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-17685	ieu-a-1127	Maternal smoking around birth	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.010888160896090706	0.011695650530355008	0.36765161623898157	14.60748527171381	15	0.4800424343616662	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1127	Maternal smoking around birth	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.010888160896090706	0.011695650530355008	0.36765161623898157	13.740802239985085	14	0.46919474439157577	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-4801	ieu-a-1127	Number of unsuccessful stop-smoking attempts	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.1092810183856474	0.055341497570713834	0.2984257486710427	19.99464453332434	2	4.552166157787782e-5	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1127	Number of unsuccessful stop-smoking attempts	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.1092810183856474	0.055341497570713834	0.2984257486710427	4.081115217383441	1	0.04336502838927734	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-a-225	ieu-a-1127	Smoking status: Current	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	-0.017765089954139265	0.01628323287186699	0.2950793740213284	38.90894689395139	14	3.767332083688006e-4	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1127	Smoking status: Current	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	-0.017765089954139265	0.01628323287186699	0.2950793740213284	35.64523589678011	13	6.73397789152518e-4	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-d-22506_114	ieu-a-1127	Tobacco smoking: Never smoked	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.21856811041838678	0.08778347061125027	0.24313184135270072	6.6053584813110104	2	0.036784480781270744	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1127	Tobacco smoking: Never smoked	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.21856811041838678	0.08778347061125027	0.24313184135270072	0.40598071914415423	1	0.5240166156264218	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
met-a-558	ieu-a-1127	1-arachidonoylglycerophosphocholine*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.001902743597676381	0.00938191599668172	0.8726151007120271	0.04160023887815644	2	0.9794147109676613	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1127	1-arachidonoylglycerophosphocholine*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.001902743597676381	0.00938191599668172	0.8726151007120271	4.684632118248266e-4	1	0.9827319260490033	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-682	ieu-a-1127	1-arachidonoylglycerophosphoethanolamine*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	2.641441637522109	1	0.10410903349908875	1-arachidonoylglycerophosphoethanolamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1127	1-arachidonoylglycerophosphoinositol*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.028757543981385268	0.09880399423113242	0.8196891121727248	6.447000739751195	2	0.0398154452694466	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1127	1-arachidonoylglycerophosphoinositol*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.028757543981385268	0.09880399423113242	0.8196891121727248	5.943503488454039	1	0.01477162740329071	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-427	ieu-a-1127	2-hydroxyisobutyrate	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.3778651185135222	1	0.5387480090800699	2-hydroxyisobutyrate (M/F) Shin/2014 [  6K]	Metabolites
met-a-500	ieu-a-1127	3-dehydrocarnitine*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.026312518394899093	0.0403991198320152	0.6324803621204417	3.0346913257009476	2	0.21929319318886495	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1127	3-dehydrocarnitine*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.026312518394899093	0.0403991198320152	0.6324803621204417	2.1307890449534583	1	0.14436642450433962	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-841	ieu-a-1127	Albumin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0538204807451156	0.05790555868933844	0.523266585113968	0.9516586031062335	2	0.6213695400106768	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1127	Albumin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0538204807451156	0.05790555868933844	0.523266585113968	0.08777618923285739	1	0.7670235384613452	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-851	ieu-a-1127	Average number of double bonds in a fatty acid chain	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.0032991228866798544	0.009372032323871106	0.7481007106059805	3.67724856748998	4	0.4514436337699831	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1127	Average number of double bonds in a fatty acid chain	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.0032991228866798544	0.009372032323871106	0.7481007106059805	3.5313829319881602	3	0.3167146118594603	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-a-362	ieu-a-1127	Betaine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.013337603310732766	0.01462976468576071	0.5293925010085034	0.9004333901593772	2	0.6374899957080399	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1127	Betaine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.013337603310732766	0.01462976468576071	0.5293925010085034	0.06928051530049975	1	0.792387243130405	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-c-875	ieu-a-1127	Cholesterol esters in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.004335673264197201	0.010312073433711799	0.6822556455707984	20.739754104614534	12	0.0543237068073299	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1127	Cholesterol esters in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.004335673264197201	0.010312073433711799	0.6822556455707984	20.411728164020335	11	0.040003742925653916	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-887	ieu-a-1127	Cholesterol esters in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.0010479321001567515	0.007138805503633032	0.8862120451026464	3.8628541231082787	11	0.9737583467259494	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1127	Cholesterol esters in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.0010479321001567515	0.007138805503633032	0.8862120451026464	3.841305715200386	10	0.9542220892176624	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-910	ieu-a-1127	Cholesterol esters in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.006119162404616156	0.0076692494876643685	0.4404425328957968	14.299466600394467	13	0.35309726200283	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1127	Cholesterol esters in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.006119162404616156	0.0076692494876643685	0.4404425328957968	13.579077318799705	12	0.3283908024846846	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-958	ieu-a-1127	Concentration of chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.007980679179464533	0.013628094044865787	0.5835744293592804	3.946139765342613	6	0.6839651628008621	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1127	Concentration of chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.007980679179464533	0.013628094044865787	0.5835744293592804	3.603206620964698	5	0.6078318965973601	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-878	ieu-a-1127	Concentration of large HDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.01342497192706687	0.009183019194914443	0.1777793842761529	13.379415387982371	10	0.20322495470617183	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1127	Concentration of large HDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.01342497192706687	0.009183019194914443	0.1777793842761529	10.811889280102253	9	0.2888237383254441	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-890	ieu-a-1127	Concentration of large VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.0017686593639060467	0.0076430907585983004	0.8228081018542107	3.5273625192690714	9	0.9396853995391118	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1127	Concentration of large VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.0017686593639060467	0.0076430907585983004	0.8228081018542107	3.473813642929679	8	0.9012124421193266	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-913	ieu-a-1127	Concentration of medium VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	4.4079964563414615e-4	0.006301420748745654	0.9453837498500796	12.250183253709059	13	0.5072433306924957	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1127	Concentration of medium VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	4.4079964563414615e-4	0.006301420748745654	0.9453837498500796	12.245189929147024	12	0.42619454061593554	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1127	Concentration of small HDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.002130825169804567	0.012565092415008021	0.8761285762105603	3.8395904703799872	4	0.4281499705459916	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1127	Concentration of small HDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.002130825169804567	0.012565092415008021	0.8761285762105603	3.8031331672033186	3	0.2835219011391976	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1127	Concentration of small VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.007116371810171141	0.00818822880221783	0.40055516543975245	18.077739835163726	14	0.203263070797875	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1127	Concentration of small VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.007116371810171141	0.00818822880221783	0.40055516543975245	17.08505723869094	13	0.19544487182637466	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-950	ieu-a-1127	Concentration of very large VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.0010403735339451178	0.01110644928448246	0.9284187048588701	3.7705434617636913	7	0.8057944870832001	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1127	Concentration of very large VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.0010403735339451178	0.01110644928448246	0.9284187048588701	3.7617688458453777	6	0.7088782417193344	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-876	ieu-a-1127	Free cholesterol in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.007520942197926231	0.00879449887226147	0.40793273655017315	26.77443385180753	14	0.02059510103695043	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1127	Free cholesterol in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.007520942197926231	0.00879449887226147	0.40793273655017315	25.348401022588526	13	0.02076597004936178	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1127	Free cholesterol in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.0035334548827865974	0.008563714973086408	0.6895496923967308	4.41156723544813	10	0.9268767061324932	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1127	Free cholesterol in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.0035334548827865974	0.008563714973086408	0.6895496923967308	4.241322107445188	9	0.8948234097387481	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1127	Free cholesterol in medium HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.010080578928850685	0.012157559349749377	0.4678242268567305	3.228729197548505	4	0.5203032241233286	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1127	Free cholesterol in medium HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.010080578928850685	0.012157559349749377	0.4678242268567305	2.5412205705946196	3	0.4678876405356666	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1127	Free cholesterol in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.007080172376910828	0.006938921310800361	0.331609810186261	12.857866741374433	11	0.3027166398371221	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1127	Free cholesterol in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.007080172376910828	0.006938921310800361	0.331609810186261	11.645429549336566	10	0.30948712720322524	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1127	Free cholesterol in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.0038662400670436492	0.008243526913002964	0.6474734283515424	13.202188880629937	13	0.4323181914868485	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1127	Free cholesterol in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.0038662400670436492	0.008243526913002964	0.6474734283515424	12.964544509915815	12	0.37162300831183287	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1127	Free cholesterol in very large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.007999868380921222	0.008219930283479511	0.35135553860842117	15.119122308556745	12	0.23498655227499315	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1127	Free cholesterol in very large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.007999868380921222	0.008219930283479511	0.35135553860842117	13.920476600364116	11	0.2374251195361433	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-573	ieu-a-1127	Isobutyrylcarnitine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.003392587245631346	0.010323803691338668	0.7978727597045875	0.763262578488901	2	0.6827467428696079	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1127	Isobutyrylcarnitine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.003392587245631346	0.010323803691338668	0.7978727597045875	0.6552728188559429	1	0.4182337933808447	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1127	Isovalerylcarnitine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.16259331295403037	0.07844401139679172	0.28616925961898154	7.033118892173743	2	0.029701449011818613	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1127	Isovalerylcarnitine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.16259331295403037	0.07844401139679172	0.28616925961898154	1.3279525053129584	1	0.24916979606439502	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-c-896	ieu-a-1127	Mean diameter for LDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	-0.0060809184473264305	0.014922533014364048	0.6977820310939485	18.87545769966162	7	0.008586564291611174	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1127	Mean diameter for LDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	-0.0060809184473264305	0.014922533014364048	0.6977820310939485	18.36713052966562	6	0.0053773179102500806	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1127	Mean diameter for VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.017587127794702916	0.011387989050051894	0.14845348058282798	16.775216532514726	13	0.20978470361479634	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1127	Mean diameter for VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.017587127794702916	0.011387989050051894	0.14845348058282798	13.993884722313712	12	0.3010989581853533	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-959	ieu-a-1127	Phospholipids in chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	-0.003025611061409244	0.010756997203509044	0.7879522094618153	4.0408402053470995	7	0.7750615804346332	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1127	Phospholipids in chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	-0.003025611061409244	0.010756997203509044	0.7879522094618153	3.961727891448853	6	0.6818558240195844	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1127	Phospholipids in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.00479797450112021	0.008928003465346552	0.6076385655516889	4.185265495726826	8	0.8400331396656464	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1127	Phospholipids in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.00479797450112021	0.008928003465346552	0.6076385655516889	3.896458857801112	7	0.7916231680516375	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1127	Phospholipids in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.0043590072834940015	0.006263388560572522	0.49871392218961674	14.633731180302394	14	0.4036411609036044	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1127	Phospholipids in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.0043590072834940015	0.006263388560572522	0.49871392218961674	14.108099373058561	13	0.366275379263457	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1127	Phospholipids in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.008573215657026031	0.00832090968940794	0.32317887111521193	15.01379724001972	13	0.30649223406248144	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1127	Phospholipids in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.008573215657026031	0.00832090968940794	0.32317887111521193	13.793568447889221	12	0.31408449203849015	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1127	Phospholipids in very large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.00833818850809746	0.01070186239049321	0.4614237295938015	4.502148484687694	8	0.8092181196366676	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1127	Phospholipids in very large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.00833818850809746	0.01070186239049321	0.4614237295938015	3.895098162341795	7	0.7917777318659351	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-355	ieu-a-1127	Proline	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01423379764223373	0.009294408897870901	0.36826444668360936	2.5382673728474976	2	0.28107501543736035	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1127	Proline	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01423379764223373	0.009294408897870901	0.36826444668360936	0.19296941826019734	1	0.6604566026307754	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1127	Pyroglutamine*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0020743176854607424	0.014517789093467248	0.9096505824502733	0.32739542850645315	2	0.8489986232776274	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1127	Pyroglutamine*	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0020743176854607424	0.014517789093467248	0.9096505824502733	0.30698041956811317	1	0.5795390586272122	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-844	ieu-a-1127	Ratio of bisallylic groups to double bonds	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-8.096147307645552e-4	0.010782473142237993	0.9469807293942073	2.670308665876972	3	0.44529662961559485	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1127	Ratio of bisallylic groups to double bonds	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-8.096147307645552e-4	0.010782473142237993	0.9469807293942073	2.6628023132455287	2	0.26410694672852486	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1127	Ratio of bisallylic groups to total fatty acids	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.007760236834226017	0.007534406216525542	0.36122475787163877	5.8040656920197	5	0.32575347906431107	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1127	Ratio of bisallylic groups to total fatty acids	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.007760236834226017	0.007534406216525542	0.36122475787163877	4.587428240908674	4	0.3323062550064883	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-a-464	ieu-a-1127	Serine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.052489079283368476	0.09737199330146473	0.6852532301737184	4.299446671221555	2	0.11651638925030677	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1127	Serine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.052489079283368476	0.09737199330146473	0.6852532301737184	3.331399526630095	1	0.06796901546891126	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-c-864	ieu-a-1127	Total cholesterol in HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.003945900598740118	0.007999784030541336	0.6324871620435073	10.932232347055283	11	0.44895802208800534	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1127	Total cholesterol in HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.003945900598740118	0.007999784030541336	0.6324871620435073	10.672572457313901	10	0.38358994143897934	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1127	Total cholesterol in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.0027739238090521766	0.00865874660854313	0.7542044738463232	20.987673098607765	13	0.07317279573890752	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1127	Total cholesterol in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.0027739238090521766	0.00865874660854313	0.7542044738463232	20.809696259034364	12	0.05323756908959322	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1127	Total cholesterol in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.002715773869637891	0.009072389611631065	0.7723062876261101	3.4781589042469956	9	0.9422947836858364	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1127	Total cholesterol in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.002715773869637891	0.009072389611631065	0.7723062876261101	3.388551514727487	8	0.9076649642554027	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1127	Total cholesterol in medium HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.014600926566660297	0.01011194137698262	0.2222523831189905	6.045206471479702	5	0.3018449572323644	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1127	Total cholesterol in medium HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.014600926566660297	0.01011194137698262	0.2222523831189905	3.9602751814034534	4	0.41140871432159987	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1127	Total cholesterol in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.00706158958955181	0.007913680757125957	0.3884368071934581	18.3959340511355	14	0.18933828287038074	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1127	Total cholesterol in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.00706158958955181	0.007913680757125957	0.3884368071934581	17.334217050542822	13	0.18447255178232266	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1127	Total cholesterol in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.0048752888860596946	0.00819835316166458	0.5615545782002507	17.73526531527044	15	0.2768391301445052	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1127	Total cholesterol in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.0048752888860596946	0.00819835316166458	0.5615545782002507	17.298323661650755	14	0.24062848796980998	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1127	Total cholesterol in very large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.010699035458979055	0.007344248524621255	0.17311972929552263	11.352547010543267	12	0.4989712150099068	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1127	Total cholesterol in very large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.010699035458979055	0.007344248524621255	0.17311972929552263	9.230306871249919	11	0.6006432228751903	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-957	ieu-a-1127	Total lipids in chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.0015519027635204562	0.010407781272087803	0.8856718835053892	2.809322019096201	8	0.9457476952885336	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1127	Total lipids in chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.0015519027635204562	0.010407781272087803	0.8856718835053892	2.7870882700326995	7	0.9039750712227664	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-877	ieu-a-1127	Total lipids in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.012578888144407939	0.009374101898257669	0.21250635102926074	13.142972948008714	10	0.215787562930753	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1127	Total lipids in large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.012578888144407939	0.009374101898257669	0.21250635102926074	10.951835703687111	9	0.2790248169851499	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-889	ieu-a-1127	Total lipids in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	2.497940889923797e-4	0.010519517227639318	0.981718122766588	6.026538615050539	8	0.6442590381540018	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1127	Total lipids in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	2.497940889923797e-4	0.010519517227639318	0.981718122766588	6.0259747532211065	7	0.5367197064553869	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-912	ieu-a-1127	Total lipids in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.0025314341577620278	0.006613469124851423	0.7099007940917269	6.99897145548589	11	0.7991667888352807	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1127	Total lipids in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.0025314341577620278	0.006613469124851423	0.7099007940917269	6.852458978369084	10	0.7392964586429625	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1127	Total lipids in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.009582467926787193	0.008421547150504643	0.2773914640483505	16.696374160435404	13	0.2135584223193965	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1127	Total lipids in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.009582467926787193	0.008421547150504643	0.2773914640483505	15.07039704819856	12	0.23760919316155993	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1127	Total lipids in very large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.007520093079863175	0.008828608736354543	0.41249270427013696	15.646750091431546	12	0.20795641978459112	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1127	Total lipids in very large HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.007520093079863175	0.008828608736354543	0.41249270427013696	14.678576678504877	11	0.1976897395818871	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1127	Total lipids in very large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.0021361560813511916	0.011299856814165475	0.856291805046774	3.0675622886879848	7	0.8786825847661466	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1127	Total lipids in very large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.0021361560813511916	0.011299856814165475	0.856291805046774	3.0318251248645214	6	0.8048419737351366	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-960	ieu-a-1127	Triglycerides in chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-8.075150918234834e-4	0.01069552696584269	0.9419291319380365	4.204260665414476	8	0.8382400078546585	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1127	Triglycerides in chylomicrons and largest VLDL particles	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-8.075150918234834e-4	0.01069552696584269	0.9419291319380365	4.198560375800535	7	0.7566442203029826	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1127	Triglycerides in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	-0.003289255089440448	0.009961282909286015	0.7509083300854443	3.6424992369036184	8	0.8878533590911751	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1127	Triglycerides in large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	-0.003289255089440448	0.009961282909286015	0.7509083300854443	3.5334645799726503	7	0.8316683459649937	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1127	Triglycerides in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.002209707174543089	0.006881009687638555	0.7541298079626411	7.343340846559534	12	0.8341154377895408	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1127	Triglycerides in medium VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.002209707174543089	0.006881009687638555	0.7541298079626411	7.2402155731529465	11	0.7793100385639709	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1127	Triglycerides in small HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	-0.004922416152599932	0.008784249839620468	0.5889031600750094	7.493601928752925	10	0.6781674796420547	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1127	Triglycerides in small HDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	-0.004922416152599932	0.008784249839620468	0.5889031600750094	7.179589169115411	9	0.618427709711165	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1127	Triglycerides in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	-0.003505908527382534	0.007012201909477314	0.6261362309948273	9.064233776300243	13	0.7680751176348094	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1127	Triglycerides in small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	-0.003505908527382534	0.007012201909477314	0.6261362309948273	8.814261217334893	12	0.718707806234913	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1127	Triglycerides in very large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.005603960535402963	0.009724939479432542	0.5824941775739068	4.51103888706962	8	0.8083276874722312	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1127	Triglycerides in very large VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.005603960535402963	0.009724939479432542	0.5824941775739068	4.178979071899908	7	0.7589472307973851	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-956	ieu-a-1127	Triglycerides in very small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	19	0.015783632283201576	0.00878280897771778	0.09010674118679884	31.153694816617538	18	0.027630712490432013	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1127	Triglycerides in very small VLDL	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	19	0.015783632283201576	0.00878280897771778	0.09010674118679884	26.180109502642615	17	0.07124104419369512	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-a-316	ieu-a-1127	Uridine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.004859384146280448	0.02338337881804683	0.8695583757101972	0.5803800970016437	2	0.7481213747215248	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1127	Uridine	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.004859384146280448	0.02338337881804683	0.8695583757101972	0.5371936044089362	1	0.46359812050134147	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-485	ieu-a-1127	X-02269	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.06654609318233798	1	0.7964336918599085	X-02269 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1127	X-03094	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.0012887823055585822	0.021801035860417036	0.9565774943827485	6.122670439048232	4	0.19017255625283808	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1127	X-03094	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.0012887823055585822	0.021801035860417036	0.9565774943827485	6.115546521398906	3	0.10612197986504047	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1127	X-10510	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	4.302479391401582e-4	0.012545653586261111	0.9781759445531655	0.12718063972560834	2	0.9383893602747329	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1127	X-10510	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	4.302479391401582e-4	0.012545653586261111	0.9781759445531655	0.12600452140668567	1	0.7226112002849191	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1127	X-11315	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01852615919827345	0.07439457196682464	0.8446256551447516	10.337393991989487	2	0.0056919806629415585	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1127	X-11315	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01852615919827345	0.07439457196682464	0.8446256551447516	9.733766241933086	1	0.0018091340723679532	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1127	X-11440	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.006624224721569759	0.008668161064895699	0.5845874503461559	0.7446644636076516	2	0.6891252551613022	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1127	X-11440	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.006624224721569759	0.008668161064895699	0.5845874503461559	0.16065999612091864	1	0.6885496000692499	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-517	ieu-a-1127	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.8836996100896773	1	0.34719038432349486	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate (M/F) Shin/2014 [  2K]	Metabolites
met-a-519	ieu-a-1127	X-11469	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.31768605219834717	1	0.573001572401825	X-11469 (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1127	X-12510--2-aminooctanoic acid	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.016295828543366104	0.020260657948025194	0.5687774265532226	7.781956414645907	2	0.020425356029503364	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1127	X-12510--2-aminooctanoic acid	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.016295828543366104	0.020260657948025194	0.5687774265532226	4.725177917576876	1	0.029724108031492773	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
prot-a-54	ieu-a-1127	Advanced glycosylation end product-specific receptor, soluble	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.0020076514581074873	0.02160908381849094	0.9318336951735551	8.44772169039339	4	0.07648779516734505	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1127	Advanced glycosylation end product-specific receptor, soluble	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.0020076514581074873	0.02160908381849094	0.9318336951735551	8.423484935114887	3	0.03802422317716247	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1127	Alcohol dehydrogenase [NADP(+)]	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.006197411278050855	0.013348453070225495	0.7232836733209198	1.670801631365741	2	0.4337006125834439	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1127	Alcohol dehydrogenase [NADP(+)]	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.006197411278050855	0.013348453070225495	0.7232836733209198	1.3745171407486156	1	0.2410372900689741	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1411	ieu-a-1127	Alpha-L-iduronidase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.05192039420516025	1	0.8197547139924386	Alpha-L-iduronidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1127	Angiopoietin-related protein 4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.05360705403762491	0.031834641525067875	0.3411559067412342	2.8715591155537847	2	0.2379298116646574	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1127	Angiopoietin-related protein 4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.05360705403762491	0.031834641525067875	0.3411559067412342	0.03596572762507628	1	0.849586285775746	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1127	Beta-1,4-galactosyltransferase 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.039431582030458316	0.0323103878127552	0.3094910532573098	24.682595802790363	4	5.826939429386911e-5	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1127	Beta-1,4-galactosyltransferase 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.039431582030458316	0.0323103878127552	0.3094910532573098	16.494008026618136	3	8.979353219167312e-4	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1127	Beta-1,4-glucuronyltransferase 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.010602623904791112	0.02673482428708744	0.7596386390414657	2.5522628236322795	2	0.27911499550350577	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1127	Beta-1,4-glucuronyltransferase 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.010602623904791112	0.02673482428708744	0.7596386390414657	2.2053988545013072	1	0.13752831868466361	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1127	Beta-crystallin B2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.16743398759890488	0.05569043096033852	0.20441896229105974	17.23196421635888	2	1.8118678306113607e-4	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1127	Beta-crystallin B2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.16743398759890488	0.05569043096033852	0.20441896229105974	1.7164817890853454	1	0.19014654655781787	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1127	C-C motif chemokine 14	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.010893005179122617	0.013618969128717589	0.5705084350117502	0.6408209361531241	2	0.7258510372390393	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1127	C-C motif chemokine 14	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.010893005179122617	0.013618969128717589	0.5705084350117502	0.001075863844761095	1	0.9738337883507234	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1127	C-C motif chemokine 17	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.011083468503127386	0.01005975381303031	0.33240121344870577	2.680114034629461	5	0.7491581869904267	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1127	C-C motif chemokine 17	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.011083468503127386	0.01005975381303031	0.33240121344870577	1.4662314584290652	4	0.8326058308908331	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1127	C-C motif chemokine 23	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03128794119746572	0.037876762697014885	0.5604637028931948	1.3592842165843504	2	0.5067983388354635	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1127	C-C motif chemokine 23	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03128794119746572	0.037876762697014885	0.5604637028931948	0.6769325330843468	1	0.41064500071515153	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1127	C-C motif chemokine 3-like 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.008823089609966167	0.0176364972686297	0.7046929853592101	0.5018791083986466	2	0.7780694011655073	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1127	C-C motif chemokine 3-like 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.008823089609966167	0.0176364972686297	0.7046929853592101	0.25160454682563616	1	0.6159475260082329	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1127	C-reactive protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0824895016659927	0.0713978516280692	0.45419393512979284	1.77817907048188	2	0.41102981060073657	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1127	C-reactive protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0824895016659927	0.0713978516280692	0.45419393512979284	0.4433456490413794	1	0.5055120576973736	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1127	Cadherin-7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.016434772900843515	0.025213575521462223	0.5814138801351763	9.125742303765424	3	0.02766495675200262	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1127	Cadherin-7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.016434772900843515	0.025213575521462223	0.5814138801351763	7.526781391341945	2	0.0232049259905093	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-488	ieu-a-1127	Cadherin-related family member 3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.7073709185084933	1	0.40031798726661383	Cadherin-related family member 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1127	Calcium/calmodulin-dependent protein kinase type 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02667998819907273	0.046702789058833925	0.6695765419167519	0.6515018151063606	2	0.72198500604678	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1127	Calcium/calmodulin-dependent protein kinase type 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02667998819907273	0.046702789058833925	0.6695765419167519	0.325150300900582	1	0.5685288183225632	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1127	Calpastatin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.014575070180735582	0.007561453425414388	0.19373022849863225	4.2007067273637455	3	0.2405911379301663	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1127	Calpastatin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.014575070180735582	0.007561453425414388	0.19373022849863225	0.4852625017293559	2	0.7845607665416943	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-550	ieu-a-1127	Carbohydrate sulfotransferase 11	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.33752025921229395	1	0.5612640844582327	Carbohydrate sulfotransferase 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-643	ieu-a-1127	Carboxypeptidase A4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.7104637773574707	1	0.3992898920428906	Carboxypeptidase A4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1127	Cardiotrophin-1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.15218908550210705	0.11015875956466482	0.39886757342991375	1.951659328807955	2	0.376879540276921	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1127	Cardiotrophin-1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.15218908550210705	0.11015875956466482	0.39886757342991375	0.042997707688726856	1	0.8357295888010772	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-722	ieu-a-1127	Cathepsin F	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	12.919972741703969	1	3.2509459418108807e-4	Cathepsin F (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1127	Cell growth regulator with EF hand domain protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.005204455242941611	0.013325113008765797	0.7337878483610802	0.42058893229441163	3	0.9359572209423783	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1127	Cell growth regulator with EF hand domain protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.005204455242941611	0.013325113008765797	0.7337878483610802	0.2680401468354457	2	0.8745725087678344	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1127	Cerebral cavernous malformations 2 protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.034844300585943545	0.026957599535286095	0.3253547025216148	12.278552376453899	3	0.006487396191517607	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1127	Cerebral cavernous malformations 2 protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.034844300585943545	0.026957599535286095	0.3253547025216148	6.690014970330893	2	0.03525995123005777	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1127	Coiled-coil domain-containing protein 134	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.08561571623822904	0.03705174440111171	0.2600157549462065	5.394158894810723	2	0.0674020768725817	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1127	Coiled-coil domain-containing protein 134	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.08561571623822904	0.03705174440111171	0.2600157549462065	0.054793166497303744	1	0.8149233364794648	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1127	Complement C1q tumor necrosis factor-related protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.006961451793969233	0.011420437860791161	0.5750793678902534	8.43452650063509	5	0.13385830618670502	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1127	Complement C1q tumor necrosis factor-related protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.006961451793969233	0.011420437860791161	0.5750793678902534	7.717627535165005	4	0.10248698744621286	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1127	Complement C1q tumor necrosis factor-related protein 5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.03219659288773699	0.03544667947690726	0.45959049930783313	6.325777386005322	3	0.09679253635065575	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1127	Complement C1q tumor necrosis factor-related protein 5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.03219659288773699	0.03544667947690726	0.45959049930783313	4.478381996435884	2	0.10654466434609505	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1127	Complement component C8	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02330122088064081	0.013140574695981597	0.32689496853989786	3.406407773235239	2	0.18209916336731885	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1127	Complement component C8	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02330122088064081	0.013140574695981597	0.32689496853989786	0.26207404035935167	1	0.608698828557046	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1127	Complement factor B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.011563990995752652	0.00801495160619194	0.28585329400550724	2.2775853248891322	3	0.5168285586861586	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1127	Complement factor B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.011563990995752652	0.00801495160619194	0.28585329400550724	0.19590670977112232	2	0.906691195482136	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1127	Complement factor H-related protein 5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.014587447801743815	0.011603005539868129	0.4277677708483059	1.7904464674303404	2	0.40851639382893035	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1127	Complement factor H-related protein 5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.014587447801743815	0.011603005539868129	0.4277677708483059	0.20986228723319741	1	0.6468753632587333	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1127	Contactin-4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.04155176021401906	0.03176281426619155	0.4154984533951896	1.7443297467377614	2	0.4180455532329862	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1127	Contactin-4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.04155176021401906	0.03176281426619155	0.4154984533951896	0.032971617993487475	1	0.8559116505895626	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1127	Contactin-5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01890608958920931	0.03655729330483146	0.6961517195751123	0.272813610804699	2	0.8724876276042702	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1127	Contactin-5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01890608958920931	0.03655729330483146	0.6961517195751123	0.005355756139482255	1	0.9416604688611521	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1127	Corneodesmosin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.008963990062809084	0.019045876959662936	0.6842263518977266	1.0154586840943192	3	0.7975114818292	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1127	Corneodesmosin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.008963990062809084	0.019045876959662936	0.6842263518977266	0.793944885749206	2	0.6723525534809962	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1127	CREB-binding protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.039734372834095116	0.013461936772583265	0.09817217797195574	10.165973334165201	3	0.017206730297963574	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1127	CREB-binding protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.039734372834095116	0.013461936772583265	0.09817217797195574	1.4539780405116323	2	0.4833621949852596	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-735	ieu-a-1127	CUB and zona pellucida-like domain-containing protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.10276462696863446	1	0.7485368638111799	CUB and zona pellucida-like domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-706	ieu-a-1127	Cystatin-8	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.16440884638753214	1	0.685129414651615	Cystatin-8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1127	Delta-like protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	7.589702627971651e-4	0.01462235106177852	0.9669860021230026	0.2597813620809759	2	0.8781914286465119	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1127	Delta-like protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	7.589702627971651e-4	0.01462235106177852	0.9669860021230026	0.2570872534245895	1	0.6121283497469769	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1127	Desmocollin-3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.06619468969659577	0.3833475118324019	0.8911448516929343	3.111417780372161	2	0.21103972561167944	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1127	Desmocollin-3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.06619468969659577	0.3833475118324019	0.8911448516929343	3.0213313535723785	1	0.08217597870856203	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1127	Diamine acetyltransferase 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01175452988881125	0.019061098126612597	0.6482093749719995	0.578619686326473	2	0.7487801650415609	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1127	Diamine acetyltransferase 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01175452988881125	0.019061098126612597	0.6482093749719995	0.19832987061869728	1	0.6560723169838518	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1127	Dihydropteridine reductase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.013950682456039318	0.010396500852478216	0.31169274071662567	2.411886672872571	3	0.49142575801495214	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1127	Dihydropteridine reductase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.013950682456039318	0.010396500852478216	0.31169274071662567	0.6112896825230794	2	0.736648200047452	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1127	Discoidin, CUB and LCCL domain-containing protein 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.010605433510807036	0.13266289702337244	0.9492148832767735	3.756027137394305	2	0.1528935167722641	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1127	Discoidin, CUB and LCCL domain-containing protein 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.010605433510807036	0.13266289702337244	0.9492148832767735	3.732175404146439	1	0.05337383735529055	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1127	DnaJ homolog subfamily B member 11	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.007512353478532521	0.014847019900743115	0.7017924744854782	0.4122198900165354	2	0.8137436043172084	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1127	DnaJ homolog subfamily B member 11	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.007512353478532521	0.014847019900743115	0.7017924744854782	0.15620015257332331	1	0.6926793162427652	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1127	DnaJ homolog subfamily B member 9	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.012555607323798124	0.039751394065188767	0.7820282592586473	7.0847926132779016	3	0.06924369242242717	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1127	DnaJ homolog subfamily B member 9	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.012555607323798124	0.039751394065188767	0.7820282592586473	6.748182215456965	2	0.034249233032768195	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1127	Dual specificity protein kinase CLK2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.00693892728857807	0.022067303052993294	0.8060507443302168	2.4475351547328876	2	0.29411995714309314	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1127	Dual specificity protein kinase CLK2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.00693892728857807	0.022067303052993294	0.8060507443302168	2.227310047126751	1	0.1355897255121224	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1127	E3 ubiquitin-protein ligase RNF8	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.008717427888836123	0.036060209444524496	0.8489965495569535	2.9317116821739346	2	0.2308803100419435	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1127	E3 ubiquitin-protein ligase RNF8	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.008717427888836123	0.036060209444524496	0.8489965495569535	2.7698385772692884	1	0.09605584765278588	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1127	Endothelin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.028105199448183835	0.014661881897630284	0.30611207461887957	3.7463655879781226	2	0.1536338977732081	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1127	Endothelin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.028105199448183835	0.014661881897630284	0.30611207461887957	0.07190232764154961	1	0.7885868667607179	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1127	Eotaxin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0029789928034517784	0.015983151113807815	0.8826907243694564	0.08702104691636806	2	0.9574224786425342	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1127	Eotaxin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0029789928034517784	0.015983151113807815	0.8826907243694564	0.05228230413055663	1	0.8191384410663817	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1127	Epididymal secretory protein E1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0232328233044177	0.009397564573436814	0.24470104211719435	7.0493938319843	2	0.029460735093780083	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1127	Epididymal secretory protein E1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0232328233044177	0.009397564573436814	0.24470104211719435	0.9375346180020042	1	0.33291268234841515	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1127	Epididymal-specific lipocalin-10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01964999713481004	0.018155378278861455	0.47484461820099283	4.490005466997701	2	0.10592725082113127	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1127	Epididymal-specific lipocalin-10	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01964999713481004	0.018155378278861455	0.47484461820099283	2.0677693585951373	1	0.15044141818792758	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1127	Epididymis-specific alpha-mannosidase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.07107528152717275	0.0347328056951875	0.2893740419827939	6.109677689006343	2	0.04713031546775275	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1127	Epididymis-specific alpha-mannosidase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.07107528152717275	0.0347328056951875	0.2893740419827939	1.177763449673148	1	0.2778117834841835	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1127	Estrogen sulfotransferase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03699059748103438	0.021737982817195727	0.3382350222654807	12.101788556703726	2	0.0023557543640910965	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1127	Estrogen sulfotransferase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03699059748103438	0.021737982817195727	0.3382350222654807	3.1064975085025517	1	0.07798048625953286	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1127	Extracellular sulfatase Sulf-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.06802597349915725	0.05728491506696643	0.44556500835553814	4.531807634895433	2	0.10373623353985799	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1127	Extracellular sulfatase Sulf-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.06802597349915725	0.05728491506696643	0.44556500835553814	1.8802917719851235	1	0.170300989656343	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-71	ieu-a-1127	fatty acid binding protein 4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03318171774051164	0.05351086280212027	0.646635927822527	0.4627240455783942	2	0.7934521662675224	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1127	fatty acid binding protein 4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03318171774051164	0.05351086280212027	0.646635927822527	0.07820857108167605	1	0.77973993965673	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1127	Ferritin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01733409439711139	0.018927368286062955	0.5279541309583301	7.291657407702939	2	0.026099771907929392	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1127	Ferritin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01733409439711139	0.018927368286062955	0.5279541309583301	3.965595775228079	1	0.04643908575317188	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1127	Fibroblast growth factor 7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.009358076135669514	0.020909036610614468	0.7320950747321764	0.21380512320309603	2	0.8986132281583982	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1127	Fibroblast growth factor 7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.009358076135669514	0.020909036610614468	0.7320950747321764	0.013493983321206788	1	0.9075228797708321	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1117	ieu-a-1127	Filamin-A	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.6001573753513176	1	0.43851798655607643	Filamin-A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1127	Galanin peptides	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0066950927602179005	0.05586168521180889	0.9240625392994517	5.663950428878501	2	0.058896405671521906	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1127	Galanin peptides	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0066950927602179005	0.05586168521180889	0.9240625392994517	5.583743736127578	1	0.018127931088096346	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1127	Gamma-interferon-inducible protein 16	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0051124754759058425	0.034517910330939296	0.9063902739982321	2.6585539969616927	2	0.26466854790344524	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1127	Gamma-interferon-inducible protein 16	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0051124754759058425	0.034517910330939296	0.9063902739982321	2.6014856982564476	1	0.10676358876412824	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1127	GDH/6PGL endoplasmic bifunctional protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.020135789810160766	0.02509364007867606	0.5065041362611914	13.975446834473379	3	0.002938765044908524	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1127	GDH/6PGL endoplasmic bifunctional protein	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.020135789810160766	0.02509364007867606	0.5065041362611914	10.57189212203035	2	0.005062240733406572	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1127	Glycolipid transfer protein domain-containing protein 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.020601971307342093	0.02368465457530195	0.5442421768082548	1.0964007239643632	2	0.5779890460371384	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1127	Glycolipid transfer protein domain-containing protein 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.020601971307342093	0.02368465457530195	0.5442421768082548	0.33977091790299735	1	0.5599614822895639	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1127	Glycosaminoglycan xylosylkinase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.07769300528200358	0.026757310451113115	0.21115113228177515	17.07619958561453	2	1.958620853059548e-4	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1127	Glycosaminoglycan xylosylkinase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.07769300528200358	0.026757310451113115	0.21115113228177515	1.8106463047115893	1	0.17843071900392615	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1127	Granulins	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.01248642134285345	0.009023151056293118	0.3006152795686673	3.239103132325873	3	0.35620868198821815	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1127	Granulins	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.01248642134285345	0.009023151056293118	0.3006152795686673	1.3241439755648585	2	0.5157815335312932	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-55	ieu-a-1127	growth differentiation factor 15	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.001143065547333067	0.014880053866612706	0.9511915901318666	0.006828166781943679	2	0.9965917379649791	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1127	growth differentiation factor 15	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.001143065547333067	0.014880053866612706	0.9511915901318666	9.270628537541378e-4	1	0.9757099978928523	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1127	Hemoglobin subunit zeta	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0025697387128347793	0.01288597888976699	0.8746883627713193	1.631285519762328	2	0.4423549079763749	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1127	Hemoglobin subunit zeta	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0025697387128347793	0.01288597888976699	0.8746883627713193	1.5688924606797592	1	0.21036792818005629	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1313	ieu-a-1127	Heparin-binding EGF-like growth factor	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	12.595478211169883	1	3.866811062575255e-4	Heparin-binding EGF-like growth factor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1127	Hepatocyte nuclear factor 4-alpha	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.015420424102708621	0.0212847858845314	0.5211602672152835	5.871710037919563	4	0.2089360875329	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1127	Hepatocyte nuclear factor 4-alpha	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.015420424102708621	0.0212847858845314	0.5211602672152835	4.997380367546026	3	0.1719890671863036	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1127	Histo-blood group ABO system transferase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.028194303878024282	0.01102637800764357	0.23733042079128908	6.544002461666375	2	0.0379304434971508	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1127	Histo-blood group ABO system transferase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.028194303878024282	0.01102637800764357	0.23733042079128908	0.005820567118395184	1	0.9391862801647995	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1127	Histone-lysine N-methyltransferase SUV420H2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01021985175710382	0.014429399272898009	0.6076817627662611	1.3994272312981502	2	0.49672753841722805	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1127	Histone-lysine N-methyltransferase SUV420H2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01021985175710382	0.014429399272898009	0.6076817627662611	0.8977866172720144	1	0.34337589447406186	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1127	HLA class II histocompatibility antigen, DQ alpha 2 chain	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.01363134199865151	0.008490675335935971	0.24961547658921313	4.691495611478533	3	0.19583221906539702	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1127	HLA class II histocompatibility antigen, DQ alpha 2 chain	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.01363134199865151	0.008490675335935971	0.24961547658921313	2.049822651504185	2	0.3588282828233453	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1127	Immunoglobulin superfamily containing leucine-rich repeat protein 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0019355562201738598	0.03662618546054008	0.9626581270001778	13.473883646871275	3	0.003716226937757589	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1127	Immunoglobulin superfamily containing leucine-rich repeat protein 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0019355562201738598	0.03662618546054008	0.9626581270001778	13.455095454950017	2	0.0011974658731783126	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1127	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01221016209119595	0.021370240856631813	0.6695328520945789	6.1913309902693285	2	0.045244892183301265	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1127	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01221016209119595	0.021370240856631813	0.6695328520945789	4.667575254649973	1	0.0307372945354953	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1127	Inducible T-cell costimulator	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.010279811112019133	0.0226801481999636	0.7290835397407095	0.30985827369553776	2	0.8564758679130408	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1127	Inducible T-cell costimulator	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.010279811112019133	0.0226801481999636	0.7290835397407095	0.10442135463428029	1	0.7465869976794738	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1127	Intercellular adhesion molecule 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0416396999227006	0.02841499459211384	0.3812187443374941	21.069673368628006	2	2.659368744829252e-5	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1127	Intercellular adhesion molecule 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0416396999227006	0.02841499459211384	0.3812187443374941	6.6942362219690805	1	0.00967250968507406	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-38	ieu-a-1127	interleukin 1 receptor like 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02666880207145242	0.03409598122032267	0.5774289180220621	5.093864874982187	2	0.07832155414023108	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1127	interleukin 1 receptor like 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02666880207145242	0.03409598122032267	0.5774289180220621	3.160382332082609	1	0.07544551205215883	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1127	Interleukin-17 receptor A	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.004419206775872287	0.008094902996770945	0.6818754144137364	0.29912492140929386	2	0.8610846523858255	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1127	Interleukin-17 receptor A	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.004419206775872287	0.008094902996770945	0.6818754144137364	0.001091239667093539	1	0.9736475406018069	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1127	Interleukin-21	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.016044247597057856	0.022324839969745547	0.6032915355784403	1.9261249236621163	2	0.3817220848084184	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1127	Interleukin-21	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.016044247597057856	0.022324839969745547	0.6032915355784403	1.270120340893518	1	0.2597441052461115	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1127	Interleukin-3 receptor subunit alpha	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.011920949048410493	0.020252260055301518	0.6613105358449656	5.432208335476443	2	0.06613189197709138	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1127	Interleukin-3 receptor subunit alpha	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.011920949048410493	0.020252260055301518	0.6613105358449656	4.0343856533457165	1	0.044581904498173994	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1540	ieu-a-1127	Interleukin-6 receptor subunit alpha	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.4434104247632775e-4	1	0.9904142845561769	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1541	ieu-a-1127	Interleukin-6 receptor subunit alpha	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	9.14005254514844e-4	1	0.9758816133147743	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1127	Interleukin-6 receptor subunit beta	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.014304149278653464	0.04114396113261974	0.761274342623735	17.80528527366825	3	4.824496717781042e-4	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1127	Interleukin-6 receptor subunit beta	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.014304149278653464	0.04114396113261974	0.761274342623735	16.790563143324526	2	2.2593085164940356e-4	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1127	Kallikrein-12	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.020258986546109085	0.013273816044798874	0.3692563369295007	2.4937180109225534	2	0.2874061216495389	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1127	Kallikrein-12	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.020258986546109085	0.013273816044798874	0.3692563369295007	0.1643192361646358	1	0.685210636529138	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1659	ieu-a-1127	Kallikrein-14	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.6224867772267907	1	0.4301246824450751	Kallikrein-14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1127	Kallikrein-7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.005172965055796126	0.008181518956784135	0.641065332964008	0.6157760121376855	2	0.7349976286736618	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1127	Kallikrein-7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.005172965055796126	0.008181518956784135	0.641065332964008	0.21600508499383764	1	0.6421008488937319	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1127	Kelch-like protein 13	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.042014458462659283	0.057253277518282034	0.5969719501902588	2.877927618767334	2	0.23717338823996093	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1127	Kelch-like protein 13	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.042014458462659283	0.057253277518282034	0.5969719501902588	1.8705894133607905	1	0.17140758853585375	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1644	ieu-a-1127	Killer cell immunoglobulin-like receptor 2DL5A	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.028132344150097625	1	0.8667980597426216	Killer cell immunoglobulin-like receptor 2DL5A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1127	Kunitz-type protease inhibitor 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.004296917184472553	0.014235110171993576	0.8133708756003417	0.3715804653227086	2	0.8304477775325662	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1127	Kunitz-type protease inhibitor 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.004296917184472553	0.014235110171993576	0.8133708756003417	0.280464957165076	1	0.5963966292041616	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2666	ieu-a-1127	L-Selectin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	6.957448535508092	1	0.008347098365658306	L-Selectin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1792	ieu-a-1127	Leucine-rich repeat neuronal protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	3.348100444392567	1	0.06728261386918252	Leucine-rich repeat neuronal protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1127	Leukocyte immunoglobulin-like receptor subfamily B member 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.022484864376186256	0.07163642839776528	0.8063805010926128	0.3719040253161628	2	0.8303134385608072	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1127	Leukocyte immunoglobulin-like receptor subfamily B member 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.022484864376186256	0.07163642839776528	0.8063805010926128	0.27338668133338595	1	0.601068952408216	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1746	ieu-a-1127	Leukocyte immunoglobulin-like receptor subfamily B member 4	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.7065993636144724	1	0.40057505756804745	Leukocyte immunoglobulin-like receptor subfamily B member 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1127	Low affinity immunoglobulin gamma Fc region receptor II-a	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	3.1198574713515884e-4	0.010450483012702768	0.9788949372149442	1.1595670532061186	3	0.7627172231226671	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1127	Low affinity immunoglobulin gamma Fc region receptor II-a	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	3.1198574713515884e-4	0.010450483012702768	0.9788949372149442	1.158675808874471	2	0.5602691955380661	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1127	Low-density lipoprotein receptor-related protein 1B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0029576566509617683	0.03743672905378324	0.9498086536618107	6.0771344100395455	2	0.047903476207361066	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1127	Low-density lipoprotein receptor-related protein 1B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0029576566509617683	0.03743672905378324	0.9498086536618107	6.039438323119496	1	0.013989734437640407	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2356	ieu-a-1127	Lysosomal Pro-X carboxypeptidase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.02132449931092609	1	0.8838984127665368	Lysosomal Pro-X carboxypeptidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1127	MAGUK p55 subfamily member 6	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01663870326485316	0.025477077003023322	0.6316893231461234	4.304579123622332	2	0.11621776517178796	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1127	MAGUK p55 subfamily member 6	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01663870326485316	0.025477077003023322	0.6316893231461234	3.0175378381261835	1	0.08236843288808567	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1127	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.03258865020593092	0.049668338910619655	0.6303345467401525	9.081599763811212	2	0.01066487250232117	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1127	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.03258865020593092	0.049668338910619655	0.6303345467401525	6.348547894341707	1	0.011747741899408123	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1127	MAP kinase-activated protein kinase 5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.006883727705060465	0.02548375190823815	0.8123864404240068	12.274348973836847	3	0.006500080013594959	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1127	MAP kinase-activated protein kinase 5	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.006883727705060465	0.02548375190823815	0.8123864404240068	11.84230603323873	2	0.0026821058807537513	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1127	Maspardin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.010022232052821618	0.01249159128225626	0.5695476750511982	2.436258406780286	2	0.2957829994768187	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1127	Maspardin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.010022232052821618	0.01249159128225626	0.5695476750511982	1.482166289446317	1	0.22343589358124602	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1127	MHC class I polypeptide-related sequence B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.01699882849636716	0.01043641906776804	0.24490497705383038	4.533339355623275	3	0.20933570140590815	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1127	MHC class I polypeptide-related sequence B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.01699882849636716	0.01043641906776804	0.24490497705383038	1.8803533120592828	2	0.39055883469093067	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1127	Multimerin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.002452351998769604	0.011904588621917445	0.8558567993243269	2.9644560939243454	3	0.39713787540968604	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1127	Multimerin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.002452351998769604	0.011904588621917445	0.8558567993243269	2.902862812080999	2	0.23423476296013876	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1127	Myeloblastin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.018380901408137012	0.01362332997824872	0.4060516343217763	2.6908004978484867	2	0.2604354479885245	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1127	Myeloblastin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.018380901408137012	0.01362332997824872	0.4060516343217763	0.8703995243282784	1	0.35084472717376103	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1127	Myeloblastin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.017873395934272295	0.028318567271366075	0.6415748513663282	5.5216537168986966	2	0.06323945665636573	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1127	Myeloblastin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.017873395934272295	0.028318567271366075	0.6415748513663282	3.948674633955251	1	0.04690829923159073	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1127	Myeloperoxidase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-1.3776535064978653e-4	0.009598200345291102	0.9898512436400249	0.1581043454326998	3	0.9840511773136249	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1127	Myeloperoxidase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-1.3776535064978653e-4	0.009598200345291102	0.9898512436400249	0.15789832970233672	2	0.9240868993461504	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1127	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.004778820987230504	0.04469808201607804	0.9321944242883455	11.412430342333298	2	0.003325234200325706	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1127	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.004778820987230504	0.04469808201607804	0.9321944242883455	11.283455246503737	1	7.820087472931331e-4	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1127	NAD-dependent protein deacetylase sirtuin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.03858404480188809	0.015956015949768844	0.24963348467802823	5.862197737802708	2	0.05333839402755461	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1127	NAD-dependent protein deacetylase sirtuin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.03858404480188809	0.015956015949768844	0.24963348467802823	0.014746850424527292	1	0.9033452202776907	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2025	ieu-a-1127	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.048004063656754525	1	0.826573477505447	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1127	Neural cell adhesion molecule 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.04543945563204025	0.04014801949314171	0.4606910860771932	1.3266226764337494	2	0.5151426954175498	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1127	Neural cell adhesion molecule 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.04543945563204025	0.04014801949314171	0.4606910860771932	0.045655542701791674	1	0.8308031779288684	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1127	Neurensin-1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.07331134612686786	0.04253065843084592	0.33466251475861436	3.4173391467955967	2	0.18110658141944522	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1127	Neurensin-1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.07331134612686786	0.04253065843084592	0.33466251475861436	0.4460961195344287	1	0.5041946988637028	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1127	Neuropeptide W	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0033601392499228743	0.013537443800931881	0.8451142498824896	0.12345511211208506	2	0.9401389870765262	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1127	Neuropeptide W	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0033601392499228743	0.013537443800931881	0.8451142498824896	0.06184652942551573	1	0.8036008750589742	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1127	Neutrophil-activating peptide 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.019862682010488245	0.04533103922826675	0.7370936658677536	1.0961494593668712	2	0.5780616646911707	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1127	Neutrophil-activating peptide 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.019862682010488245	0.04533103922826675	0.7370936658677536	0.9041568864386926	1	0.34166953707044445	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1127	PAX-interacting protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.009453551317925715	0.018447106165755997	0.6985145907410149	1.7227564440096788	2	0.4225792727370329	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1127	PAX-interacting protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.009453551317925715	0.018447106165755997	0.6985145907410149	1.3644261590339388	1	0.2427718601132407	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2341	ieu-a-1127	Peptidyl-prolyl cis-trans isomerase E	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.12126942126305156	1	0.7276617573186493	Peptidyl-prolyl cis-trans isomerase E (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1127	PH and SEC7 domain-containing protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.014021839636445661	0.02090649889036211	0.5714950849975108	8.247988687491677	3	0.04115514005132358	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1127	PH and SEC7 domain-containing protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.014021839636445661	0.02090649889036211	0.5714950849975108	6.733522184583143	2	0.03450120278250315	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1127	Platelet-activating factor acetylhydrolase IB subunit beta	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.026788466228848958	0.06612317209286642	0.754951830321404	0.28066108209126067	2	0.8690709243053203	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1127	Platelet-activating factor acetylhydrolase IB subunit beta	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.026788466228848958	0.06612317209286642	0.754951830321404	0.11653094264010502	1	0.7328278507216917	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1127	Plexin-B2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.021636891216287403	0.012841108216983428	0.34098192964668944	3.5497993055419044	2	0.1695004575473378	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1127	Plexin-B2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.021636891216287403	0.012841108216983428	0.34098192964668944	0.7106730154664983	1	0.39922047758383095	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1127	Potassium voltage-gated channel subfamily E member 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.020299243578003476	0.018949308770495246	0.47811240171544767	1.150007572233004	2	0.5627027383447992	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1127	Potassium voltage-gated channel subfamily E member 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.020299243578003476	0.018949308770495246	0.47811240171544767	0.0024540117929057474	1	0.960490568019472	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1127	PR domain zinc finger protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.29952799471472874	0.09723024609791346	0.1998225436785172	9.491887860938217	2	0.00868685834428955	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1127	PR domain zinc finger protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.29952799471472874	0.09723024609791346	0.1998225436785172	0.001759906988378721	1	0.9665375644269143	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1127	Pro-FMRFamide-related neuropeptide FF	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.04312933619698672	0.04238693308220986	0.49447337175837114	1.598073286329924	2	0.44976203681426286	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1127	Pro-FMRFamide-related neuropeptide FF	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.04312933619698672	0.04238693308220986	0.49447337175837114	0.5627367040198431	1	0.45315967978556293	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1127	Probable carboxypeptidase X1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	9.200419606915968e-4	0.013757950582585327	0.9574903169836277	0.023743320527275544	2	0.9881985298627224	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1127	Probable carboxypeptidase X1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	9.200419606915968e-4	0.013757950582585327	0.9574903169836277	0.019271258904126357	1	0.8895916307589269	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1127	Prostaglandin F2 receptor negative regulator	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.004131700327785953	0.011146092510312518	0.7740106950809351	0.33119613748849414	2	0.8473867569747793	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1127	Prostaglandin F2 receptor negative regulator	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.004131700327785953	0.011146092510312518	0.7740106950809351	0.19378803490689078	1	0.6597823930646168	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1127	Protein eva-1 homolog C	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	3.7389040791197887e-4	0.03053155848705222	0.9922043242895431	0.06848918434489612	2	0.9663351177237339	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1127	Protein eva-1 homolog C	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	3.7389040791197887e-4	0.03053155848705222	0.9922043242895431	0.06833921907269046	1	0.7937704011902386	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1127	Protein FAM3B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.050902332302058276	0.013302485466952405	0.16273066483413687	14.886411061645362	2	5.854056508254545e-4	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1127	Protein FAM3B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.050902332302058276	0.013302485466952405	0.16273066483413687	0.2440949910378758	1	0.6212640151981733	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2030	ieu-a-1127	Protein kinase C-binding protein NELL1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.7131257777563529	1	0.3984080783805009	Protein kinase C-binding protein NELL1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2329	ieu-a-1127	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	4.768633258213895	1	0.028982825518121775	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1127	Protein S100-A13	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Wald ratio	1	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1127	Protein S100-A13	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1127	Protein shisa-3 homolog	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.025537597037120534	0.021210890797165673	0.44124639970133006	15.68913772753211	2	3.9187452301436425e-4	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1127	Protein shisa-3 homolog	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.025537597037120534	0.021210890797165673	0.44124639970133006	6.4048271726224275	1	0.011381050441894835	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1127	Protein-tyrosine sulfotransferase 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.04500940331962627	0.03366109212241452	0.3129724124903621	7.9873282504195195	3	0.046274319776597773	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1127	Protein-tyrosine sulfotransferase 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.04500940331962627	0.03366109212241452	0.3129724124903621	4.217254155738095	2	0.12140453103455999	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1127	Reticulon-4 receptor	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01232926318003417	0.015136518873995681	0.564843225471201	1.365649571299683	2	0.5051879273070828	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1127	Reticulon-4 receptor	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01232926318003417	0.015136518873995681	0.564843225471201	0.7021781314722798	1	0.402052776988054	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2493	ieu-a-1127	Retinoic acid receptor responder protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	2.9055156212883237	1	0.08827701903534432	Retinoic acid receptor responder protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1127	Rho GTPase-activating protein 30	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.03547242533600021	0.01613116194532697	0.11527964752805557	5.117222345526828	4	0.2754798414005015	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1127	Rho GTPase-activating protein 30	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.03547242533600021	0.01613116194532697	0.11527964752805557	0.2816212860296323	3	0.9634471295938299	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2561	ieu-a-1127	RING finger protein 122	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.15279020432378224	1	0.6958830729791182	RING finger protein 122 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1127	rRNA methyltransferase 3, mitochondrial	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0016883803491029709	0.011704669375623996	0.8985274315057487	3.62219484607175	3	0.3052562313548298	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1127	rRNA methyltransferase 3, mitochondrial	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0016883803491029709	0.011704669375623996	0.8985274315057487	3.584898257031676	2	0.16655176307875377	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1127	Secretory phospholipase A2 receptor	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Wald ratio	1	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1127	Secretory phospholipase A2 receptor	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2820	ieu-a-1127	Serine protease inhibitor Kazal-type 6	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.4671254935651665	1	0.4943125566624851	Serine protease inhibitor Kazal-type 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1127	Serine/threonine-protein kinase 16	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.037362814214179446	0.016187325464888037	0.14732296397089623	8.142924398035397	3	0.04314841862776808	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1127	Serine/threonine-protein kinase 16	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.037362814214179446	0.016187325464888037	0.14732296397089623	2.222545030615911	2	0.32913985896582604	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2878	ieu-a-1127	Serine/threonine-protein kinase 17B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	3.477541824412453	1	0.06220708285418691	Serine/threonine-protein kinase 17B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1127	Sialic acid-binding Ig-like lectin 7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0021181487298948588	0.01139455183559021	0.8829934297607536	0.06879226093475498	2	0.9661886920424928	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1127	Sialic acid-binding Ig-like lectin 7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0021181487298948588	0.01139455183559021	0.8829934297607536	0.03423666345399391	1	0.8532043129021288	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1127	Solute carrier family 22 member 16	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0030038717537703838	0.020239597580512615	0.8956275162180838	5.623602530031592	3	0.13142991019901856	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1127	Solute carrier family 22 member 16	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0030038717537703838	0.020239597580512615	0.8956275162180838	5.562341167071137	2	0.0619659286100938	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1127	Stromal interaction molecule 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.019652031393697915	0.033573621832463964	0.662864376721658	3.4701466692440546	2	0.17638726451865208	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1127	Stromal interaction molecule 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.019652031393697915	0.033573621832463964	0.662864376721658	2.584599398657405	1	0.10790770608387114	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1127	Syntaxin-7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.007847046668623467	0.01124232360327396	0.612058727017939	0.5515564053351851	2	0.7589812521110036	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1127	Syntaxin-7	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.007847046668623467	0.01124232360327396	0.612058727017939	0.06436422739431058	1	0.7997265157712504	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1127	Tenascin-X	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.030225365243719944	0.033278250246947375	0.5305814364600977	1.3719353419017875	2	0.503602672038714	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1127	Tenascin-X	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.030225365243719944	0.033278250246947375	0.5305814364600977	0.5469957477502246	1	0.4595478348214471	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1127	Thioredoxin domain-containing protein 12	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	-0.03833117438575355	0.0390731725111328	0.3716402739042493	14.132234546699117	6	0.02819341026580698	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1127	Thioredoxin domain-containing protein 12	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	-0.03833117438575355	0.0390731725111328	0.3716402739042493	11.851167577241156	5	0.03688503011412959	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1127	Thiosulfate sulfurtransferase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-8.635238240834005e-4	0.011556941826097152	0.952520596365532	0.012896340670132673	2	0.9935725745025705	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1127	Thiosulfate sulfurtransferase	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-8.635238240834005e-4	0.011556941826097152	0.952520596365532	0.007313402815742115	1	0.9318492397250367	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1127	Torsin-1A-interacting protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0013384037757292288	0.022553594887899132	0.9580748754971893	6.114056030514477	3	0.10619110219110582	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1127	Torsin-1A-interacting protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0013384037757292288	0.022553594887899132	0.9580748754971893	6.103309256009918	2	0.047280627782302784	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1127	Transmembrane glycoprotein NMB	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.018172771694533983	0.011084717501510067	0.34868493406294176	2.7865994122580964	2	0.2482547838056697	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1127	Transmembrane glycoprotein NMB	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.018172771694533983	0.011084717501510067	0.34868493406294176	0.09882334662942864	1	0.7532462593012639	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3000	ieu-a-1127	Transmembrane protein 132C	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	5.91010024351106	1	0.01505431517906391	Transmembrane protein 132C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1127	Trefoil factor 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.03326278313131849	0.038744429290192166	0.48107125980807863	17.302293540570698	3	6.124394945506609e-4	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1127	Trefoil factor 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.03326278313131849	0.038744429290192166	0.48107125980807863	12.64301017285414	2	0.0017972364733601033	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1127	Trypsin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02491087962305337	0.027126753359827564	0.5270922648281255	1.9533543577990948	2	0.3765602647178955	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1127	Trypsin-2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02491087962305337	0.027126753359827564	0.5270922648281255	1.059704637683067	1	0.30328255990538344	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1127	Trypsin-3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.04886748644434258	0.020677810168686465	0.14190609703039742	7.366375448612752	3	0.06109309246946803	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1127	Trypsin-3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.04886748644434258	0.020677810168686465	0.14190609703039742	1.7812759518714725	2	0.41039384781762395	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2930	ieu-a-1127	Tubulin-specific chaperone A	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.9950808862389662	1	0.1578106404033704	Tubulin-specific chaperone A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1127	Tumor necrosis factor receptor superfamily member 1B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.016398012754110656	0.015331680299306748	0.4786133156280341	3.784385207433688	2	0.15074093110124	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1127	Tumor necrosis factor receptor superfamily member 1B	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.016398012754110656	0.015331680299306748	0.4786133156280341	1.7651551234694307	1	0.18398280897773192	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1127	Tyrosine-protein kinase receptor Tie-1, soluble	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.003029508296671786	0.007846106056608338	0.7366149584922148	0.5241075760452529	3	0.913564044041149	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1127	Tyrosine-protein kinase receptor Tie-1, soluble	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.003029508296671786	0.007846106056608338	0.7366149584922148	0.37502189144719267	2	0.8290200439064817	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1127	Ubiquitin carboxyl-terminal hydrolase 25	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.005352575913417847	0.018716130921512548	0.8226682520092551	1.0336423836234252	2	0.5964134217035195	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1127	Ubiquitin carboxyl-terminal hydrolase 25	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.005352575913417847	0.018716130921512548	0.8226682520092551	0.9518536428279643	1	0.32924791689527333	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1127	Ubiquitin-like protein ISG15	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.009087357802881092	0.011885689611583443	0.5244236723419542	2.0387667014092576	3	0.5643996427620447	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1127	Ubiquitin-like protein ISG15	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.009087357802881092	0.011885689611583443	0.5244236723419542	1.4542102109628603	2	0.48330608703251676	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1127	Urea transporter 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.012132625950658145	0.027449735099603707	0.7016926997642889	8.829517560475235	3	0.03164555391615024	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1127	Urea transporter 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.012132625950658145	0.027449735099603707	0.7016926997642889	8.0438031147879	2	0.017918858783962033	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3193	ieu-a-1127	Vascular cell adhesion protein 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	24.643547017173653	1	6.897532852802943e-7	Vascular cell adhesion protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1127	Vascular endothelial growth factor receptor 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0021087380806505476	0.019185711573593306	0.9225142145284744	6.671008216809996	3	0.08315691577210434	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1127	Vascular endothelial growth factor receptor 2	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0021087380806505476	0.019185711573593306	0.9225142145284744	6.630955170271499	2	0.03631670011883056	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1127	Vascular endothelial growth factor receptor 3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	9.595234886916878e-4	0.022676015970411773	0.9700925391502644	9.231453297421124	3	0.02636673123869653	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1127	Vascular endothelial growth factor receptor 3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	9.595234886916878e-4	0.022676015970411773	0.9700925391502644	9.223196166650581	2	0.00993592717401432	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1127	Xyloside xylosyltransferase 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.002410399358676578	0.03138102270560536	0.9511965962730671	0.013392499664216715	2	0.9933261200894206	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1127	Xyloside xylosyltransferase 1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.002410399358676578	0.03138102270560536	0.9511965962730671	0.007492610948620404	1	0.9310213658942862	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1127	Zinc fingers and homeoboxes protein 3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.037041502618806184	0.017642321600007543	0.28297524055130435	5.152284688861151	2	0.07606687857285016	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1127	Zinc fingers and homeoboxes protein 3	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.037041502618806184	0.017642321600007543	0.28297524055130435	0.7440396977940865	1	0.38836988390675403	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
ieu-a-1	ieu-a-1127	Adiponectin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	-0.00949960844905101	0.004623479597569417	0.07008502068752243	15.129065464774634	10	0.12742673576476765	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1127	Adiponectin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	-0.00949960844905101	0.004623479597569417	0.07008502068752243	10.298446917640272	9	0.32686896646835184	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1127	Apoliprotein A	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	222	-0.0018070674528232304	0.00144945363859609	0.2138247520687979	535.1628341127074	221	4.408400905676782e-28	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1127	Apoliprotein A	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	222	-0.0018070674528232304	0.00144945363859609	0.2138247520687979	531.4083886934443	220	8.579669257263116e-28	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-780	ieu-a-1127	HDL cholesterol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	37	5.190981115879118e-4	0.003663284704025358	0.8881271956455196	59.02457377446544	36	0.009113863773900988	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1127	HDL cholesterol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	37	5.190981115879118e-4	0.003663284704025358	0.8881271956455196	58.990730429391476	35	0.006801619589233077	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1127	HDL cholesterol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	245	-0.0012021811172041698	0.0013211447925951477	0.3637484020658478	557.9009396170113	244	1.255739855608464e-26	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1127	HDL cholesterol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	245	-0.0012021811172041698	0.0013211447925951477	0.3637484020658478	556.0063617610574	243	1.416160636680615e-26	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-299	ieu-a-1127	HDL cholesterol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	78	0.0012893142745479566	0.0028717688909687105	0.6547368856772494	176.9661714423214	77	7.690085394773607e-10	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1127	HDL cholesterol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	78	0.0012893142745479566	0.0028717688909687105	0.6547368856772494	176.49806462729583	76	5.71180987512147e-10	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1127	IGF-1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	318	-9.799896012914191e-4	0.0016098850365566131	0.5431389896509025	779.329557670714	317	7.243887667444131e-41	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1127	IGF-1	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	318	-9.799896012914191e-4	0.0016098850365566131	0.5431389896509025	778.4167520653054	316	6.044066140225174e-41	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-1049	ieu-a-1127	Iron	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.019970155441980948	0.0103044560813542	0.30326008312948655	4.1617037960109675	2	0.12482382971993022	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1127	Iron	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.019970155441980948	0.0103044560813542	0.30326008312948655	0.40581482501334437	1	0.5241014151036794	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1127	Platelet count	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	394	-4.5883800364848284e-5	0.0012288436408520245	0.9702337119700077	843.9997667324719	393	4.847185457955521e-35	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1127	Platelet count	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	394	-4.5883800364848284e-5	0.0012288436408520245	0.9702337119700077	843.9967649430334	392	3.296780076317333e-35	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ieu-a-1047	ieu-a-1127	Putamen volume	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.009799320862824095	0.01728080579148414	0.62782954194181	2.059731876917568	3	0.5601021346028685	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1127	Putamen volume	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.009799320862824095	0.01728080579148414	0.62782954194181	1.7381704275892134	2	0.41933497569549283	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1127	Reticulocyte percentage	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	249	-6.842753093454701e-4	0.001581222951695318	0.665573520082237	552.1704576745063	248	3.276891691901237e-25	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1127	Reticulocyte percentage	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	249	-6.842753093454701e-4	0.001581222951695318	0.665573520082237	551.7521242355075	247	2.4531086574083896e-25	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ieu-a-302	ieu-a-1127	Triglycerides	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	0.005773546379977118	0.003477000900056109	0.10295152598110993	188.05445238448573	52	2.7367411465613335e-17	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1127	Triglycerides	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	0.005773546379977118	0.003477000900056109	0.10295152598110993	178.4090064669586	51	4.908703170432113e-16	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-783	ieu-a-1127	Triglycerides	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	27	0.009386016366116549	0.005057498849888879	0.07529943999938261	75.27798887228906	26	1.0978411747660682e-6	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1127	Triglycerides	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	27	0.009386016366116549	0.005057498849888879	0.07529943999938261	66.16281430507593	25	1.4061459897547917e-5	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ukb-a-11	ieu-a-1127	Morning/evening person (chronotype)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	77	0.0010182221130577908	0.00460151548780582	0.8254759792667867	164.6376297069672	76	1.72237075782885e-8	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1127	Morning/evening person (chronotype)	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	77	0.0010182221130577908	0.00460151548780582	0.8254759792667867	164.53021402945106	75	1.1819794653127913e-8	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-b-4424	ieu-a-1127	Sleep duration	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	66	-7.069929639540028e-4	0.006700063214226744	0.9162929608213785	182.58204988970456	65	4.1740309886284036e-13	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1127	Sleep duration	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	66	-7.069929639540028e-4	0.006700063214226744	0.9162929608213785	182.55029029607977	64	2.4677928315836623e-13	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-a-14	ieu-a-1127	Snoring	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	0.009065257607774355	0.01962087739866445	0.6496016006457482	78.65509170168284	19	3.1677111690193654e-9	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1127	Snoring	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	0.009065257607774355	0.01962087739866445	0.6496016006457482	77.73324701726051	18	2.129367826385274e-9	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-b-15895	ieu-a-1127	Treatment/medication code: allopurinol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.01090886575973332	0.010596282432978926	0.32750215685385664	80.30417764895184	11	1.2887709388311472e-12	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1127	Treatment/medication code: allopurinol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.01090886575973332	0.010596282432978926	0.32750215685385664	72.60861630109063	10	1.386759401433204e-11	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-a-142	ieu-a-1127	Treatment/medication code: allopurinol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	-0.00814657453226281	0.01092627551604	0.4730735085754456	68.97201558803451	11	1.9149517411739296e-10	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1127	Treatment/medication code: allopurinol	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	-0.00814657453226281	0.01092627551604	0.4730735085754456	65.33970525215209	10	3.489819326069488e-10	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1127	Treatment/medication code: aspirin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	-0.02804882995387511	0.022106979507841126	0.2603784230064755	24.96826397882086	6	3.4610540962148596e-4	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1127	Treatment/medication code: aspirin	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	-0.02804882995387511	0.022106979507841126	0.2603784230064755	18.8873198580627	5	0.0020172647995341146	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1127	Treatment/medication code: insulin product	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.020011821737163357	0.017945338524596115	0.3074469524230967	44.75670500478466	7	1.5246550082911634e-7	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1127	Treatment/medication code: insulin product	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.020011821737163357	0.017945338524596115	0.3074469524230967	37.07291590488869	6	1.7041846041489147e-6	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1127	Treatment/medication code: ramipril	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	-0.017461310290250748	0.021701193497423943	0.46613873466114475	18.811656193136077	5	0.002083720016202481	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1127	Treatment/medication code: ramipril	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	-0.017461310290250748	0.021701193497423943	0.46613873466114475	16.191051658358088	4	0.002773228251310804	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ieu-a-974	ieu-a-1128	Body mass index	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	36	0.018763454915884006	0.009009840176882987	0.044886289197212624	91.36638430865561	35	6.315520560943847e-7	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1128	Body mass index	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	36	0.018763454915884006	0.009009840176882987	0.044886289197212624	81.03021708205935	34	1.032211195778942e-5	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-95	ieu-a-1128	Body mass index	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.056045559090530286	0.03858739662022758	0.18033666279893698	65.4206441336813	10	3.367504682476933e-10	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1128	Body mass index	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.056045559090530286	0.03858739662022758	0.18033666279893698	52.9981302091616	9	2.925289075022944e-8	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-b-19953	ieu-a-1128	Body mass index (BMI)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	415	0.00913950044616293	0.0023093331816668246	8.910191455349266e-5	733.2488333656138	414	4.1068548478338406e-20	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1128	Body mass index (BMI)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	415	0.00913950044616293	0.0023093331816668246	8.910191455349266e-5	706.4567044269259	413	1.0091382168601561e-17	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-248	ieu-a-1128	Body mass index (BMI)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	289	0.011305512440452267	0.0029670186403363235	1.697657302291254e-4	527.2891762541839	288	2.8560229440463857e-16	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1128	Body mass index (BMI)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	289	0.011305512440452267	0.0029670186403363235	1.697657302291254e-4	501.89851737060377	287	6.405345990699461e-14	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-34	ieu-a-1128	Comparative body size at age 10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	144	0.011199080363915639	0.0031301330580582555	4.7442425848909356e-4	245.4107703166491	143	2.1490261675031352e-7	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1128	Comparative body size at age 10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	144	0.011199080363915639	0.0031301330580582555	4.7442425848909356e-4	225.11715726113886	142	1.1017239219655284e-5	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-4650	ieu-a-1128	Comparative body size at age 10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	204	0.008278211057898222	0.002612035212112281	0.0017658169350626832	356.04760849226113	203	1.7413414877517762e-10	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1128	Comparative body size at age 10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	204	0.008278211057898222	0.002612035212112281	0.0017658169350626832	339.18220910581084	202	4.969770941986599e-9	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-a-35	ieu-a-1128	Comparative height size at age 10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	342	-0.0012471990910037098	0.002350227847329114	0.5959928338712097	549.8801772208686	341	5.13576689783469e-12	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1128	Comparative height size at age 10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	342	-0.0012471990910037098	0.002350227847329114	0.5959928338712097	549.4251040651063	340	4.390472564826951e-12	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ieu-a-85	ieu-a-1128	Extreme body mass index	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.04849732132297079	0.04064630339503289	0.2863326890493004	18.49380525608955	6	0.005109672221033733	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1128	Extreme body mass index	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.04849732132297079	0.04064630339503289	0.2863326890493004	14.395163267597422	5	0.013284862612996438	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-1034	ieu-a-1128	Height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.11762669238934349	0.14914635767685136	0.512945731019181	2.7617418645076413	3	0.42983667088028754	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1128	Height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.11762669238934349	0.14914635767685136	0.512945731019181	2.106596319994113	2	0.34878549962166383	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-51	ieu-a-1128	Hip circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.030388283363639	0.016658016422605483	0.089527565606707	40.058652225544364	15	4.443436346764762e-4	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1128	Hip circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.030388283363639	0.016658016422605483	0.089527565606707	32.3652749805135	14	0.0035535018198363773	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ukb-a-388	ieu-a-1128	Hip circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	261	0.011203177691839507	0.0034324062769107806	0.001246589234135806	549.318155320193	260	7.900187628859468e-23	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1128	Hip circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	261	0.011203177691839507	0.0034324062769107806	0.001246589234135806	527.6159808372437	259	1.626005337588489e-20	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ieu-a-101	ieu-a-1128	Hip circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.014861554119370667	0.07176486305561482	0.8492017763552369	5.032437045029691	4	0.28398541614621753	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1128	Hip circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.014861554119370667	0.07176486305561482	0.8492017763552369	4.961512337323887	3	0.1746371912786898	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ukb-a-269	ieu-a-1128	Impedance of whole body	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	333	-0.0054152766858600425	0.0030239248895385347	0.07423735241717261	724.7215796371034	332	2.598788986838342e-31	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1128	Impedance of whole body	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	333	-0.0054152766858600425	0.0030239248895385347	0.07423735241717261	717.7672551472418	331	1.1692192738350694e-30	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ieu-a-90	ieu-a-1128	Obesity class 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.0318693336953739	0.017154634065399275	0.08435820560344812	64.76425020023768	15	3.75780894072993e-8	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1128	Obesity class 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.0318693336953739	0.017154634065399275	0.08435820560344812	51.955978224374114	14	2.8606827365277583e-6	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-91	ieu-a-1128	Obesity class 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.0349978076257076	0.014319419428015932	0.04030717582893226	18.24660188473264	9	0.03241794808751958	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1128	Obesity class 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.0349978076257076	0.014319419428015932	0.04030717582893226	10.446382725168645	8	0.23508203615442433	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-93	ieu-a-1128	Overweight	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.031839889343320875	0.0230364565133643	0.1921108540536546	53.22411934392306	13	8.260272611176133e-7	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1128	Overweight	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.031839889343320875	0.0230364565133643	0.1921108540536546	45.914709096301195	12	7.177004420348073e-6	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ukb-b-16881	ieu-a-1128	Sitting height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	549	0.0025183712928998087	0.0017076221040256943	0.14084632272772854	856.130753846771	548	6.379224648176206e-16	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1128	Sitting height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	549	0.0025183712928998087	0.0017076221040256943	0.14084632272772854	852.7400853050052	547	9.451699191818127e-16	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-195	ieu-a-1128	Sitting height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	406	0.0037191008163366063	0.002111301958190256	0.07890676744940868	607.7331368808264	405	2.5422652255090023e-10	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1128	Sitting height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	406	0.0037191008163366063	0.002111301958190256	0.07890676744940868	603.1009735327331	404	4.5545585919047004e-10	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-b-10787	ieu-a-1128	Standing height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	710	-1.2476561281443932e-4	0.001286953314261257	0.922796321316927	1022.822106409161	709	8.825959843498942e-14	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1128	Standing height	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	710	-1.2476561281443932e-4	0.001286953314261257	0.922796321316927	1022.8085287373849	708	7.333673462102774e-14	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ieu-a-68	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	24	0.004047863720866383	0.014635596742498518	0.7846870166067204	51.195732293183546	23	6.404111367963581e-4	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	24	0.004047863720866383	0.014635596742498518	0.7846870166067204	51.01834008514522	22	4.264278183349203e-4	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ukb-b-9405	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	344	0.011453861495332422	0.0025829741906390922	1.246106926674811e-5	600.0978289904651	343	2.7240182212569395e-16	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	344	0.011453861495332422	0.0025829741906390922	1.246106926674811e-5	567.4705438744168	342	2.0016848948859576e-13	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ieu-a-62	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	17	0.022220018368254966	0.014676330648990965	0.15080926167747766	31.893116470704438	16	0.010324955640138361	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	17	0.022220018368254966	0.014676330648990965	0.15080926167747766	27.665453258289723	15	0.023759509572250204	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-105	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.02844427500081645	0.030519526313716332	0.42008514089037885	5.273516615832402	4	0.2603663508995943	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1128	Waist circumference	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.02844427500081645	0.030519526313716332	0.42008514089037885	4.08944646631163	3	0.2519661061801534	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-75	ieu-a-1128	Waist-to-hip ratio	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	0.025187987656944775	0.028610517574884583	0.3902594569227391	73.44923857924665	19	2.433950880590259e-8	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1128	Waist-to-hip ratio	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	0.025187987656944775	0.028610517574884583	0.3902594569227391	70.41715288542174	18	3.84090756352789e-8	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-109	ieu-a-1128	Waist-to-hip ratio	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.29882690925783695	0.12357266716158524	0.1367778932511989	8.741278959313194	3	0.03293603357227099	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1128	Waist-to-hip ratio	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.29882690925783695	0.12357266716158524	0.1367778932511989	2.227693914936539	2	0.3282935972296119	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-a-266	ieu-a-1128	Whole body fat-free mass	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	374	0.007538189214600296	0.002502352229829825	0.002768833700094909	739.5080154437312	373	2.0714190406794008e-26	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1128	Whole body fat-free mass	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	374	0.007538189214600296	0.002502352229829825	0.002768833700094909	721.8975903427714	372	1.1580640952215413e-24	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-2346	ieu-a-1128	Duration of moderate activity	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.052057559803437084	0.023103062768546193	0.08732788777175346	9.512012165471207	5	0.09030355618151298	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1128	Duration of moderate activity	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.052057559803437084	0.023103062768546193	0.08732788777175346	4.1915834815510635	4	0.3806983101113722	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-a-508	ieu-a-1128	Number of days/week of moderate physical activity 10+ minutes	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.032573216140699676	0.034692535123586214	0.39088223886663587	3.1817218101848015	6	0.7857175619184873	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1128	Number of days/week of moderate physical activity 10+ minutes	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.032573216140699676	0.034692535123586214	0.39088223886663587	2.3001672246227898	5	0.8062423087937348	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-b-969	ieu-a-1128	Time spend outdoors in summer	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	44	-0.01606879675506914	0.016133721685528676	0.3249656697981458	91.52047842119595	43	2.3324204890855325e-5	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1128	Time spend outdoors in summer	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	44	-0.01606879675506914	0.016133721685528676	0.3249656697981458	89.40879626075208	42	2.8260838440554768e-5	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-8865	ieu-a-1128	Time spent doing light physical activity	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.013683908143231723	0.06081519100296503	0.8591019662204198	0.2811389074325787	2	0.8688633170507918	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1128	Time spent doing light physical activity	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.013683908143231723	0.06081519100296503	0.8591019662204198	0.23051028038888857	1	0.631145721169715	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-a-487	ieu-a-1128	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0250238316334784	0.12193982533758946	0.8711452763031663	0.07969886369283395	2	0.9609341143356227	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1128	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0250238316334784	0.12193982533758946	0.8711452763031663	0.037585834491359604	1	0.8462771543355708	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-7663	ieu-a-1128	Types of physical activity in last 4 weeks: Strenuous sports	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.011848191333526057	0.04603982144290567	0.8096075895192392	12.753679175597231	5	0.025799714737471693	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1128	Types of physical activity in last 4 weeks: Strenuous sports	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.011848191333526057	0.04603982144290567	0.8096075895192392	12.545958036376959	4	0.013721202127350413	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-a-482	ieu-a-1128	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.21483156285389574	0.17898818438968914	0.2962625469513313	7.561552209205191	5	0.18211233187029846	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1128	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.21483156285389574	0.17898818438968914	0.2962625469513313	5.559338002648539	4	0.23456265030131498	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-16886	ieu-a-1128	Types of transport used (excluding work): Car/motor vehicle	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.042783574302574776	0.07800635748163587	0.6215529341136485	9.410132054582068	4	0.051626949254312715	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1128	Types of transport used (excluding work): Car/motor vehicle	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.042783574302574776	0.07800635748163587	0.6215529341136485	8.552562897652447	3	0.03587108919535492	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1128	Types of transport used (excluding work): Cycle	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	-0.016692264129599187	0.026038469133156324	0.5451749885164594	5.452084919789963	7	0.6049694539132016	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1128	Types of transport used (excluding work): Cycle	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	-0.016692264129599187	0.026038469133156324	0.5451749885164594	5.041124873617259	6	0.5385494787128761	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1128	Types of transport used (excluding work): Public transport	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.020254395523763975	0.025357673309248038	0.45068232188737256	11.808477709760203	8	0.15995587922673546	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1128	Types of transport used (excluding work): Public transport	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.020254395523763975	0.025357673309248038	0.45068232188737256	10.822120770147613	7	0.14656842857935912	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1128	Types of transport used (excluding work): Walk	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.17288053082483407	0.11909464769382083	0.2063187545480483	29.278134010158894	6	5.388870111973352e-5	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1128	Types of transport used (excluding work): Walk	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.17288053082483407	0.11909464769382083	0.2063187545480483	20.597489484064226	5	9.648550470031547e-4	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-4711	ieu-a-1128	Usual walking pace	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	4.58829513204577e-4	0.013644756307337268	0.9733060145335307	169.26326713180234	52	2.4647204963958936e-14	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1128	Usual walking pace	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	4.58829513204577e-4	0.013644756307337268	0.9733060145335307	169.25951434374954	51	1.3372180256080828e-14	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-1004	ieu-a-1128	Added milk to espresso	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.020485483428435872	0.09127810491430072	0.859452689635466	0.13826166795674807	2	0.9332045772233	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1128	Added milk to espresso	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.020485483428435872	0.09127810491430072	0.859452689635466	0.08789314625689833	1	0.766872867221031	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-d-1468_5	ieu-a-1128	Cereal type: Other (e.g. Cornflakes, Frosties)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.022537541691339945	0.06295601690901842	0.7296135803266028	65.45146791302864	9	1.1785077064181585e-10	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1128	Cereal type: Other (e.g. Cornflakes, Frosties)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.022537541691339945	0.06295601690901842	0.7296135803266028	64.4195005420601	8	6.285388944201953e-11	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-b-2221	ieu-a-1128	Cherry intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0630998020477206	0.2249197960983327	0.8258764185827527	5.208641124318201	2	0.07395336684755931	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1128	Cherry intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0630998020477206	0.2249197960983327	0.8258764185827527	4.828607084261852	1	0.02799123657180265	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1128	Dairy smoothie intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.1532286677237726	0.12350741985130223	0.43188859335267066	2.308168241103952	2	0.3153462238074293	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1128	Dairy smoothie intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.1532286677237726	0.12350741985130223	0.43188859335267066	0.7689721462363532	1	0.38053521503531884	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-16576	ieu-a-1128	Dried fruit intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	40	-0.011515282930228774	0.010813481907812976	0.29364090836076245	54.48861483271829	39	0.05078707893187383	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1128	Dried fruit intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	40	-0.011515282930228774	0.010813481907812976	0.29364090836076245	52.90966078568033	38	0.05465327024357662	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-3881	ieu-a-1128	Fresh fruit intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	0.0042578133437585	0.009420358670825671	0.6531999300768799	126.04387772145151	52	4.356490993158932e-8	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1128	Fresh fruit intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	0.0042578133437585	0.009420358670825671	0.6531999300768799	125.54100995029322	51	3.183045868813375e-8	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-d-1418_1	ieu-a-1128	Milk type used: Full cream	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0677538222042118	0.1926979745530973	0.7847556044365773	17.585779164829855	2	1.5180866963479222e-4	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1128	Milk type used: Full cream	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0677538222042118	0.1926979745530973	0.7847556044365773	15.650904880346456	1	7.617612401675056e-5	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1128	Milk type used: Skimmed	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.1063188924084608	0.03122782444722134	0.18187209846853447	11.99811304104133	2	0.002481091932061439	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1128	Milk type used: Skimmed	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.1063188924084608	0.03122782444722134	0.18187209846853447	0.40667204670346213	1	0.5236634944001761	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-b-14238	ieu-a-1128	Mineral and other dietary supplements: None of the above	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.0201857087332075	0.047347828713703626	0.6875999953124204	8.747067434347336	6	0.1883104366153605	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1128	Mineral and other dietary supplements: None of the above	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.0201857087332075	0.047347828713703626	0.6875999953124204	8.440254675439638	5	0.1335835412775826	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1128	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	-0.010475660385391498	0.017534283823490017	0.55765629124143	21.65989772085439	19	0.3015080739948343	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1128	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	-0.010475660385391498	0.017534283823490017	0.55765629124143	21.2387416800833	18	0.26753981152896006	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1128	Never eat eggs, dairy, wheat, sugar: Wheat products	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.051351800037471126	0.05152360884785628	0.3923833505610407	4.837049051194634	4	0.3044295769765056	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1128	Never eat eggs, dairy, wheat, sugar: Wheat products	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.051351800037471126	0.05152360884785628	0.3923833505610407	3.633835316545161	3	0.30381444170109523	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-6500	ieu-a-1128	Pancake intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.10367009931993025	0.16545161041821713	0.5949149106878722	2.7566827386438257	3	0.4306804383678959	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1128	Pancake intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.10367009931993025	0.16545161041821713	0.5949149106878722	2.3043278354460948	2	0.31595233425974245	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-8006	ieu-a-1128	Poultry intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.18038744464910517	0.19596290082432702	0.39953718745432953	12.020401833045895	6	0.0615152091720123	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1128	Poultry intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.18038744464910517	0.19596290082432702	0.39953718745432953	10.278496730670025	5	0.06771795794889941	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-4643	ieu-a-1128	Age at hysterectomy	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0560069249049205	0.053326032729664595	0.4037802733630118	1.7160524842039853	3	0.6333708778623626	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1128	Age at hysterectomy	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0560069249049205	0.053326032729664595	0.4037802733630118	0.612977828225057	2	0.7360266776430568	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-a-320	ieu-a-1128	Age at last live birth	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.10424490106142775	0.04896229608710335	0.1670161383444018	5.173406230451761	3	0.15953103888033757	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1128	Age at last live birth	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.10424490106142775	0.04896229608710335	0.1670161383444018	0.6404023455485095	2	0.726002970350197	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-b-17422	ieu-a-1128	Age at menopause (last menstrual period)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	102	-7.340043027644684e-4	0.004329780704498902	0.8657264966311673	214.16973862029957	101	3.944777394607116e-10	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1128	Age at menopause (last menstrual period)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	102	-7.340043027644684e-4	0.004329780704498902	0.8657264966311673	214.10820694711893	100	2.71210633265988e-10	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-4564	ieu-a-1128	Age last used hormone-replacement therapy (HRT)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.021695293871475625	0.04892473420991515	0.7008028052652441	13.938079032009728	3	0.002990660914178336	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1128	Age last used hormone-replacement therapy (HRT)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.021695293871475625	0.04892473420991515	0.7008028052652441	12.690356674029145	2	0.0017551896995139417	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-9487	ieu-a-1128	Age started hormone-replacement therapy (HRT)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	22	-0.04634206667892791	0.012251401399115066	0.001169047463141051	63.30514007241934	21	3.986085086839275e-6	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1128	Age started hormone-replacement therapy (HRT)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	22	-0.04634206667892791	0.012251401399115066	0.001169047463141051	36.90399922250137	20	0.012016038540407446	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-18541	ieu-a-1128	Ever used hormone-replacement therapy (HRT)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.005640886988831536	0.02176418207427102	0.8082866976731645	12.785769822951796	5	0.025471217521357538	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1128	Ever used hormone-replacement therapy (HRT)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.005640886988831536	0.02176418207427102	0.8082866976731645	12.574594056305841	4	0.013552769940178603	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18105	ieu-a-1128	Had menopause	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.048975126632308956	0.018425573624464273	0.03256159272443134	39.512929898900914	8	3.94725603401199e-6	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1128	Had menopause	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.048975126632308956	0.018425573624464273	0.03256159272443134	19.665232131181227	7	0.006340028254298026	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-a-316	ieu-a-1128	Had menopause	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.03198170665304515	0.025078255000428193	0.25825053644321727	27.494991503680907	6	1.1693305674574618e-4	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1128	Had menopause	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.03198170665304515	0.025078255000428193	0.25825053644321727	20.746772328489776	5	9.043136202473734e-4	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-b-1209	ieu-a-1128	Number of live births	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.007039170455132246	0.07576932466304764	0.9282653474177222	31.334901379039252	9	2.59306703768433e-4	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1128	Number of live births	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.007039170455132246	0.07576932466304764	0.9282653474177222	31.301131758184088	8	1.241771421503104e-4	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-a-317	ieu-a-1128	Number of live births	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.014349447453375162	0.061122120175559146	0.8532012111986015	1.459820352645551	2	0.4819522788719296	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1128	Number of live births	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.014349447453375162	0.061122120175559146	0.8532012111986015	1.3835645392121343	1	0.2394949086038138	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-26	ieu-a-1128	Average weekly red wine intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	-0.0019785494960582713	0.02005741782756997	0.9231953561536766	46.20696114969722	12	6.391216610712586e-6	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1128	Average weekly red wine intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	-0.0019785494960582713	0.02005741782756997	0.9231953561536766	46.16612220540624	11	3.021955050690699e-6	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-b-1707	ieu-a-1128	Average weekly spirits intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.2373088557496038	0.09019086147208213	0.2312182037456059	43.29924859818007	2	3.9599311187118433e-10	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1128	Average weekly spirits intake	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.2373088557496038	0.09019086147208213	0.2312182037456059	5.46491343048952	1	0.019402015210552553	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-d-20406	ieu-a-1128	Ever addicted to alcohol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.06209718651593129	1	0.8032114391314102	Ever addicted to alcohol (M/F) Neale lab/2018 [  6K]	Alcohol
ukb-b-223	ieu-a-1128	Current tobacco smoking	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	34	0.01026194349158942	0.008375187057187525	0.22941237180805996	32.01019506001022	33	0.516229917585273	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1128	Current tobacco smoking	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	34	0.01026194349158942	0.008375187057187525	0.22941237180805996	30.508885651125475	32	0.5420440840184838	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-17685	ieu-a-1128	Maternal smoking around birth	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.020159490731133562	0.025179562157723653	0.4367230598701922	29.074835263015096	15	0.015731376113848648	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1128	Maternal smoking around birth	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.020159490731133562	0.025179562157723653	0.4367230598701922	27.80189190217591	14	0.015114078228898483	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-4801	ieu-a-1128	Number of unsuccessful stop-smoking attempts	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.09090414725184612	0.10050523023607452	0.5319060690619076	10.518387833460569	2	0.0051994942552508585	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1128	Number of unsuccessful stop-smoking attempts	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.09090414725184612	0.10050523023607452	0.5319060690619076	5.785471499788906	1	0.016159162952393565	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-a-225	ieu-a-1128	Smoking status: Current	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	-0.012710441400319936	0.015073941985895215	0.41435901270585984	6.568433142278346	14	0.9500718098194773	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1128	Smoking status: Current	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	-0.012710441400319936	0.015073941985895215	0.41435901270585984	5.857436439917513	13	0.9511877738517254	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-d-22506_114	ieu-a-1128	Tobacco smoking: Never smoked	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.21656223733278096	0.13242989914200717	0.3494020948224867	2.8583456866639887	2	0.23950695010324322	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1128	Tobacco smoking: Never smoked	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.21656223733278096	0.13242989914200717	0.3494020948224867	0.1841489007986715	1	0.667831721110512	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
met-a-558	ieu-a-1128	1-arachidonoylglycerophosphocholine*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.007899257777654293	0.014232812409431868	0.6774397889614816	0.46216243434859305	2	0.7936750033764566	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1128	1-arachidonoylglycerophosphocholine*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.007899257777654293	0.014232812409431868	0.6774397889614816	0.15413377741005288	1	0.694615863962212	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-682	ieu-a-1128	1-arachidonoylglycerophosphoethanolamine*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.075453503919871	1	0.29971686925301144	1-arachidonoylglycerophosphoethanolamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1128	1-arachidonoylglycerophosphoinositol*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.16100143484674745	0.061706498670878636	0.23300186427863928	7.045560876510141	2	0.029517250074258504	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1128	1-arachidonoylglycerophosphoinositol*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.16100143484674745	0.061706498670878636	0.23300186427863928	0.23790359462178304	1	0.6257243661574542	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-427	ieu-a-1128	2-hydroxyisobutyrate	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.004529287659131654	1	0.9463428907353519	2-hydroxyisobutyrate (M/F) Shin/2014 [  6K]	Metabolites
met-a-500	ieu-a-1128	3-dehydrocarnitine*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.04227863478274366	0.04503783205018869	0.5201104702774785	2.1157121006480546	2	0.34719939096726293	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1128	3-dehydrocarnitine*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.04227863478274366	0.04503783205018869	0.5201104702774785	1.124645784558551	1	0.28892029108371237	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-841	ieu-a-1128	Albumin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.16763439532538998	0.10063972844781924	0.34420672017039433	5.81924153090546	2	0.05449639286575744	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1128	Albumin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.16763439532538998	0.10063972844781924	0.34420672017039433	1.5417182933039109	1	0.21436222176902991	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-851	ieu-a-1128	Average number of double bonds in a fatty acid chain	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.009591522616096568	0.015499093293377824	0.5798327459549053	4.625064551699146	4	0.32797452511977987	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1128	Average number of double bonds in a fatty acid chain	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.009591522616096568	0.015499093293377824	0.5798327459549053	4.101485297805755	3	0.2507120204175861	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-a-362	ieu-a-1128	Betaine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.030912055711236543	0.03602736470515859	0.548554201587339	4.525129734580638	2	0.10408318255356311	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1128	Betaine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.030912055711236543	0.03602736470515859	0.548554201587339	2.6063540826867846	1	0.10643621238703942	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-c-875	ieu-a-1128	Cholesterol esters in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.005555197004976696	0.011752116062104655	0.6456690659516949	11.504727377263464	12	0.4862286107185479	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1128	Cholesterol esters in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.005555197004976696	0.011752116062104655	0.6456690659516949	11.275684383144759	11	0.42046477890988015	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-887	ieu-a-1128	Cholesterol esters in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.010662113712083972	0.013421413863074686	0.4453998888647245	16.077822240377426	11	0.13826626031709102	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1128	Cholesterol esters in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.010662113712083972	0.013421413863074686	0.4453998888647245	15.123402126912154	10	0.12762718969399447	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-910	ieu-a-1128	Cholesterol esters in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.00535165214702124	0.011164798854680691	0.6403189610301664	12.510041869079028	13	0.4863281983875101	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1128	Cholesterol esters in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.00535165214702124	0.011164798854680691	0.6403189610301664	12.275016477424575	12	0.42385320094475226	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-958	ieu-a-1128	Concentration of chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.016191433316779743	0.022734574102889007	0.5081878350315596	6.430278258253919	6	0.3767531424115261	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1128	Concentration of chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.016191433316779743	0.022734574102889007	0.5081878350315596	5.83804303528375	5	0.3222984228399754	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-878	ieu-a-1128	Concentration of large HDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.01839571835621492	0.012841315977611486	0.1857931281796188	8.895848431756786	10	0.5420157173624343	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1128	Concentration of large HDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.01839571835621492	0.012841315977611486	0.1857931281796188	6.843673214780613	9	0.6533913291463795	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-890	ieu-a-1128	Concentration of large VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.0023386739799312263	0.011692795921149189	0.8464635669804037	8.059878815475718	9	0.5281233333976467	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1128	Concentration of large VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.0023386739799312263	0.011692795921149189	0.8464635669804037	8.019775998620922	8	0.4315407250429358	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-913	ieu-a-1128	Concentration of medium VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.004786731563689454	0.011420127086167254	0.6825128150861981	17.467597432316335	13	0.17880012395575878	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1128	Concentration of medium VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.004786731563689454	0.011420127086167254	0.6825128150861981	17.215553631377748	12	0.14166723336335169	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1128	Concentration of small HDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.007681387655655649	0.017040725938462033	0.6827444626370489	0.8911373287239975	4	0.9258288571931309	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1128	Concentration of small HDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.007681387655655649	0.017040725938462033	0.6827444626370489	0.6879469299852758	3	0.8760352247073018	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1128	Concentration of small VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.008476045547031595	0.011314489101180847	0.46711733627923135	14.524998206692516	14	0.4113746809257085	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1128	Concentration of small VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.008476045547031595	0.011314489101180847	0.46711733627923135	13.923914889657922	13	0.3792240431358347	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-950	ieu-a-1128	Concentration of very large VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.010102581147485384	0.01707579769637298	0.5756946180161006	5.51604812848836	7	0.5972488742308605	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1128	Concentration of very large VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.010102581147485384	0.01707579769637298	0.5756946180161006	5.166020203655183	6	0.5227031110103145	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-876	ieu-a-1128	Free cholesterol in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.01765131668030238	0.01141770253766931	0.14610368283606306	21.4953233192147	14	0.08959619409596874	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1128	Free cholesterol in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.01765131668030238	0.01141770253766931	0.14610368283606306	18.15720056395817	13	0.15164135487430117	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1128	Free cholesterol in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.008693810234121378	0.013124458429330741	0.5243050426018823	8.038049752185731	10	0.6251201616555163	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1128	Free cholesterol in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.008693810234121378	0.013124458429330741	0.5243050426018823	7.599258935913403	9	0.5749796513203299	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1128	Free cholesterol in medium HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	-0.0549796565594743	0.02732935811095513	0.13775096867356706	15.480838278492099	4	0.003801114391607648	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1128	Free cholesterol in medium HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	-0.0549796565594743	0.02732935811095513	0.13775096867356706	6.590290795785557	3	0.08616886777346233	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1128	Free cholesterol in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.003137748702420157	0.010102473330491713	0.762487722964812	10.665617831200082	11	0.4716868438515649	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1128	Free cholesterol in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.003137748702420157	0.010102473330491713	0.762487722964812	10.56371236979274	10	0.3925023885345028	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1128	Free cholesterol in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.008156763738992807	0.013329138514820352	0.5519895250538982	14.903801258642545	13	0.31339671276628833	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1128	Free cholesterol in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.008156763738992807	0.013329138514820352	0.5519895250538982	14.452775229118622	12	0.27273367037227775	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1128	Free cholesterol in very large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.010989578555623195	0.014544412916873162	0.4657686374607153	19.742359634770423	12	0.0721193225816717	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1128	Free cholesterol in very large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.010989578555623195	0.014544412916873162	0.4657686374607153	18.768265054201017	11	0.0653821876977249	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-573	ieu-a-1128	Isobutyrylcarnitine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.00225406400982986	0.01584170280719388	0.9100214343243969	0.034319304105911025	2	0.9829867362562063	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1128	Isobutyrylcarnitine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.00225406400982986	0.01584170280719388	0.9100214343243969	0.0140737920131711	1	0.9055661086432918	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1128	Isovalerylcarnitine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0736104704438351	0.1779376507511593	0.7502862501244398	3.382719292827787	2	0.1842688131615631	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1128	Isovalerylcarnitine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0736104704438351	0.1779376507511593	0.7502862501244398	2.8884065532067544	1	0.08921912704053672	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-c-896	ieu-a-1128	Mean diameter for LDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.01913775392735782	0.013087116464458507	0.19396818916811487	5.920304545973589	7	0.5490852845481528	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1128	Mean diameter for LDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.01913775392735782	0.013087116464458507	0.19396818916811487	3.7818796708141615	6	0.7061657367093597	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1128	Mean diameter for VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	-0.01117108352281178	0.01830546006731347	0.5530717549659429	15.926546002277304	13	0.2531191011135662	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1128	Mean diameter for VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	-0.01117108352281178	0.01830546006731347	0.5530717549659429	15.447147847287187	12	0.217888975722172	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-959	ieu-a-1128	Phospholipids in chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.004663416244302954	0.016586600389641635	0.7880351784130134	3.228199866258574	7	0.8631200380452663	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1128	Phospholipids in chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.004663416244302954	0.016586600389641635	0.7880351784130134	3.1491513724792153	6	0.7899074413781475	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1128	Phospholipids in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.0041796673690385425	0.013667020522026715	0.768635189985537	3.977638573018122	8	0.8591353268666483	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1128	Phospholipids in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.0041796673690385425	0.013667020522026715	0.768635189985537	3.884111843462529	7	0.7930245911579616	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1128	Phospholipids in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.002945776066238961	0.009200710049802246	0.7539284887314117	10.772655669503324	14	0.7037962336940958	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1128	Phospholipids in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.002945776066238961	0.009200710049802246	0.7539284887314117	10.670147903372014	13	0.6384285875304474	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1128	Phospholipids in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.00918495404562599	0.013362799400249988	0.5049287047755338	15.757319029952932	13	0.26248326139178124	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1128	Phospholipids in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.00918495404562599	0.013362799400249988	0.5049287047755338	15.160435614592451	12	0.23277974000981388	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1128	Phospholipids in very large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.021210663099055952	0.016430043609516293	0.23771169107065807	6.692023006326877	8	0.5701959233892282	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1128	Phospholipids in very large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.021210663099055952	0.016430043609516293	0.23771169107065807	5.025424226916986	7	0.6568604517043235	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-355	ieu-a-1128	Proline	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.022088041423923944	0.0142849060282625	0.3654643420936182	2.5000441381621274	2	0.28649847403237283	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1128	Proline	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.022088041423923944	0.0142849060282625	0.3654643420936182	0.10915388980478966	1	0.741109483891678	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1128	Pyroglutamine*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.009040726580270744	0.054150749836412486	0.8946846329123493	6.1766418483619985	2	0.045578419813624385	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1128	Pyroglutamine*	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.009040726580270744	0.054150749836412486	0.8946846329123493	6.00914358752243	1	0.014231933231878732	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-844	ieu-a-1128	Ratio of bisallylic groups to double bonds	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.006431694066016686	0.018027572243756756	0.7553893715074587	3.366220677921753	3	0.3385317932294308	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1128	Ratio of bisallylic groups to double bonds	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.006431694066016686	0.018027572243756756	0.7553893715074587	3.1648050194819066	2	0.2054808349988787	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1128	Ratio of bisallylic groups to total fatty acids	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	-4.795335984696518e-4	0.012776505831482309	0.9718589187142851	5.613801802728537	5	0.3456283899304833	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1128	Ratio of bisallylic groups to total fatty acids	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	-4.795335984696518e-4	0.012776505831482309	0.9718589187142851	5.611825479145933	4	0.23007339827536316	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-a-464	ieu-a-1128	Serine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.19686833645706497	0.08128543603016385	0.24928174900172775	6.091472398687961	2	0.04756128450905458	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1128	Serine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.19686833645706497	0.08128543603016385	0.24928174900172775	0.2256857379902013	1	0.6347414066213121	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-c-864	ieu-a-1128	Total cholesterol in HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.031121049107574256	0.01689400809628476	0.09526491369376346	27.032719665144356	11	0.0045432213059944685	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1128	Total cholesterol in HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.031121049107574256	0.01689400809628476	0.09526491369376346	20.183518300338122	10	0.027563923582005503	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1128	Total cholesterol in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.017482439833534376	0.012612280926630522	0.19091974459554423	21.753897933510164	13	0.05929423349875938	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1128	Total cholesterol in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.017482439833534376	0.012612280926630522	0.19091974459554423	18.751480162718543	12	0.09470506982019236	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1128	Total cholesterol in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	10	0.012544345981329783	0.013877382889996634	0.39243260044422834	5.436246861085456	9	0.7947433615801968	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1128	Total cholesterol in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	10	0.012544345981329783	0.013877382889996634	0.39243260044422834	4.619136146813141	8	0.7973989649218511	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1128	Total cholesterol in medium HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	-0.03226976139904517	0.02849348051030255	0.3206972461364771	18.078690182773563	5	0.002849383653362268	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1128	Total cholesterol in medium HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	-0.03226976139904517	0.02849348051030255	0.3206972461364771	13.689165563042428	4	0.008356132492217132	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1128	Total cholesterol in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	15	0.002690580099563614	0.011688927259012534	0.821532860101185	16.182751038974693	14	0.30234176641563765	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1128	Total cholesterol in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	15	0.002690580099563614	0.011688927259012534	0.821532860101185	16.117063181701255	13	0.24286626585268695	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1128	Total cholesterol in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	16	0.012739020579297565	0.014114452988234879	0.3820303346092008	22.80230515650709	15	0.08842843397481594	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1128	Total cholesterol in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	16	0.012739020579297565	0.014114452988234879	0.3820303346092008	21.54849200035365	14	0.08838007256884582	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1128	Total cholesterol in very large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.020835391929502685	0.015064994210878176	0.19408286295057695	23.061758276454036	12	0.0272061861573078	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1128	Total cholesterol in very large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.020835391929502685	0.015064994210878176	0.19408286295057695	19.645599743431003	11	0.050444452605711704	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-957	ieu-a-1128	Total lipids in chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.006944789996554383	0.01602445647876955	0.6777752266374969	4.098754301455253	8	0.8481053334915283	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1128	Total lipids in chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.006944789996554383	0.01602445647876955	0.6777752266374969	3.9109300704522845	7	0.789977522690812	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-877	ieu-a-1128	Total lipids in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	0.018615727003135428	0.013025981193529797	0.18674526163283034	8.879038520172672	10	0.5436205418391575	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1128	Total lipids in large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	0.018615727003135428	0.013025981193529797	0.18674526163283034	6.836646479697504	9	0.6541222735071306	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-889	ieu-a-1128	Total lipids in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.0012571477995049149	0.01610749770928444	0.9399744965947507	2.499552562574795	8	0.9617518071838873	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1128	Total lipids in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.0012571477995049149	0.01610749770928444	0.9399744965947507	2.493461170940229	7	0.9275886399373792	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-912	ieu-a-1128	Total lipids in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.0039098214585441505	0.01259140741231108	0.7625446254577626	15.623953323750968	11	0.1556755310007747	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1128	Total lipids in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.0039098214585441505	0.01259140741231108	0.7625446254577626	15.474746446597067	10	0.1156881478862426	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1128	Total lipids in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.010679781703604684	0.012776956690279317	0.41956463698000257	15.670135897351415	13	0.2674020844420985	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1128	Total lipids in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.010679781703604684	0.012776956690279317	0.41956463698000257	14.807982483733724	12	0.25210572877017007	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1128	Total lipids in very large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.022383165619022958	0.012683440988220242	0.10531512581421232	16.752824026429774	12	0.15913417863821103	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1128	Total lipids in very large HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.022383165619022958	0.012683440988220242	0.10531512581421232	13.05628186993133	11	0.2896627816542516	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1128	Total lipids in very large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.013376341613710676	0.01736562401461143	0.47036727508727405	4.611937199591766	7	0.7071995904635378	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1128	Total lipids in very large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.013376341613710676	0.01736562401461143	0.47036727508727405	4.018610467935195	6	0.6741577813652406	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-960	ieu-a-1128	Triglycerides in chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.00801160427117073	0.016507254562980567	0.6422573279464778	5.789621047864171	8	0.6707839911997082	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1128	Triglycerides in chylomicrons and largest VLDL particles	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.00801160427117073	0.016507254562980567	0.6422573279464778	5.554067699863318	7	0.5926705471220163	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1128	Triglycerides in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.00919988813671167	0.015289055552511612	0.5663239631536027	2.8418527391853012	8	0.9438865554161809	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1128	Triglycerides in large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.00919988813671167	0.015289055552511612	0.5663239631536027	2.4797733732526206	7	0.9286124329574755	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1128	Triglycerides in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	13	0.015379592450627968	0.011402599283629536	0.20451973227967857	15.054582302789928	12	0.2384650610833769	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1128	Triglycerides in medium VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	13	0.015379592450627968	0.011402599283629536	0.20451973227967857	12.918148178624769	11	0.29870887423432013	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1128	Triglycerides in small HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	-4.6832483734852515e-4	0.013442837526302289	0.9729691666144586	4.802138364673979	10	0.9039972773314056	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1128	Triglycerides in small HDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	-4.6832483734852515e-4	0.013442837526302289	0.9729691666144586	4.800924661514214	9	0.8513053451623495	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1128	Triglycerides in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	14	0.003919703664681107	0.012695672856527241	0.7628111833857486	16.92693715856547	13	0.202665654883651	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1128	Triglycerides in small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	14	0.003919703664681107	0.012695672856527241	0.7628111833857486	16.793537119566174	12	0.1575301918116515	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1128	Triglycerides in very large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	9	0.019500322869596264	0.014943820556900052	0.23318114219865177	6.580021772961739	8	0.5825459019654712	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1128	Triglycerides in very large VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	9	0.019500322869596264	0.014943820556900052	0.23318114219865177	4.87723481074201	7	0.6749418707261647	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-956	ieu-a-1128	Triglycerides in very small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	19	0.01999946571726756	0.011027690192485366	0.08743681218739821	21.0138663439237	18	0.2787140511690687	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1128	Triglycerides in very small VLDL	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	19	0.01999946571726756	0.011027690192485366	0.08743681218739821	17.60733506182672	17	0.41400768701854757	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-a-316	ieu-a-1128	Uridine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02533345526630454	0.0356048405327909	0.6063055110611915	0.5088301466983626	2	0.7753698998633982	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1128	Uridine	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02533345526630454	0.0356048405327909	0.6063055110611915	0.002573467805566465	1	0.9595411821263421	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-485	ieu-a-1128	X-02269	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.0042978327008684055	1	0.9477298416126472	X-02269 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1128	X-03094	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.01873724507301179	0.023296651450263356	0.4800612570921132	2.6106707316669127	4	0.6249340186181556	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1128	X-03094	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.01873724507301179	0.023296651450263356	0.4800612570921132	1.963789620271658	3	0.5799562166636849	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1128	X-10510	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03772025771921568	0.034441692353785504	0.47109605297333396	7.194932769869001	2	0.027393038014534032	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1128	X-10510	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03772025771921568	0.034441692353785504	0.47109605297333396	3.271249241396637	1	0.07050391624701997	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1128	X-11315	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.04350353546808009	0.03669935412205591	0.4461200353967614	1.4219591915918248	2	0.4911628206878737	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1128	X-11315	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.04350353546808009	0.03669935412205591	0.4461200353967614	0.016778208979302652	1	0.8969377139042827	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1128	X-11440	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.012778532594909945	0.025224774393488168	0.7014870844419404	4.570357838864354	2	0.10175585437778811	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1128	X-11440	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.012778532594909945	0.025224774393488168	0.7014870844419404	3.6369957062435745	1	0.056508817267937377	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-517	ieu-a-1128	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.06515520608268595	1	0.7985260159519694	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate (M/F) Shin/2014 [  2K]	Metabolites
met-a-519	ieu-a-1128	X-11469	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.002073619829000131	1	0.9636792709614724	X-11469 (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1128	X-12510--2-aminooctanoic acid	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0037975425566817377	0.014331772901088705	0.8351020245582979	0.08181656994796407	2	0.9599171647384197	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1128	X-12510--2-aminooctanoic acid	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0037975425566817377	0.014331772901088705	0.8351020245582979	0.011605520698308542	1	0.9142107263484923	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
prot-a-54	ieu-a-1128	Advanced glycosylation end product-specific receptor, soluble	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.007952692023540918	0.019676956796816268	0.7131800745827881	2.7941052933739163	4	0.5928506729895829	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1128	Advanced glycosylation end product-specific receptor, soluble	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.007952692023540918	0.019676956796816268	0.7131800745827881	2.6307578037926853	3	0.45212280429570306	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1128	Alcohol dehydrogenase [NADP(+)]	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.02044382920031903	0.017931283051811617	0.4583777944495234	1.2999046117100146	2	0.5220706758817522	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1128	Alcohol dehydrogenase [NADP(+)]	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.02044382920031903	0.017931283051811617	0.4583777944495234	2.9119420302599846e-5	1	0.9956944432662956	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1411	ieu-a-1128	Alpha-L-iduronidase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	2.560128256095763	1	0.10958969237481586	Alpha-L-iduronidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1128	Angiopoietin-related protein 4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01629660885228285	0.04905713128459141	0.795818796822016	0.2206026766786196	2	0.8955642267948333	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1128	Angiopoietin-related protein 4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01629660885228285	0.04905713128459141	0.795818796822016	0.1102481412165204	1	0.7398618072654704	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1128	Beta-1,4-galactosyltransferase 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.02899204070402079	0.021045810309919716	0.262116692785653	3.928235082337344	4	0.4158052912141704	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1128	Beta-1,4-galactosyltransferase 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.02899204070402079	0.021045810309919716	0.262116692785653	2.0305407170372978	3	0.5660921233264506	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1128	Beta-1,4-glucuronyltransferase 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0010970217950713194	0.029833595819740287	0.9766011695429884	1.157723155105449	2	0.5605361303875398	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1128	Beta-1,4-glucuronyltransferase 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0010970217950713194	0.029833595819740287	0.9766011695429884	1.156159873560162	1	0.282263374890239	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1128	Beta-crystallin B2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.21789899774737184	0.16930696924028055	0.42052351400037374	17.749623150608027	2	1.3986798069307027e-4	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1128	Beta-crystallin B2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.21789899774737184	0.16930696924028055	0.42052351400037374	6.681876217095424	1	0.009739805295828387	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1128	C-C motif chemokine 14	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.028208099342894963	0.02094329657275885	0.4065810294195862	2.1109270258154975	2	0.3480310730195469	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1128	C-C motif chemokine 14	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.028208099342894963	0.02094329657275885	0.4065810294195862	0.2968423133167374	1	0.5858688122006602	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1128	C-C motif chemokine 17	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.020908165553688175	0.015377770173096765	0.24553975484457885	3.6144747449745918	5	0.6061412923786795	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1128	C-C motif chemokine 17	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.020908165553688175	0.015377770173096765	0.24553975484457885	1.765865465829315	4	0.7787211880629183	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1128	C-C motif chemokine 23	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.012241048961049423	0.05641491845478021	0.863973277766423	0.26948925396971263	2	0.8739390636470628	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1128	C-C motif chemokine 23	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.012241048961049423	0.05641491845478021	0.863973277766423	0.2224078569909633	1	0.6372113450206125	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1128	C-C motif chemokine 3-like 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02505861134985616	0.026727203751081265	0.5205054517496448	0.9071506510008064	2	0.6353524939640667	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1128	C-C motif chemokine 3-like 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02505861134985616	0.026727203751081265	0.5205054517496448	0.02811406314522895	1	0.8668409413310341	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1128	C-reactive protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.13193663291068716	0.11517665003415992	0.45688851198836405	2.4984073412308523	2	0.2867330399150154	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1128	C-reactive protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.13193663291068716	0.11517665003415992	0.45688851198836405	1.0805298948137634	1	0.29857904516306955	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1128	Cadherin-7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.00687871031938336	0.019622174944949132	0.759399769772093	0.3889795624123151	3	0.9425095320556529	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1128	Cadherin-7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.00687871031938336	0.019622174944949132	0.759399769772093	0.26608865408429394	2	0.8754262861908171	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-488	ieu-a-1128	Cadherin-related family member 3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.07465246276280915	1	0.7846794729036877	Cadherin-related family member 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1128	Calcium/calmodulin-dependent protein kinase type 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02778602331256941	0.07119412935904723	0.7631114278225644	0.1856586601635494	2	0.9113490268878013	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1128	Calcium/calmodulin-dependent protein kinase type 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02778602331256941	0.07119412935904723	0.7631114278225644	0.03333603185809398	1	0.8551263416291964	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1128	Calpastatin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.002544213777349165	0.011478879008641436	0.8451647542513292	1.5102269946663964	3	0.679911964837741	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1128	Calpastatin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.002544213777349165	0.011478879008641436	0.8451647542513292	1.46110135215358	2	0.4816436873927983	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-550	ieu-a-1128	Carbohydrate sulfotransferase 11	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.10373892825283859	1	0.7473880886691586	Carbohydrate sulfotransferase 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-643	ieu-a-1128	Carboxypeptidase A4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.052983453057273096	1	0.8179508547395791	Carboxypeptidase A4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1128	Cardiotrophin-1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.34988789328794145	0.32599173376983265	0.477501269439878	7.974787726640135	2	0.018547989782519012	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1128	Cardiotrophin-1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.34988789328794145	0.32599173376983265	0.477501269439878	3.705792115303016	1	0.054223928162804816	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-722	ieu-a-1128	Cathepsin F	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	3.085160560677526	1	0.07900946683874664	Cathepsin F (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1128	Cell growth regulator with EF hand domain protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.006316504831988034	0.028490112567415255	0.8451200175173513	4.0302027245835665	3	0.25822119619445866	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1128	Cell growth regulator with EF hand domain protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.006316504831988034	0.028490112567415255	0.8451200175173513	3.933526991500463	2	0.13990894011395033	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1128	Cerebral cavernous malformations 2 protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.039813927591133225	0.06915048043629811	0.6229296472391417	21.85927254007752	3	6.978022586443567e-5	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1128	Cerebral cavernous malformations 2 protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.039813927591133225	0.06915048043629811	0.6229296472391417	18.751276338465274	2	8.476412412623077e-5	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1128	Coiled-coil domain-containing protein 134	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.013681842712126139	0.05822210058924279	0.8530641786424996	0.14543864441504895	2	0.9298617849550614	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1128	Coiled-coil domain-containing protein 134	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.013681842712126139	0.05822210058924279	0.8530641786424996	0.09021647724426231	1	0.7639021298489765	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1128	Complement C1q tumor necrosis factor-related protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	0.01897469267369419	0.012633664360293709	0.2075298582624527	4.7262835454515475	5	0.4501894198366829	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1128	Complement C1q tumor necrosis factor-related protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	0.01897469267369419	0.012633664360293709	0.2075298582624527	2.4705342443469327	4	0.6499197511401538	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1128	Complement C1q tumor necrosis factor-related protein 5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.016736955739078224	0.03643054898207716	0.6910346727064084	0.529643413286605	3	0.9123322533105942	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1128	Complement C1q tumor necrosis factor-related protein 5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.016736955739078224	0.03643054898207716	0.6910346727064084	0.31857584644318626	2	0.8527507968626628	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1128	Complement component C8	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0034836991827547296	0.020166436391727192	0.8911003587127682	0.05138526927526673	2	0.9746346124957557	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1128	Complement component C8	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0034836991827547296	0.020166436391727192	0.8911003587127682	0.021543609714434322	1	0.8833077113777063	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1128	Complement factor B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0013190535256422135	0.018817570806028142	0.9504947757823872	4.417896098467518	3	0.21973172906103428	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1128	Complement factor B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0013190535256422135	0.018817570806028142	0.9504947757823872	4.407068863506665	2	0.1104122234344298	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1128	Complement factor H-related protein 5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-4.993845684525057e-4	0.018010944546620708	0.982353137657971	0.42262094545040296	2	0.8095226931442979	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1128	Complement factor H-related protein 5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-4.993845684525057e-4	0.018010944546620708	0.982353137657971	0.4218521739802313	1	0.516014289413013	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1128	Contactin-4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.047615186657288346	0.04843811628070716	0.5054540597357347	1.1267418339490085	2	0.5692868072234697	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1128	Contactin-4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.047615186657288346	0.04843811628070716	0.5054540597357347	0.1604317949756183	1	0.6887592845142116	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1128	Contactin-5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01647280051594856	0.055966998326929744	0.8177692238929136	0.7444141737115808	2	0.6892115011020586	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1128	Contactin-5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01647280051594856	0.055966998326929744	0.8177692238929136	0.6577836682685564	1	0.4173434838083933	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1128	Corneodesmosin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0683182745576607	0.030886414808482626	0.15748395104315338	7.908854940637466	3	0.047933439453798764	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1128	Corneodesmosin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0683182745576607	0.030886414808482626	0.15748395104315338	2.2948863962438115	2	0.317447382712925	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1128	CREB-binding protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.005325816234559239	0.020364907673822194	0.8181609008058431	0.8179609742430108	3	0.8451663574481952	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1128	CREB-binding protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.005325816234559239	0.020364907673822194	0.8181609008058431	0.7495686342047605	2	0.6874375313213178	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-735	ieu-a-1128	CUB and zona pellucida-like domain-containing protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.3052758312433388	1	0.5805936970784462	CUB and zona pellucida-like domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-706	ieu-a-1128	Cystatin-8	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.488609318918548	1	0.22243235727431696	Cystatin-8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1128	Delta-like protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.012908548657450341	0.0227486310748463	0.6714173910695991	0.3813531152208693	2	0.8263998376671844	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1128	Delta-like protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.012908548657450341	0.0227486310748463	0.6714173910695991	0.059361696935598444	1	0.8075076634193256	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1128	Desmocollin-3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.2620417038726065	0.33084647131930595	0.5735508185052205	0.656137044446064	2	0.7203136605209209	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1128	Desmocollin-3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.2620417038726065	0.33084647131930595	0.5735508185052205	0.028818948814564392	1	0.8651977477725268	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1128	Diamine acetyltransferase 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.04065608530515927	0.029102487666025287	0.3955098926658379	2.536595777883803	2	0.2813100354283502	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1128	Diamine acetyltransferase 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.04065608530515927	0.029102487666025287	0.3955098926658379	0.5849954149432071	1	0.44436091216020585	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1128	Dihydropteridine reductase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.025629885699360064	0.017904127757815184	0.2886092477655654	5.222345312964406	3	0.15622139916784478	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1128	Dihydropteridine reductase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.025629885699360064	0.017904127757815184	0.2886092477655654	2.579437496135233	2	0.27534821441776997	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1128	Discoidin, CUB and LCCL domain-containing protein 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.04525872842994362	0.10729619453428269	0.7458826860445422	0.9567781512461344	2	0.6197810083827324	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1128	Discoidin, CUB and LCCL domain-containing protein 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.04525872842994362	0.10729619453428269	0.7458826860445422	0.7788535268175895	1	0.37749200150738976	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1128	DnaJ homolog subfamily B member 11	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02146622129613817	0.03709239475708801	0.6660116342556303	3.5281244676600845	2	0.1713473949568761	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1128	DnaJ homolog subfamily B member 11	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02146622129613817	0.03709239475708801	0.6660116342556303	2.642947668831878	1	0.10401040182481562	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1128	DnaJ homolog subfamily B member 9	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.01783299880495636	0.03340402455359605	0.6468313946430173	0.7654355317859016	3	0.8577152547661004	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1128	DnaJ homolog subfamily B member 9	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.01783299880495636	0.03340402455359605	0.6468313946430173	0.4804313892957402	2	0.786458207944349	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1128	Dual specificity protein kinase CLK2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	3.0122240759804545e-4	0.022635045653107932	0.9915284985770174	0.03181085513702364	2	0.9842203957699657	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1128	Dual specificity protein kinase CLK2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	3.0122240759804545e-4	0.022635045653107932	0.9915284985770174	0.03163375789361022	1	0.8588338563320287	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1128	E3 ubiquitin-protein ligase RNF8	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.03624837267245977	0.03332803715580802	0.4732947889352254	1.5223230063463111	2	0.4671235463108191	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1128	E3 ubiquitin-protein ligase RNF8	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.03624837267245977	0.03332803715580802	0.4732947889352254	0.33939706780117557	1	0.5601774527019394	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1128	Endothelin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0162558764821833	0.022428143906410743	0.6007274519673904	0.641385428195006	2	0.725646197580932	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1128	Endothelin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0162558764821833	0.022428143906410743	0.6007274519673904	0.11605311707653782	1	0.7333552654159281	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1128	Eotaxin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.011006201244152828	0.024421702190047627	0.7304466360917026	1.089016913342868	2	0.5801268707607407	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1128	Eotaxin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.011006201244152828	0.024421702190047627	0.7304466360917026	0.8859107806001928	1	0.34658785856590657	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1128	Epididymal secretory protein E1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.008457070758254	0.02125230516157758	0.7588953186838086	2.517151745405986	2	0.28405827372324505	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1128	Epididymal secretory protein E1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.008457070758254	0.02125230516157758	0.7588953186838086	2.1730426909272476	1	0.1404481051092192	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1128	Epididymal-specific lipocalin-10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.004480963756626638	0.01932696980791532	0.8549620917784743	0.6838387342440246	2	0.71040548443858	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1128	Epididymal-specific lipocalin-10	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.004480963756626638	0.01932696980791532	0.8549620917784743	0.6300841724283069	1	0.4273244405844135	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1128	Epididymis-specific alpha-mannosidase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.017850040929173847	0.04934958047420193	0.7790515229999315	0.6723108363589669	2	0.7145120490242803	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1128	Epididymis-specific alpha-mannosidase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.017850040929173847	0.04934958047420193	0.7790515229999315	0.5414795828472881	1	0.4618201854218286	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1128	Estrogen sulfotransferase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.006701987652933311	0.018762947213715138	0.7815960397822574	0.1354193483859251	2	0.934531752880974	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1128	Estrogen sulfotransferase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.006701987652933311	0.018762947213715138	0.7815960397822574	0.007832728108777692	1	0.9294771375674764	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1128	Extracellular sulfatase Sulf-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01925333164182192	0.06422055575159177	0.814569577131203	0.6648727108699939	2	0.7171743116586092	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1128	Extracellular sulfatase Sulf-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01925333164182192	0.06422055575159177	0.814569577131203	0.5749925865840982	1	0.4482817879570866	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-71	ieu-a-1128	fatty acid binding protein 4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.051880813938135026	0.08082857158356241	0.6367235975669134	0.6793983605273844	2	0.7119844695315872	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1128	fatty acid binding protein 4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.051880813938135026	0.08082857158356241	0.6367235975669134	0.2674111312802479	1	0.6050737179659242	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1128	Ferritin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0010949935848264686	0.014579282519830108	0.9522755505968984	0.006850374510230359	2	0.996580672007152	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1128	Ferritin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0010949935848264686	0.014579282519830108	0.9522755505968984	0.001209442751521537	1	0.9722575262246286	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1128	Fibroblast growth factor 7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01903957385792171	0.03306683711324667	0.6674118585663029	0.6670686892537824	2	0.7163872941631234	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1128	Fibroblast growth factor 7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01903957385792171	0.03306683711324667	0.6674118585663029	0.3355338785104855	1	0.5624185666121931	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1117	ieu-a-1128	Filamin-A	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.08363706748207045	1	0.7724277663046246	Filamin-A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1128	Galanin peptides	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.022914220451227894	0.035821898120308664	0.6377126876000423	0.7334845509761565	2	0.692988222082867	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1128	Galanin peptides	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.022914220451227894	0.035821898120308664	0.6377126876000423	0.32430588206393923	1	0.5690313857692576	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1128	Gamma-interferon-inducible protein 16	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.018190840583259538	0.032528691583800805	0.6753890117940591	0.3367727013149102	2	0.8450272947583655	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1128	Gamma-interferon-inducible protein 16	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.018190840583259538	0.032528691583800805	0.6753890117940591	0.024040684098118624	1	0.8767814379261436	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1128	GDH/6PGL endoplasmic bifunctional protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.023462887612727197	0.021572750051555626	0.39037364586170487	5.103112857715365	3	0.16440056151251378	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1128	GDH/6PGL endoplasmic bifunctional protein	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.023462887612727197	0.021572750051555626	0.39037364586170487	3.2065700944489532	2	0.20123436659336613	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1128	Glycolipid transfer protein domain-containing protein 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.018337444803482674	0.036002277279233816	0.700093104314328	1.1505906591643764	2	0.5625387099501762	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1128	Glycolipid transfer protein domain-containing protein 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.018337444803482674	0.036002277279233816	0.700093104314328	0.8911621532904224	1	0.34516256962253494	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1128	Glycosaminoglycan xylosylkinase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.048866115944642005	0.030409467587084644	0.3543786104335691	3.034144316412659	2	0.2193531790984698	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1128	Glycosaminoglycan xylosylkinase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.048866115944642005	0.030409467587084644	0.3543786104335691	0.45189596303627383	1	0.5014359642245487	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1128	Granulins	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.026646842992336914	0.020967361234228387	0.33159327514083037	8.418688378352464	3	0.038106619544841756	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1128	Granulins	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.026646842992336914	0.020967361234228387	0.33159327514083037	4.657491598715031	2	0.09741785203408732	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-55	ieu-a-1128	growth differentiation factor 15	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0028371815106461	0.024780092202443246	0.927426627858946	1.1868082202032992	2	0.5524435017463727	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1128	growth differentiation factor 15	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0028371815106461	0.024780092202443246	0.927426627858946	1.1714517007855902	1	0.2791031557770265	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1128	Hemoglobin subunit zeta	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0042242992702797326	0.015613070601068377	0.831782573639108	0.09061917449761776	2	0.9557015630115414	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1128	Hemoglobin subunit zeta	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0042242992702797326	0.015613070601068377	0.831782573639108	0.017415528990802665	1	0.8950096746599172	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1313	ieu-a-1128	Heparin-binding EGF-like growth factor	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.26578148509303373	1	0.606175729859448	Heparin-binding EGF-like growth factor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1128	Hepatocyte nuclear factor 4-alpha	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.015323258007143787	0.02568336206426325	0.592783193904154	1.925601288246484	4	0.749440545059407	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1128	Hepatocyte nuclear factor 4-alpha	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.015323258007143787	0.02568336206426325	0.592783193904154	1.5696435161267352	3	0.6662923658917448	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1128	Histo-blood group ABO system transferase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.018925819624375888	0.01680962241200086	0.46234434490471005	1.2695999065558956	2	0.530041510779275	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1128	Histo-blood group ABO system transferase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.018925819624375888	0.01680962241200086	0.46234434490471005	0.0019670803918729815	1	0.9646239977563109	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1128	Histone-lysine N-methyltransferase SUV420H2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.005922714368888683	0.022291747670051442	0.8346754603403312	0.18292532797645114	2	0.9125953881881089	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1128	Histone-lysine N-methyltransferase SUV420H2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.005922714368888683	0.022291747670051442	0.8346754603403312	0.11233367678354621	1	0.7375027610597107	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1128	HLA class II histocompatibility antigen, DQ alpha 2 chain	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.011968351790020424	0.013579504146143506	0.47109301630573364	3.0995711562269137	3	0.3765265873956181	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1128	HLA class II histocompatibility antigen, DQ alpha 2 chain	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.011968351790020424	0.013579504146143506	0.47109301630573364	2.2324890701561184	2	0.3275074306757189	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1128	Immunoglobulin superfamily containing leucine-rich repeat protein 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.011355091791095593	0.042759119357152695	0.8154466272153806	8.076789720751256	3	0.044451067672459633	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1128	Immunoglobulin superfamily containing leucine-rich repeat protein 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.011355091791095593	0.042759119357152695	0.8154466272153806	7.801694687651705	2	0.02022476685182607	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1128	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02470374833179177	0.022878252352831776	0.47558788753169373	5.132950784937231	2	0.07680577913786676	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1128	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02470374833179177	0.022878252352831776	0.47558788753169373	2.3698378142649457	1	0.12369990240768015	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1128	Inducible T-cell costimulator	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0634411125212432	0.034913769227382645	0.3202829094277538	3.4941637315270806	2	0.17428177975110662	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1128	Inducible T-cell costimulator	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0634411125212432	0.034913769227382645	0.3202829094277538	0.19238392877208457	1	0.6609398567148136	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1128	Intercellular adhesion molecule 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0361414166847193	0.016749136108461918	0.27627307900906756	4.99975666594231	2	0.08209498626936537	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1128	Intercellular adhesion molecule 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0361414166847193	0.016749136108461918	0.27627307900906756	0.34362212642345036	1	0.5577458864181676	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-38	ieu-a-1128	interleukin 1 receptor like 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.003913776508087973	0.029108212372652528	0.9149128913658745	0.09494289062719707	2	0.9536377035694121	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1128	interleukin 1 receptor like 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.003913776508087973	0.029108212372652528	0.9149128913658745	0.07686444969856865	1	0.781592459585486	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1128	Interleukin-17 receptor A	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.006591037153715794	0.012222887232540322	0.6851644054653836	0.30246971053347427	2	0.8596457826100354	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1128	Interleukin-17 receptor A	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.006591037153715794	0.012222887232540322	0.6851644054653836	0.011692805625425979	1	0.9138899715666416	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1128	Interleukin-21	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0031349051268174757	0.0310261063639471	0.9358929482811928	0.016033503412868872	2	0.9920152967488407	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1128	Interleukin-21	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0031349051268174757	0.0310261063639471	0.9358929482811928	0.005824243741805977	1	0.9391671136266209	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1128	Interleukin-3 receptor subunit alpha	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.007118548422662591	0.023310357535224927	0.8113145127651034	2.51293889071318	2	0.2846572524701197	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1128	Interleukin-3 receptor subunit alpha	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.007118548422662591	0.023310357535224927	0.8113145127651034	2.2985785822589295	1	0.12949245309678256	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1540	ieu-a-1128	Interleukin-6 receptor subunit alpha	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.0069410467180132645	1	0.9336027078714154	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1541	ieu-a-1128	Interleukin-6 receptor subunit alpha	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.007305636264374009	1	0.9318853479918187	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1128	Interleukin-6 receptor subunit beta	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.004856237011345736	0.034667788250473903	0.9014313808748073	5.1518226232962725	3	0.16101158749415098	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1128	Interleukin-6 receptor subunit beta	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.004856237011345736	0.034667788250473903	0.9014313808748073	5.1017686858199776	2	0.07801264555679342	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1128	Kallikrein-12	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0014163261916727288	0.02081055281147245	0.9567395932905072	1.053539204373937	2	0.590509472379626	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1128	Kallikrein-12	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0014163261916727288	0.02081055281147245	0.9567395932905072	1.0486818132443296	1	0.3058108725213117	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1659	ieu-a-1128	Kallikrein-14	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.4181109311247246	1	0.23371458492328248	Kallikrein-14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1128	Kallikrein-7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.023303782731355333	0.012653429114299692	0.31667737313265937	4.25148698704454	2	0.1193442036305228	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1128	Kallikrein-7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.023303782731355333	0.012653429114299692	0.31667737313265937	0.8596390622822501	1	0.3538397171345364	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1128	Kelch-like protein 13	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.04744009300479833	0.06325563054993613	0.5903449691507012	0.5677820456087643	2	0.7528486835741927	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1128	Kelch-like protein 13	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.04744009300479833	0.06325563054993613	0.5903449691507012	0.0053206954405914785	1	0.9418513985970157	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1644	ieu-a-1128	Killer cell immunoglobulin-like receptor 2DL5A	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.2923196326959474	1	0.2556209115976618	Killer cell immunoglobulin-like receptor 2DL5A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1128	Kunitz-type protease inhibitor 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.034273225718548614	0.021945106569805032	0.36257098004353516	3.1227508532752197	2	0.20984724312735917	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1128	Kunitz-type protease inhibitor 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.034273225718548614	0.021945106569805032	0.36257098004353516	0.6836229532105037	1	0.40834195796043	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2666	ieu-a-1128	L-Selectin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.009304413232768727	1	0.9231557283906813	L-Selectin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1792	ieu-a-1128	Leucine-rich repeat neuronal protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.2534820149500312	1	0.6146338854622331	Leucine-rich repeat neuronal protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1128	Leukocyte immunoglobulin-like receptor subfamily B member 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.04755670713504487	0.12489327989608451	0.7683803328051418	1.5108013027376956	2	0.46982234205274465	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1128	Leukocyte immunoglobulin-like receptor subfamily B member 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.04755670713504487	0.12489327989608451	0.7683803328051418	1.3194858124665891	1	0.2506843521125551	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1746	ieu-a-1128	Leukocyte immunoglobulin-like receptor subfamily B member 4	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.35475809895255805	1	0.5514319652298333	Leukocyte immunoglobulin-like receptor subfamily B member 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1128	Low affinity immunoglobulin gamma Fc region receptor II-a	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.01657523160400944	0.02051655084247863	0.5039658605177808	4.282612799985311	3	0.23251983365853088	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1128	Low affinity immunoglobulin gamma Fc region receptor II-a	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.01657523160400944	0.02051655084247863	0.5039658605177808	3.2288764878586487	2	0.19900242987017047	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1128	Low-density lipoprotein receptor-related protein 1B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.029307607117877308	0.023197980105405813	0.4262536394347302	1.9891087884898329	2	0.3698882321511635	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1128	Low-density lipoprotein receptor-related protein 1B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.029307607117877308	0.023197980105405813	0.4262536394347302	0.3930077554652207	1	0.5307226198629738	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2356	ieu-a-1128	Lysosomal Pro-X carboxypeptidase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.010238883571637575	1	0.9194017236189994	Lysosomal Pro-X carboxypeptidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1128	MAGUK p55 subfamily member 6	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.007955294121464498	0.02307531099522297	0.7886465335293955	0.3087330425946688	2	0.8569578701331584	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1128	MAGUK p55 subfamily member 6	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.007955294121464498	0.02307531099522297	0.7886465335293955	0.18987807005138257	1	0.6630181181166762	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1128	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01624507724306934	0.030272119387557438	0.6864493154411894	0.989079263001846	2	0.6098515991458675	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1128	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01624507724306934	0.030272119387557438	0.6864493154411894	0.7011021945346892	1	0.40241358858622234	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1128	MAP kinase-activated protein kinase 5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.009561535310904664	0.016772647077787584	0.62613334342065885	2.584815980814017	3	0.46015772197230276	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1128	MAP kinase-activated protein kinase 5	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.009561535310904664	0.016772647077787584	0.62613334342065885	2.22352002653952	2	0.32897944305982213	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1128	Maspardin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.019029271924109286	0.015675521001930204	0.4386697116399892	1.538657968812641	2	0.46332386156203964	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1128	Maspardin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.019029271924109286	0.015675521001930204	0.4386697116399892	0.06498751663141197	1	0.7987798739732925	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1128	MHC class I polypeptide-related sequence B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0018795186324314682	0.016170147249784477	0.9180864530476984	0.5435779845479213	3	0.9092183554624838	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1128	MHC class I polypeptide-related sequence B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0018795186324314682	0.016170147249784477	0.9180864530476984	0.5300676743256241	2	0.7671799903424187	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1128	Multimerin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.03155542033777932	0.015275495354469192	0.1748421996038016	5.758518947992747	3	0.12396844353936728	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1128	Multimerin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.03155542033777932	0.015275495354469192	0.1748421996038016	1.491178086309381	2	0.47445474329378357	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1128	Myeloblastin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.04492033659768638	0.022737510052229258	0.29830389659857875	6.010202404454445	2	0.049533741149848716	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1128	Myeloblastin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.04492033659768638	0.022737510052229258	0.29830389659857875	1.225817721832012	1	0.2682219360828367	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1128	Myeloblastin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.024441672286689784	0.021876299820033737	0.4647760933979895	1.427565517897675	2	0.4897879390758584	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1128	Myeloblastin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.024441672286689784	0.021876299820033737	0.4647760933979895	0.17927951757519597	1	0.6719931441919885	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1128	Myeloperoxidase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0016893913907710632	0.014818839819142194	0.9196483971246943	1.449935744067068	3	0.6938723783619146	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1128	Myeloperoxidase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0016893913907710632	0.014818839819142194	0.9196483971246943	1.4369390724459856	2	0.4874977830116467	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1128	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.030537909844332804	0.034230946390264624	0.5362599760213325	5.174811592814473	2	0.07521490999967376	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1128	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.030537909844332804	0.034230946390264624	0.5362599760213325	2.8815106969630073	1	0.08960192367134788	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1128	NAD-dependent protein deacetylase sirtuin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.009396778005218782	0.02430312837559437	0.7651228937683299	0.48649143376508425	2	0.7840788286940836	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1128	NAD-dependent protein deacetylase sirtuin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.009396778005218782	0.02430312837559437	0.7651228937683299	0.33699405704988483	1	0.5615694694477783	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2025	ieu-a-1128	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.7225096417995448	1	0.3953219329993307	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1128	Neural cell adhesion molecule 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.010404896708145223	0.0617882719043973	0.8937922262033958	0.6299720144251182	2	0.7297990861210971	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1128	Neural cell adhesion molecule 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.010404896708145223	0.0617882719043973	0.8937922262033958	0.6016148077546548	1	0.4379625662217458	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1128	Neurensin-1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01002034258927279	0.06525734646543009	0.9030038713967314	0.22420376425930735	2	0.8939531750073164	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1128	Neurensin-1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01002034258927279	0.06525734646543009	0.9030038713967314	0.20062579921126458	1	0.654216192417145	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1128	Neuropeptide W	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.005610112017528238	0.02064493410873151	0.831082177456771	0.3860541147729964	2	0.8244596661134729	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1128	Neuropeptide W	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.005610112017528238	0.02064493410873151	0.831082177456771	0.3122099702385412	1	0.576327215033297	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1128	Neutrophil-activating peptide 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.14156852294702665	0.19319541089240325	0.597411308610345	12.213817970366112	2	0.0022274251871856154	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1128	Neutrophil-activating peptide 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.14156852294702665	0.19319541089240325	0.597411308610345	7.946751410607984	1	0.004817377338906414	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1128	PAX-interacting protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.003767327204284978	0.02609978865158637	0.9087385860448669	1.1400152909824053	2	0.5655211149962991	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1128	PAX-interacting protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.003767327204284978	0.02609978865158637	0.9087385860448669	1.1167478916559208	1	0.29061979616060835	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2341	ieu-a-1128	Peptidyl-prolyl cis-trans isomerase E	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.3569220540401157	1	0.550220637022297	Peptidyl-prolyl cis-trans isomerase E (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1128	PH and SEC7 domain-containing protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.009522194498189763	0.017703975320080247	0.6445193997493708	0.3620705350642145	3	0.9479614069886018	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1128	PH and SEC7 domain-containing protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.009522194498189763	0.017703975320080247	0.6445193997493708	0.07278114550399237	2	0.9642636048359603	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1128	Platelet-activating factor acetylhydrolase IB subunit beta	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.08675602527367127	0.11344664689781958	0.5843753408494019	1.9740577424090848	2	0.372682334920325	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1128	Platelet-activating factor acetylhydrolase IB subunit beta	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.08675602527367127	0.11344664689781958	0.5843753408494019	1.2456103710125812	1	0.26439253171887644	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1128	Plexin-B2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.011920968392383935	0.019727505833792028	0.6539578266166672	0.8886196797774099	2	0.6412667000401259	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1128	Plexin-B2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.011920968392383935	0.019727505833792028	0.6539578266166672	0.5234634519921894	1	0.46936799968082304	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1128	Potassium voltage-gated channel subfamily E member 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.009401069103336027	0.029675696909201334	0.8046903846953789	0.21923515554966305	2	0.8961767876947005	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1128	Potassium voltage-gated channel subfamily E member 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.009401069103336027	0.029675696909201334	0.8046903846953789	0.11887700797673051	1	0.7302556707652362	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1128	PR domain zinc finger protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.27108392599982767	0.15164700572868814	0.32470085591010095	3.200203684299084	2	0.20187595746625975	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1128	PR domain zinc finger protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.27108392599982767	0.15164700572868814	0.32470085591010095	0.0046960879724428466	1	0.9453653247816136	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1128	Pro-FMRFamide-related neuropeptide FF	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.09342282466966245	0.06770124287486182	0.3992214166352517	3.122694580538693	2	0.20985314754973494	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1128	Pro-FMRFamide-related neuropeptide FF	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.09342282466966245	0.06770124287486182	0.3992214166352517	1.075233765008369	1	0.29976624748073805	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1128	Probable carboxypeptidase X1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.015534754026442586	0.02095723275488714	0.5939105161787868	1.3910896569315707	2	0.4988026120780219	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1128	Probable carboxypeptidase X1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.015534754026442586	0.02095723275488714	0.5939105161787868	0.8416235753146171	1	0.3589328399834966	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1128	Prostaglandin F2 receptor negative regulator	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.0022423627814595706	0.017484399842152828	0.9187972017866619	0.537120097187896	2	0.7644795155115226	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1128	Prostaglandin F2 receptor negative regulator	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.0022423627814595706	0.017484399842152828	0.9187972017866619	0.5206722033700086	1	0.47055507996505197	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1128	Protein eva-1 homolog C	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.01613557275937025	0.09355393357396073	0.8912696862094567	4.206128333261915	2	0.12208177564393238	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1128	Protein eva-1 homolog C	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.01613557275937025	0.09355393357396073	0.8912696862094567	4.084622645598545	1	0.0432751133150371	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1128	Protein FAM3B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.05346407869689897	0.02032690499285823	0.23129638481872575	6.930250390887378	2	0.03126909043361696	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1128	Protein FAM3B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.05346407869689897	0.02032690499285823	0.23129638481872575	0.012232829064853146	1	0.911931865868959	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2030	ieu-a-1128	Protein kinase C-binding protein NELL1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.3005190555451143	1	0.5835572024338475	Protein kinase C-binding protein NELL1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2329	ieu-a-1128	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.22412106002841653	1	0.6359176593280593	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1128	Protein S100-A13	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Wald ratio	1	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1128	Protein S100-A13	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1128	Protein shisa-3 homolog	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.02210240915612932	0.012844886593052175	0.3351461258927957	3.238378062287584	2	0.19805925385891748	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1128	Protein shisa-3 homolog	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.02210240915612932	0.012844886593052175	0.3351461258927957	0.2775125598856978	1	0.5983362271387092	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1128	Protein-tyrosine sulfotransferase 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.019325537484470467	0.03508440165577986	0.6370627487706589	1.1418610685342099	3	0.7669794578022132	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1128	Protein-tyrosine sulfotransferase 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.019325537484470467	0.03508440165577986	0.6370627487706589	0.8384474888940663	2	0.6575570540679624	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1128	Reticulon-4 receptor	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.0014659334487228985	0.023088509858955452	0.9596339818758662	0.3915676852812004	2	0.8221899378774641	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1128	Reticulon-4 receptor	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.0014659334487228985	0.023088509858955452	0.9596339818758662	0.38753646342275216	1	0.5335971918550784	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2493	ieu-a-1128	Retinoic acid receptor responder protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.45291068584051	1	0.5009559472974858	Retinoic acid receptor responder protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1128	Rho GTPase-activating protein 30	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	5	0.006022749166778345	0.02794918798418188	0.8432049112318944	3.859281436879867	4	0.42538487797667235	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1128	Rho GTPase-activating protein 30	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	5	0.006022749166778345	0.02794918798418188	0.8432049112318944	3.8004559391967883	3	0.28383310183736293	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2561	ieu-a-1128	RING finger protein 122	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.7141102174007212	1	0.3980826869384045	RING finger protein 122 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1128	rRNA methyltransferase 3, mitochondrial	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0030075485693775465	0.013335865088923917	0.8425207391961849	0.0815385922507106	3	0.9939568291677439	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1128	rRNA methyltransferase 3, mitochondrial	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0030075485693775465	0.013335865088923917	0.8425207391961849	0.030677824405445437	2	0.9847781297150007	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1128	Secretory phospholipase A2 receptor	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Wald ratio	1	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1128	Secretory phospholipase A2 receptor	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2820	ieu-a-1128	Serine protease inhibitor Kazal-type 6	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.2085053736842138	1	0.6479414073234847	Serine protease inhibitor Kazal-type 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1128	Serine/threonine-protein kinase 16	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-7.356470730273218e-4	0.023553287129522486	0.9779201002502265	0.05616200263809662	3	0.9965192151345047	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1128	Serine/threonine-protein kinase 16	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-7.356470730273218e-4	0.023553287129522486	0.9779201002502265	0.055186483104969056	2	0.9727839744366283	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2878	ieu-a-1128	Serine/threonine-protein kinase 17B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.08257843854804181	1	0.7738331301135019	Serine/threonine-protein kinase 17B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1128	Sialic acid-binding Ig-like lectin 7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01751726710798719	0.01770292384999732	0.5033557926549778	1.272500092213653	2	0.5292734583937004	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1128	Sialic acid-binding Ig-like lectin 7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01751726710798719	0.01770292384999732	0.5033557926549778	0.2933648058671145	1	0.5880723083563878	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1128	Solute carrier family 22 member 16	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.026083343776151208	0.018442761068681972	0.2928750423931102	3.1364908445485247	3	0.3710559484354662	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1128	Solute carrier family 22 member 16	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.026083343776151208	0.018442761068681972	0.2928750423931102	1.1362851886111127	2	0.5665768249929048	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1128	Stromal interaction molecule 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.022432652119148053	0.032060975499439565	0.6113334700634679	0.5652459040475096	2	0.7538039545396598	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1128	Stromal interaction molecule 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.022432652119148053	0.032060975499439565	0.6113334700634679	0.0756838160002381	1	0.7832340972483388	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1128	Syntaxin-7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.01462093782131019	0.017228064257455288	0.5519971019698011	1.462055054391948	2	0.48141406981246826	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1128	Syntaxin-7	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.01462093782131019	0.017228064257455288	0.5519971019698011	0.7418146275659603	1	0.38908020758337014	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1128	Tenascin-X	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.025724768390205786	0.08895557268829658	0.8207870458715206	3.064857935671645	2	0.21601034739566036	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1128	Tenascin-X	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.025724768390205786	0.08895557268829658	0.8207870458715206	2.828327856237443	1	0.09261474450306141	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1128	Thioredoxin domain-containing protein 12	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	0.003897532447571454	0.057338642549796356	0.9484409249999654	10.807617390907131	6	0.09450735944465907	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1128	Thioredoxin domain-containing protein 12	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	0.003897532447571454	0.057338642549796356	0.9484409249999654	10.79763939136794	5	0.055543145402508334	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1128	Thiosulfate sulfurtransferase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.021457627381341337	0.017603417030615336	0.4373864745235438	1.6449136608336705	2	0.43935091675896915	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1128	Thiosulfate sulfurtransferase	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.021457627381341337	0.017603417030615336	0.4373864745235438	0.15908256417954106	1	0.6900025857560406	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1128	Torsin-1A-interacting protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.002116622971051411	0.019733227715688882	0.9243716182897952	1.740187873901561	3	0.62803638023823	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1128	Torsin-1A-interacting protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.002116622971051411	0.019733227715688882	0.9243716182897952	1.7286827644376148	2	0.4213289560080522	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1128	Transmembrane glycoprotein NMB	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.007778720061745344	0.016970515959713394	0.7263872610821946	0.41834832970295033	2	0.8112539314181799	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1128	Transmembrane glycoprotein NMB	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.007778720061745344	0.016970515959713394	0.7263872610821946	0.208248262165636	1	0.6481438762923716	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3000	ieu-a-1128	Transmembrane protein 132C	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.004466318460442977	1	0.9467166259300555	Transmembrane protein 132C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1128	Trefoil factor 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.0049796033905143994	0.03775763163071599	0.9071472586362025	5.255934328252973	3	0.15398743838437762	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1128	Trefoil factor 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.0049796033905143994	0.03775763163071599	0.9071472586362025	5.210619598872551	2	0.07388024559339927	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1128	Trypsin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.005320803039482374	0.03991767248245536	0.9156394134893528	0.07536224531952648	2	0.9630199771840591	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1128	Trypsin-2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.005320803039482374	0.03991767248245536	0.9156394134893528	0.05759484266138253	1	0.8103385862605136	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1128	Trypsin-3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0016278139610948804	0.032398316186636404	0.9644946811549895	1.1566554878574797	3	0.7634177600422959	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1128	Trypsin-3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0016278139610948804	0.032398316186636404	0.9644946811549895	1.1541310501488922	2	0.5615437873251816	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2930	ieu-a-1128	Tubulin-specific chaperone A	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	1.267904877238058	1	0.2601600917481038	Tubulin-specific chaperone A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1128	Tumor necrosis factor receptor superfamily member 1B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.008867897740823241	0.01762637896237327	0.70325398995646	0.3022218000795408	2	0.8597523468025877	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1128	Tumor necrosis factor receptor superfamily member 1B	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.008867897740823241	0.01762637896237327	0.70325398995646	0.049108394784417767	1	0.824622059512311	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1128	Tyrosine-protein kinase receptor Tie-1, soluble	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.015144701189127653	0.011896973554349814	0.3309785020958592	1.8044245572315067	3	0.6139725761578526	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1128	Tyrosine-protein kinase receptor Tie-1, soluble	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.015144701189127653	0.011896973554349814	0.3309785020958592	0.18392683281583208	2	0.9121385182381887	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1128	Ubiquitin carboxyl-terminal hydrolase 25	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.014799513980737316	0.029223546666372113	0.7015693135776225	0.3226829225217355	2	0.8510014374660728	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1128	Ubiquitin carboxyl-terminal hydrolase 25	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.014799513980737316	0.029223546666372113	0.7015693135776225	0.06621735724408921	1	0.7969260926290543	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1128	Ubiquitin-like protein ISG15	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.006700051595073471	0.019370641376375758	0.7624235864375326	2.3322127629682234	3	0.5063779008373467	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1128	Ubiquitin-like protein ISG15	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.006700051595073471	0.019370641376375758	0.7624235864375326	2.2005767221634973	2	0.33277511047043845	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1128	Urea transporter 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.0026598149606146507	0.021140715138652046	0.9113854846858389	0.7449241923417136	3	0.862589839112048	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1128	Urea transporter 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.0026598149606146507	0.021140715138652046	0.9113854846858389	0.7290948270906783	2	0.6945109059874759	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3193	ieu-a-1128	Vascular cell adhesion protein 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	2	NA	NA	NA	0.6959752663455735	1	0.4041393767555889	Vascular cell adhesion protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1128	Vascular endothelial growth factor receptor 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	8.075869828217862e-4	0.0344344177001395	0.9834185747467764	9.177687458500882	3	0.027019382638190457	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1128	Vascular endothelial growth factor receptor 2	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	8.075869828217862e-4	0.0344344177001395	0.9834185747467764	9.175164111489243	2	0.010177437121996468	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1128	Vascular endothelial growth factor receptor 3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	-0.017218339769569928	0.023411267132863872	0.5386071154701952	5.364319598441398	3	0.1469828179682478	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1128	Vascular endothelial growth factor receptor 3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	-0.017218339769569928	0.023411267132863872	0.5386071154701952	4.222345036389157	2	0.12109589601821467	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1128	Xyloside xylosyltransferase 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	0.041827717139717974	0.048141065242322534	0.5446001871833013	0.7828950603284107	2	0.6760775232406957	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1128	Xyloside xylosyltransferase 1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	0.041827717139717974	0.048141065242322534	0.5446001871833013	0.027982010182651413	1	0.8671511234327381	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1128	Zinc fingers and homeoboxes protein 3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.011327262780757857	0.027276005737455027	0.7494190735147768	0.31602085512846945	2	0.8538408784414546	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1128	Zinc fingers and homeoboxes protein 3	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.011327262780757857	0.027276005737455027	0.7494190735147768	0.14356084575566727	1	0.7047664010467942	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
ieu-a-1	ieu-a-1128	Adiponectin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	11	-0.0014540876211766066	0.006582651250363213	0.8301026461531456	7.940258849786861	10	0.6346724365333591	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1128	Adiponectin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	11	-0.0014540876211766066	0.006582651250363213	0.8301026461531456	7.891463384780438	9	0.5451201144032082	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1128	Apoliprotein A	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	222	4.0534164415723844e-4	0.001805687671552234	0.822591797288421	351.31623962785636	221	5.472417859393501e-8	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1128	Apoliprotein A	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	222	4.0534164415723844e-4	0.001805687671552234	0.822591797288421	351.2357882912548	220	4.362552816162574e-8	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-780	ieu-a-1128	HDL cholesterol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	37	-0.0012911187812448045	0.0064506558871995434	0.8425193055831164	78.62908737203604	36	5.192903615711588e-5	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1128	HDL cholesterol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	37	-0.0012911187812448045	0.0064506558871995434	0.8425193055831164	78.53919082190076	35	3.4626933597715924e-5	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1128	HDL cholesterol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	245	-0.0011942293750414207	0.0017703683334735875	0.5005931232431013	427.6454871631696	244	3.333646527013451e-12	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1128	HDL cholesterol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	245	-0.0011942293750414207	0.0017703683334735875	0.5005931232431013	426.84618063558946	243	2.9795387851519587e-12	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-299	ieu-a-1128	HDL cholesterol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	78	-0.004987254351681866	0.0038726037405727763	0.2017128006221125	140.76589210702898	77	1.2680115853361998e-5	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1128	HDL cholesterol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	78	-0.004987254351681866	0.0038726037405727763	0.2017128006221125	137.75964051832585	76	1.8934050611837372e-5	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1128	IGF-1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	318	-0.0028265374223362494	0.0021144077254867627	0.1822499750807517	576.4037295578585	317	2.5647916238714895e-17	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1128	IGF-1	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	318	-0.0028265374223362494	0.0021144077254867627	0.1822499750807517	573.1624042603236	316	3.9697636989485026e-17	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-1049	ieu-a-1128	Iron	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	3	-0.008072695684222064	0.015796180540167716	0.699228114346399	0.333373019464642	2	0.8464649282648207	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1128	Iron	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	3	-0.008072695684222064	0.015796180540167716	0.699228114346399	0.07219718867329715	1	0.7881641338933879	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1128	Platelet count	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	394	-0.002109747694704059	0.0016594237513250926	0.20434958034439152	662.5523590726852	393	4.459005017594227e-16	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1128	Platelet count	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	394	-0.002109747694704059	0.0016594237513250926	0.20434958034439152	659.8315788136955	392	6.001333231762892e-16	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ieu-a-1047	ieu-a-1128	Putamen volume	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	4	0.028341475099444974	0.033131145476775266	0.4824357363145356	4.3515370158355315	3	0.22592131927122375	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1128	Putamen volume	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	4	0.028341475099444974	0.033131145476775266	0.4824357363145356	3.185878754508073	2	0.20332707751943624	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1128	Reticulocyte percentage	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	249	-0.0010358842300320526	0.0021439845367137032	0.6294112277055437	434.6052886979838	248	2.2806175785131393e-12	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1128	Reticulocyte percentage	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	249	-0.0010358842300320526	0.0021439845367137032	0.6294112277055437	434.1949268874398	247	1.870924509817517e-12	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ieu-a-302	ieu-a-1128	Triglycerides	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	53	0.002932681258997379	0.0036682479240075644	0.4277216417259826	86.49455279412462	52	0.0018836696550891797	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1128	Triglycerides	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	53	0.002932681258997379	0.0036682479240075644	0.4277216417259826	85.42396590391897	51	0.0017944523298818729	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-783	ieu-a-1128	Triglycerides	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	27	0.0031763809550510546	0.005984310298916045	0.6002519404961657	40.05061540332799	26	0.03856819180951878	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1128	Triglycerides	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	27	0.0031763809550510546	0.005984310298916045	0.6002519404961657	39.60430262675758	25	0.03201126842876979	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ukb-a-11	ieu-a-1128	Morning/evening person (chronotype)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	77	0.0011608096453348813	0.006010969996111457	0.8473907674704678	116.58979131948057	76	0.00191205322877475	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1128	Morning/evening person (chronotype)	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	77	0.0011608096453348813	0.006010969996111457	0.8473907674704678	116.53184628046161	75	0.0015156591864215626	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-b-4424	ieu-a-1128	Sleep duration	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	66	0.008055462890309567	0.008323219944876538	0.33677250727387986	123.07885963466241	65	1.838063684217803e-5	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1128	Sleep duration	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	66	0.008055462890309567	0.008323219944876538	0.33677250727387986	121.30347874038661	64	2.0407050808534873e-5	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-a-14	ieu-a-1128	Snoring	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	20	0.017946944651889833	0.023428787419590126	0.453592729015176	48.50988383160177	19	2.164159609896418e-4	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1128	Snoring	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	20	0.017946944651889833	0.023428787419590126	0.453592729015176	46.9784180197869	18	2.1323823659755354e-4	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-b-15895	ieu-a-1128	Treatment/medication code: allopurinol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.0051859207280171345	0.007836486545969152	0.5230770705260894	17.793688180303114	11	0.08649289081734006	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1128	Treatment/medication code: allopurinol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.0051859207280171345	0.007836486545969152	0.5230770705260894	17.047135636287972	10	0.07332747343123633	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-a-142	ieu-a-1128	Treatment/medication code: allopurinol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	12	0.0072088210271903244	0.008984671805875475	0.4410034128454374	20.25730664769348	11	0.041934301370026926	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1128	Treatment/medication code: allopurinol	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	12	0.0072088210271903244	0.008984671805875475	0.4410034128454374	19.032096241861748	10	0.03985690012476413	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1128	Treatment/medication code: aspirin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	7	-0.0017284568130587598	0.021245022795923135	0.9383134070643713	7.333317383704988	6	0.2911188318358041	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1128	Treatment/medication code: aspirin	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	7	-0.0017284568130587598	0.021245022795923135	0.9383134070643713	7.323622143185384	5	0.19766304302427382	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1128	Treatment/medication code: insulin product	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	8	0.008944825185184743	0.023438236059182674	0.7158826428132901	26.67028388156831	7	3.820171853040915e-4	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1128	Treatment/medication code: insulin product	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	8	0.008944825185184743	0.023438236059182674	0.7158826428132901	26.038230039272673	6	2.1902088877926763e-4	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1128	Treatment/medication code: ramipril	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inverse variance weighted	6	-0.016323948530840234	0.020743792192655795	0.4753281374176189	6.924141514161418	5	0.22634341313251052	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1128	Treatment/medication code: ramipril	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MR Egger	6	-0.016323948530840234	0.020743792192655795	0.4753281374176189	5.995886064308689	4	0.19945571539485796	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
